tsawon lokacin da wadannan alamun ke faruwa?
kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman tare da shekarunka
da kuma tare da zazzabi
kuma kuma yana bukatar a duba yawan cholesterol naka da kuma karfin jini
kuma kana da zazzabi yanzu?
Shin kana da wannan ciwon kirji yanzu?
kuma banda haka kana da wahalar numfashi
kuma za ku iya gaya mani waɗanne alamun da kuke da su tare da wannan?
kuma yawan zazzabin da kake da shi
kuma ina da tari ma
kuma ina da ɗan sanyi da tari
kuma ina da ciwon kirji sosai yau
kuma wannan shine lokacin da ya dace don zazzabin hay
kuma yana samun ciwon kirji
kuma ina ganin ina da ɗan zazzabi
kuma ina son ka bayyana inda ciwon kirji yake
kuma suna da wasu zazzabi da
kuma da tarihin ciwon sukari
kuma ka san shi ji kamar kirji ne kamar yadda idan zai murkushe
kuma ka san mutane suna tari a kaina a koyaushe
kuma kana da ciwon kirji
kuma ka ce wannan matsin lamba ne a kirjinka
duk wanda ke cikin iyali yana da matsalar zuciya cututtukan zuciya bugun zuciya high cholesterol high jini
wani alamun ko matsaloli da ka lura da su tare da ciwon tsoka?
akwai wasu mutane marasa lafiya kamar ku a gida da alamun ku?
kuna da wasu alamun cutar?
kana da wani numfashi?
har yanzu kuna da ciwon kirji
saboda wannan shine lokacin mura
amma kuma bai kamata a bar mu a gefe ba saboda zuciya asalin zuciya ciwon kirji
amma wata matsala mafi muhimmanci yanzu ita ce wannan ciwon kirji
amma ina da wahalar numfashi
amma na san mutane da yawa suna tari a kaina
amma muna bukatar mu kula da duk wani ciwon kirji da matukar tsanani
amma kana numfashi daidai yanzu dama?
Saboda wannan ciwon kirji na manta gaba daya
kana jin kamar wani yana matsa maka kirji
har yanzu ina jin kamar naƙasasshe numfashi
suna gunaguni cewa suna rashin lafiya irin wannan alamun?
kuna da wani ciwo na kullum kamar hawan jini ko wani abu makamancin haka?
kuna da wasu cututtuka masu tsanani kamar ciwon sukari?
kana da wani numfashi tare da wannan ciwon kirji?
kana da hawan jini?
Shin kana da wani shortness na numfashi ya zo tare da cewa?
Shin kun san irin alamun da ta ke da su?
ka ga hoton?
sha ruwa mai yawa a yau
Duk da haka ina yin gwaje-gwaje don ciwon sukari
duk da haka tana da alamun da suka yi kama da nawa
Yaya yawan zafin jikinka?
Yaya karfin jini naka?
idan kana ci gaba da samun zazzabi mai yawa
idan kana da zazzabi na ɗari da biyu ko sama
idan ka ga cewa alamun cututtukanka ko matsalolin da kake da su sun sa ya kamata a duba su da kyau
Ina da zazzabi jiya
Ni ma ina da zazzabi kadan
Ina da zazzabi jiya
Ina da ciwo mai tsanani a cikin kirji
Ina da wahalar numfashi ma
Zan aiko maka da hoto
Ina da ciwon kirji yau
Ina da ciwon kai da zazzabi yau
a ganina cutar mura ce
A ganina wannan dan kadan ne a cikin mura
Shin kamar wani mutum mai nauyi ne mai nauyi yana zaune a kirjinka?
duk ya fara da ciwon kai da zazzabi a lokaci guda
yana ciwo a tsakiyar kirji na
yana da matsin lamba kamar ciwon kirji
Yana cikin kirji na
Yana tsakiyar kirji na
yana tsakiyar kirji
Ina da ciwo a kirji
Na damu sosai da wannan ciwon kirji
Ina so ka gaya mini a kwatanta wannan kirji zafi
kamar hawan jini ko ciwon sukari
kamar daidai a tsakiyar kirji
Yanzu don zazzabi zaka iya shan tachipirina mai dadi
Yanzu Mary kwana nawa ne da ka ke da alamun
kin ce kina da ciwon kirji yanzu
wani lokaci ina da ciwon kirji
lafiya kana da wasu alamun tare da wannan banda kawai ciwo
ko kuma wani yana zaune a kan kirjinka?
kusan iri daya ne da zazzabi da tari ciwon kai da ciwon tsoka
daidai a tsakiyar kirji na
nuna mani a wannan hoton inda kake jin zafi
tun da kana da zazzabi
to kana ganin wasu daga cikin wadannan alamun zasu iya danganta da kasancewa cikin ciki?
to yaranku suna da wasu daga cikin alamun iri daya?
Ka gaya mani game da ciwon kirjinka
zazzabi yana ƙaruwa da dare
zazzabin da nake da shi na kwanaki biyu da suka gabata
zazzabi ya fara tashi a daren jiya
Wannan shi ne Dr. Porter a cikin dakin gaggawa na cibiyar bincike
To za ka iya gaya min kadan game da ciwon kirjinka?
To ina jin ciwo a gaban jikina a cikin kirji
To ina fama da ciwo mai tsanani a kirji
To lokacin da nake da wannan ciwo a kirji na
wane irin ciwo kake da shi a kirjinka?
lokacin da wannan ciwon kirji ya fara?
ina ciwon kirjinka?
inda kake jin wannan ciwon kirji wannan kirji t
kana jin kamar ka matsa a kirjinka
ka san ina da ciwon sukari da sauransu
kin ce kina da wannan ciwon kirji
Saurin karuwar yawan kamuwa da cutar coronavirus (COVID-19) a Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila, daga 1 ga Janairu zuwa 15 ga Maris 2020
Yawan kamuwa da cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin ƙasashen Tarayyar Turai / Yankin Tattalin Arzikin Turai da Ingila yana tabbatar da cewa, yayin da yake a wani mataki daban-daban dangane da ƙasar, annobar COVID-19 tana ci gaba cikin sauri a duk ƙasashe.
Dangane da kwarewar Italiya, ƙasashe, asibitoci da sassan kulawa da hankali ya kamata su ƙara shirye-shiryen su don karuwar marasa lafiya da COVID-19 waɗanda za su buƙaci kula da lafiya, musamman kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an ba da rahoton tarin cututtukan ciwon huhu na rashin sani a Wuhan, Lardin Hubei, China.
A ranar 9 ga Janairun 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta China ta ba da rahoton cewa mai haifar da cutar shine sabon coronavirus wanda yanzu ake kira da cutar coronavirus mai tsanani mai tsanani 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Shaida har zuwa yau ita ce kusan kashi 80% na mutanen da ke da COVID-19 suna da cutar mai sauƙi, watau kamuwa da cutar numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan suna murmurewa.
A cikin kusan kashi 14% na lokuta, COVID-19 ya zama mummunan cuta wanda ke buƙatar asibiti yayin da sauran kashi 6% na lokuta ke fuskantar mummunan cuta wanda ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da aka kwantar a asibiti saboda COVID-19 kusan 4%.
A cikin wannan binciken, mun kimanta yanayin haɗuwa da cutar COVID-19 a kowace ƙasa ta Tarayyar Turai / Yankin Tattalin Arzikin Turai (EU / EEA) da United Kingdom (UK) kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin masu cutar COVID-19 a yanzu a cikin ƙasashen EU/EEA da Burtaniya da na Italiya a lokacin 31 ga Janairu15 ga Maris 2020.
Cutar COVID-19 a cikin ƙasashen EU/EEA da UK
Bayan China, COVID-19 ya kara yaduwa a yankuna kuma halin da annobar COVID-19 ke ciki a sauran duniya a halin yanzu yana bin wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon yanayin COVID-19 da aka tabbatar a Turai bisa ga ma'anar shari'ar WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon lokuta uku da aka tabbatar a ranar 24 ga Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, Lardin Hubei, China.
Ya zuwa ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashe 30 na EU/EEA da United Kingdom (UK), inda tsakanin 31 ga Disamba, 2019 da wannan ranar, an ba da rahoton shari'o'i 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun jimlar adadin da kuma yawan adadin masu kamuwa da cutar COVID-19
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta adadin masu cutar COVID-19 a kowace ƙasa a duniya, wanda aka samo daga tushen hukuma kawai kamar su ma'aikatar lafiya ta ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana da ƙarfe 8:00 na safe.
An yi amfani da waɗannan bayanan don kimanta yanayin COVID-19 a cikin EU/EEA da Burtaniya, da kuma kwatanta su da na Italiya.
A matsayin mai wakiltar yaduwar masu cutar COVID-19, mun lissafa yawan adadin masu cutar COVID-19 na kwanaki 14, don haka muna la'akari da yanayin COVID-19, a kowace EU / EEA da Burtaniya, a lokacin 1 ga Janairu  15 ga Maris 2020.
Mun kuma gabatar da jimlar adadin masu cutar da aka sanar a kowace ƙasa a ranar 15 ga Maris, 2020 da ƙarfe 8:00 na safe idan aka kwatanta da na Italiya don lokacin 31 ga Janairu zuwa 15 ga Maris, 2020.
Hanyoyin COVID-19 a cikin ƙasashen EU/EEA da UK
Hanyoyin da aka samu na kwanaki 14 na raguwar yawan masu kamuwa da cutar COVID-19 a cikin ƙasashen EU/EEA da UK gabaɗaya sun bi na lardin Hubei (China) (Hoto na 1).
Ga EU/EEA da UK gabaɗaya, yawan kamuwa da COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu sannan ya ƙaru sosai a kusan 28 ga Fabrairu 2020 (Sarin bayani).
Wannan galibi ya samo asali ne daga saurin karuwar adadin masu cutar daga Italiya, amma duk sauran ƙasashen EU / EEA da Burtaniya sun nuna irin wannan karuwar yanayin haɗuwa da cutar COVID-19 (Sarin bayani).
Hoto na 2 ya nuna yawan adadin masu kamuwa da COVID-19, a cikin ƙasashen EU/EEA da Burtaniya idan aka kwatanta da na Italiya na tsawon 31 ga Janairu zuwa 15 ga Maris 2020.
Ya jaddada cewa, a ranar 15 ga Maris da karfe 8:00 na safe, wasu ƙasashe 15 na EU/EEA da Burtaniya sun riga sun ba da rahoton jimlar adadin shari'o'in da za a iya kwatanta da na Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa yawan masu kamuwa da COVID-19 da aka sanar suna karuwa cikin sauri a EU/EEA da UK.
Hanyoyin da aka lura a cikin yawan kamuwa da COVID-19 ya nuna cewa annobar tana ci gaba da saurin daidaitawa a duk ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa, kuma wataƙila ma'anar shari'ar daban-daban a cikin ƙasashe da ladabi daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa na Italiya sun bayyana halin da kusan kashi 10% na marasa lafiya da ke da COVID-19 ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da sassan kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai kan shigar da masu cutar COVID-19 asibiti da/ko sashin kulawa mai tsanani a halin yanzu ana samun su a matakin EU/EEA don kashi 6% da 1% na masu cutar, bi da bi (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara su ta hanyar da ta dace don haɓaka bayanan sa ido na yanzu waɗanda ke mai da hankali kan yawan adadin da aka ruwaito da yawan mutuwar.
Wani bincike da aka gudanar a 201011 ya nuna bambancin da ke tsakanin wuraren kula da marasa lafiya a Turai, daga 29.2 a Jamus zuwa 4.2 a kowace 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da albarkatu fiye da Italiya (12.5 gadaje masu kulawa da kulawa da matsakaici ga kowane mazauna 100,000 a 201011).
Ana ba da yanayin samfurin da ya shafi ƙoshin lafiyar lafiya, tare da kimantawa ga kowace ƙasa ta EU / EEA da Burtaniya na yawan cututtukan COVID-19 da aka kwantar a asibiti da ke da alaƙa da haɗarin 90% na wucewa ƙarfin gadajen kulawa mai tsanani a cikin sabuntawa na shida na kimanta haɗarin ECDC mai sauri akan COVID-19.
Tun da har yanzu an tattara masu cutar a wasu yankuna a cikin EU/EEA da Birtaniya, kuma asibitoci da cibiyoyin kulawa da hankali suna ba da sabis ga yawan mutanen yankin da aka ƙayyade, ya kamata a ba da bayanai game da lokuta da gadaje masu kulawa da hankali a cikin Nomenclature of territorial units for statistics 2 (NUTS-2).
Kwarewar Italiya da abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba cikin sauri a cikin EU/EEA da Burtaniya.
Don haka, ƙasashe, asibitoci da sassan kulawa da hankali ya kamata su shirya kansu don yanayin ci gaba da watsawa na al'umma na SARS-CoV-2 da ƙaruwar yawan marasa lafiya da COVID-19 da ke buƙatar kula da lafiya, musamman kulawa mai tsanani, kamar wanda ke faruwa a yankunan da cutar ta shafa na Italiya.
Kamar yadda aka nuna a cikin sabon kimanta haɗarin ECDC, hanzari, mai saurin aiki da cikakkiyar hanya yana da mahimmanci don jinkirta yaduwar SARS-COV-2, tare da sauyawa daga hanyar hanawa zuwa hanyar ragewa, saboda saurin karuwar adadin shari'o'in da ake tsammani na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita amsar su daidai idan ba a aiwatar da su ba a gaba.
Har ila yau, kimantawar haɗarin cikin sauri ta lissafa matakan kiwon lafiyar jama'a don rage tasirin annobar.
Akwai ɗan gajeren lokaci na dama wanda ƙasashe ke da damar ƙara haɓaka ƙoƙarin sarrafa su don rage saurin yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan ba haka ba, da alama tsarin kiwon lafiya na sauran ƙasashen EU/EEA za su fuskanci karuwar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki masu zuwa ko makonni.
Cutar Coronavirus ta 2019 (COVID-19), wadda ta haifar da cutar coronavirus 2 (SARS-CoV-2), ta kashe mutane sama da 3,000 kuma ta kamu da sama da 80,000 a China da sauran wurare a duniya, wanda hakan ya haifar da bala'i ga mutane.
Kamar kwayar cutar ta homologous, SARS-CoV, wacce ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya yaduwa daga jemage kuma yana haifar da irin wannan alamun ta hanyar irin wannan tsari.
Koyaya, COVID-19 yana da ƙananan tsanani da mutuwa fiye da SARS amma yana da yawa fiye da yaduwa kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
Domin yawan littattafan da ake wallafawa game da wannan cuta, wannan talifin yana ƙoƙari ya ba da cikakken bayani game da wannan cuta da ake yi a yau.
Za mu tattauna abubuwa na asali game da cututtukan cututtuka, cututtukan cututtuka, cututtukan cututtuka, ganewar asali, magani, tsinkaya, da kuma rigakafin cutar.
Ko da yake har yanzu akwai tambayoyi da yawa da suke bukatar amsoshi, muna fatan wannan bita zai taimaka wajen fahimtar wannan cuta mai barazana da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairun 2020 ya zama abin tunawa da ba a taɓa mantawa da shi ba ga duk Sinawa waɗanda aka aririce su su zauna a gida duk lokacin hutu da kuma makonni da yawa bayan haka saboda barkewar sabon cutar kwayar cuta.
Kwayar cutar tana da kama da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar cututtukan numfashi mai tsanani (SARS) a cikin 2003; don haka, Hukumar Lafiya ta Duniya (WHO) ta kira ta SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma an kira cutar da ke tattare da ita Cutar CoV-19 (COVID-19).
Cutar ta fara ne a Wuhan, China, kuma ta bazu cikin sauri a duk faɗin ƙasar da kuma kusan wasu 50 a duk faɗin duniya.
Ya zuwa ranar 2 ga Maris, 2020, kwayar cutar ta haifar da sama da mutane 80,000 da aka tabbatar da cutar COVID-19, tare da sama da marasa lafiya 40,000 da aka sallama kuma sama da marasa lafiya 3,000 da suka mutu.
WHO ta yi gargadin cewa COVID-19 shine maƙiyi na jama'a mai lamba 1 kuma mai yuwuwa ya fi ta'addanci ƙarfi.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga takardu sama da 200 akan COVID-19 gami da ilimin ƙwayoyin cuta, ilimin annoba, ilimin ƙwayoyin cuta, ganewar asali, da magani tun daga rahoton farko a ranar 7 ga Janairu, 2020 wanda ya ƙayyade jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa.
Wannan bita yana ƙoƙarin taƙaita ci gaban bincike a cikin sabon yanki mai saurin ci gaba.
Duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da kuma wata cuta da CoV ke haifarwa, ciwon numfashi na Gabas ta Tsakiya (MERS, barkewar cutar a shekarar 2012).
Za mu kuma tattauna abin da muka koya har yanzu game da hana cutar da kuma yadda za a magance ta da kuma wasu tambayoyi da suke ci gaba da kasancewa da gaggawa.
CoVs an ɗauka a al'adance magungunan cuta ne marasa mutuwa ga mutane, galibi suna haifar da kusan kashi 15% na cututtukan sanyi 4.
Koyaya, a cikin wannan karni, mun haɗu da CoVs na ɗan adam masu cutarwa sau biyu, watau, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar da farko a China a 2003 da Saudi Arabiya a 2012, bi da bi, kuma ba da daɗewa ba suka bazu zuwa wasu ƙasashe da yawa tare da mummunan rashin lafiya da mutuwa.
Saboda haka, COVID-19 na yanzu shine barkewar CoV na uku a tarihin da aka rubuta na mutane.
Kamar yadda aka nuna a Fig. Fig.1,1, an fara bayar da rahoton tarin cututtukan huhu da ba a san asalin su ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Kiwon Lafiyar Kasa ta China.
Bayan kwana bakwai an saki jerin CoV.
A ranar 15 ga Janairun 2020, an ba da rahoton farkon yanayin mutuwa daga Wuhan.
A wannan lokacin, annobar ta bazu cikin sauri zuwa birane da larduna da kuma ƙasashe da ke kusa.
A ranar 20 ga Janairu, an ba da rahoton kamuwa da masu ba da kiwon lafiya, wanda ke nuna cewa yana yiwuwa mutum ya kamu da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an kulle birnin Wuhan tare da dakatar da duk hanyoyin sufuri na jama'a.
A ranar 24 ga Janairu, binciken asibiti na farko kan cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da ke da tabbacin shari'ar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan wanda aka ɗauka asalin cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin wannan rahoton, cutar ta riga ta bazu ko'ina cikin China da kusan wasu ƙasashe 50 a duk faɗin duniya (Fig. (Fig.2).2).
Kamar yadda halin da ake ciki ke ci gaba cikin sauri, har yanzu ba a tantance iyakar cutar da kuma tsananin cutar ba.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi da yawa akan marasa lafiya 8,866 ciki har da 4,021 da aka tabbatar da marasa lafiyar COVID-19 sun gabatar da ƙarin hoto na cutar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane a kowane zamani, amma galibi a cikin shekaru 30-65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun haura shekaru 50, kaɗan ne a ƙarƙashin 20, kuma mutane 14 kawai da suka kamu da cutar sun kasance ƙasa da shekaru 10.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya bazu a cikin rukuni-rukuni musamman a cikin da kewayen Hubei.
COVID-19 ya ɗauki matsakaita kwanaki 5 (2-9) daga farawa zuwa ganewar asali.
Matsakaicin lokacin incubation ya kasance kwanaki 4. 8 (3. 0-7. 2).
Matsakaicin lokacin daga farawa zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13).
Adadin yawan haifuwa (R0) ya kasance 3. 77 (95% CI: 3.51- 4. 05), kuma R0 da aka daidaita ya kasance 2. 23-4. 82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin da aka yi yawan sufuri kafin bikin bazara a China.
Mutuwar marasa lafiya tare da tabbatar da lokuta ya kasance 1. 44% (CI 95%: 1. 10-1. 86%), kuma daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (CI 95%: 2.02- 4. 59%).
Manyan abubuwan haɗari guda uku don COVID-19 sune jinsi (maza), shekaru (≥60), da mummunar cutar huhu.
CoVs ƙananan ƙwayoyin cuta ne masu girma da ke ɗauke da RNA guda ɗaya.
Ana iya raba su zuwa jinsuna huɗu, watau, alpha, beta, gamma, da delta, wanda aka san cewa alpha- da beta-CoVs suna kamuwa da mutane.
Glycoprotein envelope spike (S) yana ɗaurewa da masu karɓar kwayoyin halitta na angiotensin-converting enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan haɗuwa da membrane yana faruwa.
Ana sakin kwayar RNA ta kwayar cutar zuwa cikin cytoplasm; bayan sake fasalin kwayar cutar, RNA ta kwayar halitta tare da glycoproteins na envelope da sunadarai na nucleocapsid suna samar da vesicles masu dauke da virion, wanda daga baya ya haɗu da membrane plasma don sakin kwayar cutar.
An ba da rahoton jerin kwayoyin halittar farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV tare da fiye da 99.98% asalin kwayoyin halitta tsakanin samfuran 10 da aka tattara daga asalin wurin barkewar cutar, Kasuwar Abinci na Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan Ruwan
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar microscopy na lantarki na watsawa, an sami ƙwayoyin SARS-CoV-2 a cikin ƙananan sassan ƙwayoyin cuta na numfashi na mutum.
An gano cewa ACE2 na ɗan adam mai karɓar SARS-CoV-2 ne da kuma SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaurewa da ACE2 na ɗan adam da rauni fiye da na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta mai ƙarancin tsanani a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da sabon ƙaramin furotin da aka tsara ta hanyar orf3b da furotin da aka ɓoye wanda aka tsara ta hanyar orf8.
Orf3b na SARS-CoV-2 na iya taka rawa a cikin cutar kwayar cutar da hana bayyanar IFNβ; duk da haka, orf8 ba ta ƙunshi kowane yanki ko dalili na aiki da aka sani ba.
A ranar 18 ga Fabrairun 2020, Zhou, et al., sun ba da rahoton tsarin cryo-EM na cikakken ACE2 na ɗan adam a ƙudurin 2.9 Å a cikin hadaddun tare da mai jigilar amino acid B0AT1.
Sun gano cewa hadadden, wanda ke da bude da rufe tsari, an tara shi azaman dimer kuma hadadden ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da shaida don ganewar CoV da kamuwa da cuta.
B0AT1 na iya zama maƙasudin magani don tantance magunguna don hana kamuwa da cutar SARS-CoV-2.
Asalin da kuma mai watsa shiri na tsakiya
An san cewa duka SARS-CoV da MERS-CoV sun samo asali ne daga jemage kuma an watsa su ga mutane ta hanyar kuliyoyin civet da raƙuma, bi da bi.
Ta hanyar kwatancen ilimin halitta na SARS-CoV-2 tare da sauran CoVs, an ɗauki kwari a matsayin mai karɓar bakuncin SARS-CoV-2 saboda sabon kwayar cutar ta kasance daidai da kashi 96% ga CoVs iri ɗaya na SARS daga kwari da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, wane mai watsa shiri na tsakiya ya taimaka wa kwayar cutar ta ƙetare shingen jinsuna don kamuwa da mutane har yanzu ba a san shi ba, kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, et al., sun ba da shawarar macizai a matsayin mai ɗaukar kwayar cutar daga jemage zuwa mutane wanda ya ƙunshi sake haɗuwa cikin homologous a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun ba da shawarar cewa pangolins - masu dogon baki, masu shayar da tururuwa da ake amfani da su a cikin maganin gargajiya na kasar Sin - sune mai yiwuwar mai karɓar bakuncin SARS-CoV-2 bisa ga 99% na kwayoyin halitta a cikin CoV da aka gano a cikin pangolins da SARS-CoV-2.
Koyaya, bambancin 1% ya bazu cikin dukkanin kwayoyin halittar biyu har yanzu babban bambanci ne; saboda haka ana jiran sakamako mai gamsarwa don hujjoji masu mahimmanci (Fig. (Fig.33).
Har yanzu ba a san kaddarorin kimiyyar jiki na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin in vitro na tsawon awanni 48 a cikin bushewar yanayi kuma har zuwa kwanaki 5 a ƙarƙashin 20 °C da zafi 40%-50%.
SARS-CoV-2 na iya samun irin wannan kaddarorin.
An bayar da rahoton cewa SARS-CoV-2 yana da ƙarancin haske ga hasken ultraviolet da zafi a 56 °C na mintuna 30; ether, 75% ethanol, maganin kashe ƙwayoyin cuta mai ɗauke da chlorine, peracetic acid, chloroform, da sauran ƙwayoyin mai mai, amma ba chlorhexidine ba, na iya kashe kwayar cutar yadda ya kamata.
Gabaɗaya yawan jama'ar ɗan adam ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon ƙwayar cuta.
A halin yanzu ba a ba da rahoton cikakken bincike game da amsar rigakafi ga SARS-CoV-2 ba.
Don haka, zamu iya komawa ne kawai ga binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Gabaɗaya, bayan kwayar cutar ta mamaye mai masaukin, tsarin rigakafin mahalarta ya fara gane ta ta hanyar masu karɓar ƙirar (PRRs) gami da masu karɓar nau'in C-type lectin-like, mai karɓar Toll-like (TLR), mai karɓar NOD-like (NLR), da mai karɓar RIG-I-like (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan kumburi, balaga na ƙwayoyin dendritic, da kuma hadawar nau'ikan interferons na I (IFNs) waɗanda ke iyakance yaduwar kwayar cutar da hanzarta phagocytosis na macrophage na ƙwayoyin cuta.
Koyaya, furotin N na SARS-CoV na iya taimaka wa kwayar cutar ta tsere daga martani na rigakafi.
Ba da daɗewa ba, tsarin rigakafin jiki zai soma yaƙi da kwayar.
Kwayoyin T lymphocytes ciki har da CD4 + da CD8 + T sel suna taka muhimmiyar rawa a cikin tsaro.
Kwayoyin T na CD4 + suna motsa ƙwayoyin B don samar da ƙwayoyin cuta na musamman, kuma ƙwayoyin CD8 + T kai tsaye suna kashe ƙwayoyin cuta da ƙwayoyin cuta suka kamu da su.
Kwayoyin T masu taimakawa suna samar da cytokines masu taimakawa don taimakawa kwayoyin karewa.
Koyaya, CoV na iya hana ayyukan ƙwayoyin T ta hanyar haifar da apoptosis na ƙwayoyin T.
Tsarin rigakafin humoral wanda ya hada da kari kamar C3a da C5a da kuma kwayoyin rigakafi ma yana da mahimmanci wajen yakar kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka ware daga mai haƙuri da ya warke sun kawar da MERS-CoV.
A gefe guda kuma, yawan aiki na tsarin rigakafi yana haifar da yawan 'yanci a cikin gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin, kuma, a cikin mafi munin yanayin, gazawar gabobin da yawa har ma da mutuwa.
Cutar SARS-CoV-2, wacce ke nuna farawar rukuni, tana iya shafar tsofaffi da ke fama da cututtuka da mata masu ciki.
Yana da kyau cewa ga mutanen da ke fuskantar yawan ƙwayoyin cuta ko kuma waɗanda aikin rigakafi ya lalace, suna da damar kamuwa da cutar fiye da wasu.
Matsakaicin lokacin kamuwa da cutar SARS-CoV-2 ya kai kwanaki 1-14, galibi kwanaki 3-7 bisa binciken da aka yi kan mutane 425 da suka kamu da cutar a Wuhan.
Koyaya, bincike akan shari'o'i 1,099 ya nuna cewa lokacin incubation ya kasance kwanaki 3 a matsakaita kuma ya kasance daga 0 zuwa 24 days.
Wani binciken da aka yi kwanan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin kamuwa da cutar ya kasance kwanaki 4.8 (3.0-7.2) bisa ga yanayin yawan mutane 8,866.
Yana da matukar mahimmanci ga hukumomin kiwon lafiya su daidaita lokacin keɓewar da ya dace bisa ga lokacin ɓoyewa mafi daidai, don haka hana mutane masu kamuwa da cutar amma marasa alamun cutar daga watsa kwayar cutar ga wasu.
A matsayin al'ada, ana buƙatar mutane da suka kamu da cutar, ko kuma suka kamu da cutar, su keɓe kansu na kwanaki 14.
Shin ya kamata a kara wa'adin killacewa zuwa kwanaki 24?
Zazzabi ne sau da yawa babban kuma farkon alamun COVID-19, wanda zai iya kasancewa ba tare da wata alama ba ko wasu alamun kamar bushewa tari, numfashi, ciwon tsoka, maƙarƙashiya, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, zawo, tashin zuciya, da amai.
Wasu marasa lafiya sun sami dyspnea da / ko hypoxemia mako guda bayan farkon cutar.
A cikin mawuyacin hali, marasa lafiya da sauri sun ci gaba zuwa ciwon cututtukan numfashi, septic shock, acidosis na metabolism, da coagulopathy.
Marasa lafiya da zazzabi da / ko alamun numfashi da zazzabi mai tsanani, koda ba tare da ƙarancin hoto na huhu ba, ya kamata a bincika su don cutar don ganewar asali.
Wani binciken alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa kashi 98 cikin ɗari na alamun cutar sun kasance don zazzabi, kashi 76 cikin ɗari don tari mai bushe, kashi 55 cikin ɗari don dyspnea, da kashi 3 cikin ɗari don zawo; 8% na marasa lafiya suna buƙatar tallafin iska.
An bayar da rahoton irin wannan binciken a cikin binciken biyu na kwanan nan na ƙungiyar iyali da ƙungiyar da aka haifar ta hanyar watsawa daga mutum mara alamomi.
Hakanan, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiyar MERS-CoV suma suna da zazzabi (98%), tari mai bushe (47%), da dyspnea (55%) a matsayin manyan alamun su.
Koyaya, kashi 80% daga cikinsu suna buƙatar tallafin iska, fiye da marasa lafiyar COVID-19 kuma ya dace da mafi girman mutuwar MERS fiye da COVID-19.
An kuma lura da gudawa (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiyar SARS, an nuna cewa zazzabi (99%-100%), tari mai bushe (29%-75%), dyspnea (40%-42%), zawo (20-25%), da ciwon makogwaro (13-25%) sune manyan alamun kuma ana buƙatar tallafin iska don kusan 14%-20% na marasa lafiya.
Zuwa 14 ga Fabrairu, mutuwar COVID-19 ya kai 2% lokacin da aka tabbatar da shari'o'in sun kai 66,576 a duniya.
Idan aka kwatanta, mutuwar SARS a watan Nuwamba 2002 ya kasance 10% na mutane 8,096 da aka tabbatar.
Ga MERS, bisa ga binciken alƙaluma a watan Yunin 2012, mutuwar ta kasance 37% na 2,494 da aka tabbatar da shari'ar.
Wani binciken da aka yi a baya ya ba da rahoton cewa R0 na SARS-CoV-2 ya kai 6.47 tare da tazarar amincewa ta 95% (CI) na 5.71-7.23, yayin da R0 na SARS-CoV kawai ya kasance daga 2 zuwa 4.
Kwatanta SARS-CoV-2 tare da MERS-CoV da SARA-CoV dangane da alamun su, mutuwarsu, da R0 an gabatar da su a cikin Tebur Table1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma ba shi da kisa fiye da na biyun.
Don haka, yana da matukar wahala a sarrafa annobar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Sau da yawa yakan faru a cikin iyali ɗaya ko daga taro ɗaya ko abin hawa kamar jirgin ruwa.
Marasa lafiya galibi suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna masu fama da cutar ko hulɗa da mutane masu kamuwa da cutar ko marasa lafiya a cikin makonni biyu da suka gabata kafin farkon cutar.
Koyaya, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da alamomi ba fiye da makonni biyu kuma marasa lafiya da aka warkar da su daga asibitoci na iya ɗaukar kwayar cutar kuma, wanda ke aika ƙararrawa don ƙara lokacin keɓewa.
Marasa lafiya suna da al'ada ko rage yawan ƙwayoyin jini na fararen jini (musamman lymphocytes) a farkon mataki.
Misali, an gano cutar lymphopenia tare da adadin farin jini &lt; 4×109/L gami da yawan lymphocyte &lt; 1×109/L, da kuma ƙaruwa na aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 COVID-19.
An kara yawan hanta da ƙwayar tsoka da myoglobin a cikin jinin wasu marasa lafiya, kuma sun karu da furotin C- mai amsawa da kuma erythrocyte a cikin jini na yawancin marasa lafiya.
A cikin marasa lafiya da ke da mummunan yanayi, matakin D- dimer, samfurin lalacewar fibrin a cikin jini, ya karu, kuma yawan ƙwayoyin lymphocyte ya ragu a hankali.
Ana samun rashin daidaito a cikin radiography na kirji a cikin yawancin marasa lafiyar COVID-19 kuma ana nuna su ta inuwa mai ɓoyewa ta bangarorin biyu ko rashin haske na gilashin ƙasa a cikin huhu.
Marasa lafiya sukan kamu da ciwon huhu, da ciwon huhu, da kuma ciwon numfashi.
Sa'ad da cutar ta ARDS ta faru, ƙonewa da ba a sarrafawa, tarin ruwa, da kuma ci gaba da ciwon ƙwayoyin cuta suna ɓata tsarin gas sosai.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, mafi munin binciken radiography na kirji sau da yawa yana daidai da mafi tsananin cutar.
A ranar 18 ga Fabrairun 2020, bincike na farko na cutar COVID-19 ya nuna ɓarna na ƙwayoyin cuta, samuwar membrane na hyaline, da kutsewar ƙwayoyin cuta na ƙwayoyin cuta, da ƙwayoyin cuta masu yawa a cikin huhu na mai haƙuri wanda ya mutu daga cutar, wanda ya dace da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar juyawa-transcriptase polymerase chain reaction (RT-PCR) a matsayin babban ma'auni don ganewar asali na COVID-19.
Koyaya, saboda yawan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Haka ma ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen dakin gwaje-gwaje, da binciken radiological yana da mahimmanci kuma dole ne don yin ganewar asali mai tasiri.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da fasahar SHERLOCK mai tushe da CRISPR don gano SARS-CoV-2, wanda ke gano gutsuttsarin RNA na SARS-CoV-2 a cikin 20 × 10-18 mol / L zuwa 200 × 10-18 mol / L (kwafin 10-100 a kowane microliter na shigarwa) ta amfani da dipstick a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki masu ƙwarewa ba.
Da fatan, sabuwar hanyar zata iya haɓaka ƙwarewa da dacewa idan an tabbatar da su a cikin samfuran asibiti.
Saboda rashin gogewa game da sabon CoV, likitoci na iya ba da kulawa ta tallafi ga marasa lafiyar COVID-19, yayin ƙoƙarin magungunan daban-daban waɗanda aka yi amfani da su ko aka ba da shawarar a baya don maganin sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table2).2).
Wadannan magungunan sun hada da maganin yanzu da kuma na gaba da magungunan rigakafin cutar, masu hana rigakafi, steroids, plasma daga marasa lafiya da suka warke, maganin kasar Sin, da tallafin tunani.
Har ma an ba da shawarar yin amfani da jini daga marasa lafiya da suka warke don magani.
Kamfanonin magunguna suna tsere don samar da kwayoyin rigakafi da alluran rigakafi da cutar.
SARS-CoV-2 galibi yana kai hari ga huhu a farkon kuma mai yiwuwa kuma yana kai hari, a cikin ƙaramin mataki, wasu gabobin da ke bayyana ACE2, kamar tsarin hanji da kodan.
Duk da haka, rashin aiki na numfashi da rashin aiki sune babbar barazana ga marasa lafiya kuma babban dalilin mutuwa.
Don haka, tallafin numfashi yana da mahimmanci don sauƙaƙe alamun cututtuka da ceton rayuka kuma ya haɗa da maganin oxygen na gaba ɗaya, oxygen mai gudana mai yawa, iska mai iska, da iska mai iska mai ƙarfi dangane da tsananin cutar.
Masu fama da mummunan cututtukan numfashi dole ne a tallafa musu ta hanyar oxygenation na membrane na waje (ECMO), ingantacciyar hanyar hanyar zuciya da huhu da ake amfani da ita don maganin zuciya ko rashin ƙarfi na numfashi mai barazanar rai.
Bugu da kari, kiyaye daidaiton wutan lantarki, rigakafi da maganin kamuwa da cuta ta biyu da harin septic, da kare ayyukan gabobin rayuwa ma suna da mahimmanci ga marasa lafiya SARS-CoV-2.
An san cewa guguwar cytokine sakamakon mummunan tasirin tsarin garkuwar jiki ne a cikin marasa lafiya na SARS da MERS.
Cytokine guguwa wani nau'i ne na amsawar kumburi na tsarin da aka nuna ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna haifar da kwayoyin rigakafi don sakin adadi mai yawa na 'yanci wanda shine babban dalilin ARDS da gazawar gabobin da yawa.
Maganin rigakafi yana da mahimmanci a maganin guguwar cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tocilizumab, anti-IL6 monoclonal antibody, don magance guguwar cytokine.
Sauran maganin rigakafin rigakafin cutar cytokine sun haɗa da daidaitawar amsar rigakafin da aka tsara ta kwayar T; toshewar IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; mai hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da kwayoyin steroid, a matsayin masu hana rigakafi, a cikin maganin SARS don rage tsananin lalacewar kumburi.
Koyaya, steroids a manyan allurai ba su da fa'ida ga mummunan raunin huhu a cikin marasa lafiya SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman cutar ƙwayoyin cuta, wanda ke shafar cutar sosai.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na corticosteroids a ƙananan zuwa matsakaitan allurai don amfani da hankali ga marasa lafiya masu cutar COVID-19.
A lokacin rubuce-rubuce, ba a tabbatar da maganin rigakafin cutar ba.
Koyaya, gudanar da jijiyoyin jini tare da remdesivir, kwatankwacin nucleotide, an gano yana da tasiri a cikin wani mai haƙuri na Amurka tare da COVID-19.
Remdesivir wani sabon magani ne na rigakafin kwayar cuta wanda Gilead ta haɓaka da farko don maganin cututtukan da ƙwayoyin cuta na Ebola da Marlburg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta na RNA guda ɗaya ciki har da ƙwayoyin cuta na MERS da SARS.
Bisa ga waɗannan, Gilead ta samar da mahaɗin ga China don gudanar da gwaje-gwaje biyu akan mutanen da ke da cutar SARS-CoV-2, kuma ana sa ran sakamakon sosai.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ ritonavir, da ribavirin an ba da shawarar azaman hanyoyin magance marasa lafiya da ke da alamun cututtukan numfashi.
Za a iya samun gudawa, tashin zuciya, vomiting, lalacewar hanta, da sauran halayen da ba su dace ba bayan maganin haɗin lopinavir / ritonavir.
Dole ne a lura da hulɗar waɗannan magungunan tare da wasu magunguna da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da kwayoyin cutar
Tarin jini daga marasa lafiya da suka warke daga wata cuta mai yaduwa don kula da wasu marasa lafiya da ke fama da wannan cuta ko kuma don kāre lafiyayyu daga kamuwa da cutar yana da tarihi mai tsawo.
Hakika, marasa lafiya da suka warke sau da yawa suna da yawan ƙwayoyin cuta a cikin jinin su.
Kwayoyin rigakafi sune immunoglobulin (Ig) wanda kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwan waje kuma suna gane kwayoyin halitta na musamman a cikin ƙwayoyin cuta kuma suna kawar da su kai tsaye.
Bisa ga wannan, an tattara plasma daga jinin ƙungiyar marasa lafiya waɗanda suka warke daga COVID-19 kuma an yi musu allurar cikin marasa lafiya 10 masu fama da rashin lafiya.
Alamun su sun inganta cikin awanni 24, tare da rage kumburi da nauyin kwayar cuta da ingantaccen ƙoshin oxygen a cikin jini.
Koyaya, ana buƙatar tabbatarwa da bayyani don ba da shawarar hanyar don amfani da yawa kafin a haɓaka takamaiman magunguna.
Bugu da ƙari, saboda tasirin maganin, wasu rashin amfani da ke tattare da plasma ya kamata a yi la'akari da hankali.
Misali, kwayoyin cutar na iya kara karfin karfin garkuwar jiki da kuma haifar da cutar sakin cytokine, wanda zai iya zama mai barazanar rai.
Yawan ƙwayoyin cuta a cikin jini yawanci ƙasa ne, kuma ana bukatar jini sosai don kula da marasa lafiya masu tsanani.
Yana da wuya a samar da takamaiman ƙwayoyin cuta da sauri don yaƙi da annobar duniya.
Don haka, ya fi mahimmanci da amfani don ware ƙwayoyin B daga marasa lafiya da suka warke da kuma gano lambobin kwayoyin da ke ɓoye ƙwayoyin cuta masu tasiri ko allon don ƙwayoyin cuta masu tasiri da mahimman sunadarai na kwayar cutar.
Ta wannan hanyar, zamu iya ƙara yawan samar da kwayoyin cutar.
An yi amfani da TCM don magance cututtuka daban-daban a China tsawon dubban shekaru.
Koyaya, tasirinsa yafi dogaro da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali na cutar bisa ga ka'idodin TCM.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba su da tabbas saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwan ko kuma haɗin haɗin su.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na madadin marasa lafiya tare da alamun bayyanar cututtuka masu sauƙi zuwa matsakaici ko waɗanda suka warke daga matakai masu tsanani.
Misali, an gano cewa capsules na Shu Feng Jie Du da Lian Hua Qing Wen suna da tasiri wajen maganin COVID-19.
An lura da mafi girman adadin warkewa a cikin maganin marasa lafiyar COVID-19 a larduna da yawa a China waɗanda suka yi amfani da TCM a cikin kashi 87% na marasa lafiyarsu, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da TCM a kusan kashi 30% na marasa lafiyar COVID-19 kawai, yana da mafi ƙarancin adadin warkewa (13%).
Duk da haka, wannan kwatancen ne mai mahimmanci saboda yawancin sauran abubuwan tasiri kamar yawan marasa lafiya da kuma tsanani ya kamata a haɗa su a cikin kimantawa.
A ranar 18 ga Fabrairun 2020, Boli Zhang da abokan aikinsa sun buga wani bincike don kwatanta maganin maganin Yammacin Turai (WM) shi kaɗai tare da haɗin maganin WM da TCM.
Sun gano cewa lokutan da ake bukata don dawo da zafin jiki na jiki, bayyanar cututtuka, da kuma asibiti sun kasance da ɗan gajeren lokaci a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Mafi ban sha'awa, yawan ci gaban bayyanar cututtuka (daga haske zuwa mai tsanani) ya kasance ƙasa da ƙasa ga ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (7.4% vs. 46.2%) kuma mutuwar ta kasance ƙasa a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% vs. 39%).
Duk da haka, inganci da amincin TCM har yanzu suna jiran ƙarin gwaji mai kyau a cikin manyan sikelin da kuma cibiyoyi da yawa.
Hakanan zai zama mai ban sha'awa don bayyana tsarin aikin da kuma bayyana ingantattun abubuwan haɗin maganin TCM ko haɗuwa da su idan ya yiwu.
Marasa lafiya da ake zargi ko tabbatar da COVID-19 galibi suna fuskantar babban tsoro game da cutar mai saurin yaduwa har ma da kisa, kuma mutanen da ke keɓewa suna fuskantar gundura, kaɗaici, da fushi.
Ƙari ga haka, alamun kamuwa da cuta kamar zazzabi, rashin isashen iskar shaka, da tari da kuma sakamako marar kyau na magani kamar rashin barci da kwayoyin cutar suke jawowa na iya sa mutum ya ƙara damuwa da kuma baƙin ciki.
A farkon lokacin barkewar cutar SARS, an ba da rahoton wasu cututtukan ƙwaƙwalwa da suka haɗa da ci gaba da baƙin ciki, damuwa, harin firgici, tashin hankali na hankali, alamun cutar ƙwaƙwalwa, hauka, har ma da son kashe kansa.
Binciken tuntuɓar tilas da keɓewa, a matsayin ɓangare na amsoshin lafiyar jama'a ga ɓarkewar COVID-19, na iya sa mutane su ƙara damuwa da laifi game da tasirin kamuwa da cuta, keɓewa, da ƙyama ga danginsu da abokansu.
Don haka, ya kamata a ba da kulawar lafiyar kwakwalwa ga marasa lafiyar COVID-19, mutanen da ake zargi, da mutanen da ke hulɗa da su da kuma jama'a gaba ɗaya waɗanda ke cikin buƙata.
Tallafin ilimin halin mutum ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar ƙwaƙwalwa da yawa, sadarwa mai kyau tare da sabuntawa na yau da kullun da daidai game da barkewar SARS-CoV-2 da tsare-tsaren magani da amfani da na'urorin lantarki na ƙwararru da aikace-aikace don kauce wa kusanci da juna.
Alluran rigakafi masu inganci suna da mahimmanci don katse sarkar watsawa daga wuraren ajiyar dabbobi da mutane masu kamuwa da cuta zuwa masu karɓar cutar kuma galibi suna haɓaka maganin antiviral a cikin kula da annoba da sabbin ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari don haɓaka alluran rigakafin S-protein don samar da antibodies masu lalatawa na dogon lokaci da ƙarfi da / ko rigakafin kariya ga SARS-CoV.
An kimanta alluran rigakafin da aka rage su a cikin samfurin dabbobi don SARS.
Koyaya, ingancin in vivo na waɗannan alluran rigakafi a cikin tsofaffi da samfuran ƙalubalen kisa da kariyar su daga kamuwa da cutar kwayar cutar dabbobi har yanzu ba a ƙaddara su ba kafin a fara binciken asibiti.
Wannan mai yiwuwa saboda SARS ya mutu shekaru 17 da suka gabata kuma ba a samu wani sabon shari'a ba tun daga lokacin.
Akasin haka, lokuta da yawa da kuma tarin MERS suna ci gaba da faruwa a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna saboda ci gaba da tushen cututtukan dabbobi a yankunan da ke fama da cutar.
An kirkiro dabarun allurar rigakafi don MERS ta hanyar amfani da kwayar cutar da ba ta aiki, plasmids na DNA, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da ƙwayoyin cuta masu haɗuwa kuma an kimanta wasu a cikin samfuran dabbobi.
Ci gaban allurar rigakafi mai lafiya da tasiri kan SARS-CoV-2 ga mutanen da ba su da rigakafi aiki ne na gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Koyaya, yana da ƙalubale don shawo kan wahalar saboda tsawon lokaci (a matsakaita watanni 18) da ake buƙata don haɓaka allurar rigakafi da canjin canjin CoVs.
A matsayin sabon cuta, COVID-19 ya fara bayyana cikakkiyar hanyarsa ta asibiti a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya murmurewa a hankali ba tare da wata cuta ba.
Koyaya, kamar SARS da MERS, COVID-19 kuma yana da alaƙa da yawan rashin lafiya da mutuwa a cikin marasa lafiya tare da mawuyacin yanayi.
Don haka, gina samfurin tsinkaya don cutar yana da mahimmanci ga hukumomin kiwon lafiya don ba da fifiko ga ayyukansu, musamman a yankunan da ke da iyakance albarkatu.
Dangane da nazarin asibiti da aka ruwaito zuwa yanzu, abubuwan da ke gaba na iya shafar ko alaƙa da cutar COVID-19 (Table (Table33):
Shekaru: Shekaru sune muhimmin abin da ke haifar da cutar SARS, wanda kuma gaskiya ne ga COVID-19.
COVID-19 ya faru ne a cikin shekaru 30-65 tare da kashi 47.7% na waɗannan marasa lafiyar da ke sama da shekaru 50 a cikin binciken shari'o'i 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi saurin samun cututtuka da rikitarwa kuma sun fi tsufa sosai fiye da waɗanda ba su yi ba (a matsakaicin shekaru 66 da 51), yana ba da shawarar shekaru a matsayin babban abin da ke haifar da sakamakon marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka bayyana a sama.
Cutar da ke tattare da ita da kuma rikitarwa: Marasa lafiya da ke da COVID-19 waɗanda ke buƙatar kulawa mai tsanani suna iya shan wahala daga mummunan rauni na zuciya da arrhythmia.
Abubuwan da ke faruwa na zuciya sune babban dalilin mutuwar marasa lafiya na SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya ɗaure kansa ga cholangiocytes masu ACE2-positive, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiya COVID-19.
Yana da kyau a lura cewa shekaru da kuma ciwo suna da nasaba sosai kuma suna iya shafan juna.
Abubuwan da aka gano a cikin dakin gwaje-gwaje: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma an ba da shawarar cewa yana iya zama mai yiwuwa mai haifar da cutar, amsawa ga magani, da kuma dawowa.
Hakanan an ba da shawarar alaƙar matakin CRP zuwa tsananin cutar da cutar COVID-19.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna bayyana sosai a cikin gabobin da yawa, musamman a zuciya da hanta, kuma ana sakin su yayin lalacewar kyallen takarda.
Saboda haka, alamun da aka saba amfani da su wajen nuna ciwon zuciya ko kuma na hanta ne.
Manyan alamun asibiti: Radiography na kirji da ci gaban lokaci na alamun asibiti ya kamata a yi la'akari da su tare da sauran batutuwan don hango sakamakon da rikitarwa na COVID-19.
Amfani da kwayoyin steroid: Kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi da ake amfani dasu a matsayin magani mai mahimmanci don cututtukan cututtuka don rage tsananin lalacewar kumburi.
Tunda ana amfani da babban allurai na corticosteroids a cikin marasa lafiya masu tsanani na SARS, yawancin waɗanda suka tsira sun sha wahala daga cutar osteonecrosis ta hanyar rashin lafiya na tsawon rai da ƙarancin rayuwa.
Don haka, idan an buƙata, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya COVID-19.
Matsin lamba: Kamar yadda aka bayyana a sama, yayin barkewar COVID-19 marasa lafiya da yawa sun sha wahala daga damuwa ta musamman yayin da galibi suke jimre wa tsawan lokacin keɓewa da rashin tabbas sosai kuma suna ganin mutuwar dangin dangi da sauran marasa lafiya.
Yana da mahimmanci a ba da shawara ta hankali da tallafi na dogon lokaci don taimakawa waɗannan marasa lafiya su dawo daga damuwa da komawa rayuwar yau da kullun.
Dangane da nazarin alƙaluma har zuwa yanzu, COVID-19 kamar yana da halaye na annoba daban-daban daga SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi cikin inganci a cikin hanyoyin numfashi na sama kuma yana haifar da alamun rashin lafiya ko babu alamomi a farkon lokacin kamuwa da cuta, kwatankwacin sauran CoVs waɗanda ke haifar da sanyi na yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko lokacin kamuwa da cutar na iya samar da kwayar cuta mai yawa yayin ayyukan yau da kullun, wanda ke haifar da babbar matsala ga sarrafa annobar.
Koyaya, ana ɗaukar watsa SARS-CoV yana faruwa lokacin da marasa lafiya ke da mummunan rashin lafiya, yayin da yawancin watsawa ba ya faruwa a farkon matakin.
Don haka, barkewar cutar COVID-19 ta yanzu ta fi tsanani da wahalar sarrafawa fiye da barkewar SARS.
A halin yanzu ana yin manyan ƙoƙari a China ciki har da kulle Wuhan da biranen da ke kewaye da shi da kuma keɓewar kusan dukkanin jama'a a ci gaba da fatan katse yaduwar SARS-CoV-2.
Kodayake waɗannan ayyukan sun lalata tattalin arziki da sauran ɓangarorin ƙasar, yawan sabbin marasa lafiya yana raguwa, yana nuna raguwar annobar.
Mafi kyawun kimantawa shine cewa barkewar cutar za ta ƙare a watan Maris kuma lokacin raguwa zai ɗauki watanni 3-4.
Amma, wasu masana ba su da ra'ayin da ya dace.
Paul Hunter, et al., ya kiyasta cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare a cikin 2020 ba.
Ira Longini, et al., ya kafa wani tsari don hango sakamakon annobar kuma ya ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata kungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin duka tsakiya na turbinate da kuma swabs na makogwaro na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon ƙwayoyin cuta da aka gano na iya zama wani yanayi mai kama da mura.
Koyaya, alamun da ke ba da bege sun faru a China dangane da raguwar sabbin shari'o'in, wanda ke nuna dabarun yanzu na iya aiki.
An yi hasashen cewa cutar Ebola za ta kai mutum miliyan daya da kuma mutuwar mutane miliyan biyar.
Koyaya, ta hanyar keɓewa da keɓewa, cutar ta ƙarshe ta kasance ƙarƙashin iko.
Zai yiwu, kamar SARS-CoV, cewa SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cuta kuma daga ƙarshe ya mutu ko ya zama ƙarancin ƙwayar cuta mai cutarwa tare da mutane.
An ba da kwatancen annobar COVID-19 tare da na SARS da MERS a ƙasa (Fig. (Fig.55).
SARS-CoV-2 yana da saurin yaduwa ta hanyar tari ko hancin, kuma mai yiwuwa kuma ta hanyar tuntuɓar kai tsaye da kayan da cutar ta gurɓata.
An kuma gano kwayar cutar a cikin ƙazanta, wanda ke haifar da sabuwar damar yaduwar ƙazanta zuwa baki.
Wani binciken kwanan nan akan shari'o'i 138 ya ba da rahoton cewa 41% na shari'o'in wataƙila sun haifar da cututtukan cututtukan asibiti, gami da marasa lafiya 17 tare da wasu cututtukan da suka gabata da masu ba da kiwon lafiya 40.
Saboda haka, ya kamata a yi hattara sosai don kāre mutane, musamman ma masu kula da lafiya, ma'aikatan zamantakewa, iyalan, abokan aiki, har ma da waɗanda suke kusa da marasa lafiya ko kuma waɗanda suka kamu da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine ta hanyar sanya abin rufe fuska; duka amfani da abin rufe fuska na tiyata da abin rufe fuska na N95 (jerin # 1860s) yana taimakawa sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana ɗigon ruwa daga mutumin da ke da cutar daga tafiya cikin iska ko mannewa a saman kayan aiki, inda za su iya wucewa ga wasu.
Koyaya, kawai masks na N95 (jerin # 1860s) na iya karewa daga shan ƙananan virions kamar 10 zuwa 80 nm, tare da kashi 5% na virions kawai suna iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma duka suna da kusan 85 nm.
Tunda ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Baya ga abin rufe fuska, masu ba da kiwon lafiya ya kamata su sa rigunan keɓewa don ƙara rage hulɗa da ƙwayoyin cuta.
Kwayoyin cutar kuma za su iya kamuwa da mutum ta idanunsa.
A ranar 22 ga Janairun 2020, an kamu da likitan da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga jikinsa ta idanunsa masu kumburi.
Saboda haka, masu ba da kiwon lafiya su ma su sa rigar fuska ko tabarau yayin aiki da marasa lafiya.
Ga jama'a a cikin yankunan da cutar ta shafa ko kuma za a iya kamuwa da ita, ana ba da shawarar sosai cewa kowa ya wanke hannayensa da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda ya saba, yi ƙoƙarin kasancewa a cikin gida don keɓe kai da iyakance hulɗa da mutanen da ke da cutar.
An dauki kafa uku a matsayin tazara da ta dace da mutane su nisanta kansu da mai jinya.
Wadannan ayyuka hanyoyi ne masu tasiri don rage haɗarin kamuwa da cuta da kuma hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 ya zo a matsayin sabon kwayar cuta ga duniyar ɗan adam, babban kamannin sa da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 ya kamata ya haifar da faɗakarwa ga China bisa ga zurfin ƙwaƙwalwar ajiyarta game da barkewar SARS a 2003.
Koyaya, ba har zuwa 19 ga Janairun 2020 ne daraktan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan ƙasa ta hanyar cewa sabon kwayar cutar tana da ƙarancin kamuwa da cuta da iyakantaccen haifuwa daga mutum zuwa mutum kuma ba matsala ba ce don hanawa da hana cutar.
Wannan sakon ya sauƙaƙa damuwar jama'a sosai, musamman lokacin da duk ƙasar ke shirin bikin bazara, kuma an rasa lokacin mahimmanci don hana cutar a ƙaramar sikelin ta a Wuhan.
Hukumomin yaki da cututtuka a kasar Sin na iya koyon darasi daga wannan mummunan lamari kuma su yi gagarumin ci gaba a nan gaba.
Misali, wadannan hukumomin ya kamata (1) su kara taka tsantsan wajen yin sanarwar jama'a saboda kowace kalma tana da mahimmanci ga 'yan kasa kuma suna iya canza halinsu da yanke shawara; (2) su kara kulawa da kuma amsawa ga bayanai marasa kyau daga asibitoci maimakon jiran rahotanni na yau da kullun daga likitoci ko jami'ai; (3) kara takaitawa don dakile wata annobar da ke iya faruwa a farkon matakinta maimakon kokarin kwantar da hankalin jama'a; da (4) yawanci bayar da atisaye masu tasiri da tasiri don kara wayar da kan jama'a game da cututtukan annoba da kuma gwadawa da inganta tsarin amsawar al'umma a kai a kai.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya yadu a duk fadin kasar Sin da kusan wasu kasashe 50 a duniya a lokacin da ake rubuta wannan.
Tunda kwayar cutar tana kama da SARS-CoV kuma alamun cutar ma sun yi kama da COVID-19 da SARS, barkewar COVID-19 ya haifar da jin cewa SARS yana sake faruwa.
Koyaya, akwai wasu bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana annobar da kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa kuma maza fiye da mata, kuma tsananin cutar da mutuwar ma sun fi girma a cikin tsofaffi fiye da matasa.
SARS yana da yawan mutuwar fiye da COVID-19 (10.91% da 1.44%).
Marasa lafiya da COVID-19 suna watsa kwayar cutar koda kuwa basu da alamomi yayin da marasa lafiya na SARS ke yin hakan yawanci idan suna da ciwo mai tsanani, wanda ke haifar da matsala sosai wajen hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wani ɓangare dalilin da yasa SARS-CoV-2 ya bazu da sauri kuma ya fi SARS-CoV yawa.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke suna iya sake samun kwayar cutar.
Wadannan binciken sun kara yawan hadarin yaduwar kwayar cutar.
Ganin irin wannan ci gaba mai sauri a cikin bincike kan COVID-19, akwai wasu mahimman batutuwa da za a warware, kamar haka:
Daga ina ne SARS-CoV-2 ya fito?
Kodayake an sami daidaiton kwayoyin halitta 96% tsakanin SARS-CoV-2 da CoVs guda biyu masu kama da SARS, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 daga bats ba.
Wane dabba ne ya zama ɗan tsakiya da ya ɗauki kwayar cutar daga mai shi, kamar su jemage, zuwa mutane?
Ba tare da sanin amsoshin # 1 da 2, ba za mu iya dakatar da watsawar yadda ya kamata ba, kuma barkewar cutar na iya sake dawowa a kowane lokaci.
Kodayake samfurin kwayoyin halitta da nazarin halittu sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, ta yaya ainihin kwayar cutar ke shiga cikin ƙwayoyin hanyar numfashi kuma yana haifar da canje-canje na rashin lafiya na gaba?
Shin kwayar cutar tana ɗaure kwayoyin da ke bayyana ACE2 a wasu gabobin jiki?
Idan ba mu sami amsoshi masu kyau ba, ba za mu iya yin bincike da sauri ba kuma ba za mu iya yin magani mai kyau ba.
Har yaushe ne annobar za ta ci gaba?
Ta yaya kwayar cutar ke juyin halitta yayin watsawa tsakanin mutane?
Zai zama annoba a dukan duniya, ya mutu kamar SARS ko kuma ya sake dawowa a kai a kai kamar mura?
Yana da muhimmanci amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Koyaya, duk da duk abin da zai buƙaci, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu zuwa al'ada.
Asalin dabbobi na coronavirus na mutum
Juyin halitta da daidaitawa sun haifar da co-juyin halitta na coronaviruses (CoVs) da masu karɓar su, gami da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa CoVs guda biyu na mutum (HCoVs) suna haifar da rashin lafiya mai sauƙi, kamar sanyi.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake sanya CoVs cikin hasken haske kuma ya ba mu mamaki da yawan yaduwar sa amma rage cutar idan aka kwatanta da 'yar'uwarsa SARS-CoV.
Cutar HCoV cuta ce ta dabbobi kuma fahimtar asalin dabbobi na HCoVs zai taimaka mana sosai.
Yawancin HCoVs sun samo asali ne daga jemage inda ba su da cutar.
Hakanan an san masu karɓar bakunan ajiyar matsakaici na wasu HCoVs.
Gano dabbobi masu karɓar baƙi yana da tasiri kai tsaye kan rigakafin cututtukan ɗan adam.
Binciken hulɗar CoV-mai masauki a cikin dabbobi na iya samun mahimman bayanai game da cutar CoV a cikin mutane.
A cikin wannan bita, muna gabatar da bayyani game da ilimin da ake da shi game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da asalin su na dabbobi da watsawa tsakanin jinsuna.
Abu mai mahimmanci, muna kwatanta da bambancin HCoVs daban-daban daga mahangar juyin halittar kwayar cutar da sake haɗuwa da kwayoyin halitta.
An tattauna cutar CoV ta yanzu ta 2019 (COVID-19) a cikin wannan mahallin.
Bugu da kari, ana kuma jaddada bukatun don sauya mai masaukin da ya yi nasara da kuma tasirin juyin halittar kwayar cutar akan tsananin cutar.
Coronaviruses (CoVs) suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na murfin, mai jin daɗi, ƙwayoyin RNA guda ɗaya.
Wadannan ƙwayoyin cuta da ke ɗauke da mafi girman kwayoyin halitta na kilobases 26 zuwa 32 a tsakanin ƙwayoyin cuta na RNA an kira su CoVs saboda siffarsu kamar kambi a ƙarƙashin madubin lantarki.
A tsarin, CoVs suna da kwayoyin halittar da ba a rarraba su ba waɗanda ke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta sun ƙunshi manyan manyan manyan manyan manyan manyan manyan (ORF1a da ORF1b), waɗanda aka fassara zuwa pp1a da pp1ab replicase polyproteins.
Ana ci gaba da sarrafa polyproteins don samar da sunadarai 16 marasa tsari, wanda aka sanya nsp1 ~ 16.
Sauran ɓangaren kwayoyin halitta yana ƙunshe da ORFs don sunadarai masu tsari, ciki har da ƙwanƙwasa (S), murfi (E), membrane (M) da nucleoprotein (N).
Hakanan ana tsara wasu furotin masu amfani da layi daban-daban ta hanyar layi daban-daban na CoVs.
Dangane da bambanci a cikin jerin sunadarai, ana rarraba CoVs zuwa jinsi huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), daga cikinsu jinsunan beta-CoV suna ƙunshe da yawancin HCoVs kuma an raba su zuwa zuriya huɗu (A, B, C da D).
Shaidar Phylogenetic ta nuna cewa jemage da rodents suna aiki a matsayin tushen kwayoyin halitta na yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban ma'ajiyar gamma-CoVs da delta-CoVs.
A cikin dubban shekaru, CoVs koyaushe suna ƙetare shingen jinsuna kuma wasu sun fito a matsayin mahimman ƙwayoyin cuta na ɗan adam.
Zuwa yau, an san CoVs guda bakwai na mutum (HCoVs).
Daga cikin su HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoVs guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, coronavirus mai ciwon numfashi mai tsanani (SARS-CoV), coronavirus na ciwon numfashi na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya, kamar sanyi da / ko zawo.
Sabanin haka, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 da aka gano suna da cutar cuta sosai, suna haifar da mummunar kamuwa da cutar ƙananan hanyoyin numfashi a cikin marasa lafiya da yawa tare da mafi girman damar haɓaka cutar rashin lafiyar numfashi (ARDS) da bayyanar cututtuka.
An ware HCoV-229E na farko, B814, daga ɓoyayyen hanci na marasa lafiya da sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar zurfin karatu kan HCoV-229E da HCoV-OC43, dukansu suna haifar da alamun cutar kai tsaye.
A zahiri, ra'ayin da aka yarda da shi cewa kamuwa da cutar HCoVs gabaɗaya ba shi da lahani har zuwa barkewar SARS.
Cutar SARS da ta faru a 2003 tana daya daga cikin mafi muni a tarihin yanzu, ta kamu da mutane sama da 8,000 tare da mutuwar mutum kusan 10%.
Shekaru goma bayan haka, barkewar cutar cututtukan numfashi ta Gabas ta Tsakiya (MERS) ta haifar da barkewar annoba a cikin yankin Larabawa tare da yaduwar bazuwar zuwa sauran duniya.
Sabuwar HCoV ta 2019 (2019-nCoV), wacce daga baya aka sake masa suna SARS-CoV-2, ita ce sanadin yaduwar cutar coronavirus ta 2019 (COVID-19), wacce ta kashe mutane sama da 3,120 kuma ta kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi kararrawa kuma dole ne duniya ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin HCoVs bakwai suna da asalin dabbobi daga jemage, beraye ko dabbobin gida.
Hanyoyi da yawa na shaida suna tallafawa asalin juyin halitta na duk HCoVs daga bats, inda ƙwayoyin cuta suka dace da kyau kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin HCoVs na dabbobi yana ba da tsarin don fahimtar tarihin halitta, ƙarfin motsawa da abubuwan ƙuntatawa na tsalle-tsalle na jinsuna.
Wannan kuma na iya jagorantar ko sauƙaƙa binciken mai tanadin, matsakaici da haɓaka mai karɓar dabbobi na SARS-CoV-2, tare da mahimman tasiri wajen hana yaduwar gaba.
A cikin wannan bita mun gabatar da bayyani game da asalin zoonotic, watsawa tsakanin jinsuna da kuma cutar ta HCoVs.
Musamman, muna haskakawa da tattauna batun gama gari cewa ƙwayoyin cuta na iyaye na HCoVs yawanci ba su da cutar a cikin masu riƙe da su na halitta amma sun zama masu cutar bayan watsawa tsakanin nau'ikan zuwa sabon mai masaukin.
Mun kuma sake nazarin yanayin juyin HCoV wanda yawan karuwar yaduwar cutar sau da yawa yana zuwa tare da raguwar cutar.
Hakanan ana tattauna sakamakon barkewar cutar SARS-CoV-2 a wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin a fara ware HCoV-229E nau'in B814 daga ɓoyayyen hanci na marasa lafiya waɗanda suka kamu da sanyi, an ware CoVs daban-daban a cikin dabbobi daban-daban da ke fama da cutar, gami da turkey, linzamin kwamfuta, saniya, alade, cat da kare.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Takaitaccen tarihin gano HCoV a cikin tsari na lokaci (Table 1) zai zama mai ba da bayani da kuma koyarwa.
An ware nau'in HCoV-229E na farko daga hanyoyin numfashi na marasa lafiya da ke fama da kamuwa da cutar na sama a cikin shekara ta 1966, kuma daga baya an daidaita shi don girma a cikin layin ƙwayoyin WI-38.
Marasa lafiya da ke dauke da HCoV-229E sun nuna alamun sanyi na yau da kullun, gami da ciwon kai, hancin, rashin lafiya da ciwon makogwaro, tare da zazzabi da tari da aka gani a cikin kashi 10 ~ 20%.
Daga baya a cikin 1967, an ware HCoV-OC43 daga al'adun gabobin jiki da kuma wucewa ta jere a cikin kwakwalwar berayen shayarwa.
Abubuwan asibiti na kamuwa da cutar HCoV-OC43 suna kama da waɗanda HCoV-229E ke haifarwa, waɗanda alamun cututtuka ba za a iya rarrabe su da kamuwa da wasu cututtukan cututtukan numfashi kamar ƙwayoyin cuta na mura A da rhinoviruses ba.
Dukansu HCoV-229E da HCoV-OC43 suna rarraba a duniya, kuma galibi ana watsa su ne a lokacin hunturu a cikin yanayin zafi.
Gabaɗaya, lokacin ɓoye waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, sannan kuma kusan makonni 2 na rashin lafiya.
Dangane da binciken da aka yi kan masu sa kai, mutane masu lafiya da ke dauke da cutar HCoV-229E sun kamu da cutar sanyi mai sauƙi.
Kawai wasu marasa lafiya marasa lafiya sun nuna mummunan kamuwa da ƙananan cututtukan numfashi.
SARS, wanda kuma aka sani da atypical pneumonia, shine farkon annobar da HCoV ta haifar a tarihin ɗan adam kuma mai haifar da cutar shine SARS-CoV, HCoV na uku da aka gano.
Ana iya gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na China.
Cutar ta SARS ta haifar da rahotanni 8,096 da suka shafi mutuwar 774, wanda ya bazu a ƙasashe da nahiyoyi da yawa.
Baya ga masu yaduwar cutar, an kiyasta cewa kowace shari'a na iya haifar da kusan shari'o'i biyu na biyu, tare da lokacin kwantar da hankali na kwanaki 4 zuwa 7 kuma mafi girman nauyin kwayar cutar yana bayyana a rana ta 10 na cutar.
Marasa lafiya da ke dauke da SARS-CoV da farko suna da ciwon jijiyoyin jiki, ciwon kai, zazzabi, rashin lafiya da sanyi, sannan kuma rashin numfashi, tari da wahalar numfashi a matsayin alamun bayyanar cututtuka.
Lymphopenia, gwajin aikin hanta da haɓaka creatine kinase sune abubuwan da suka faru na dakin gwaje-gwaje na SARS.
Hakanan ana lura da lalacewar alveolar mai yaduwa, yaduwar ƙwayoyin epithelial da ƙaruwar macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa mai tsanani da iska mai iska.
Baya ga ƙananan hanyoyin numfashi, gabobin da yawa ciki har da na hanji, hanta da koda suma suna iya kamuwa da cutar a cikin waɗannan mawuyacin yanayi, yawanci tare da guguwar cytokine, wanda zai iya zama mai kisa musamman a cikin marasa lafiya marasa lafiya.
An fara ware kwayar cutar daga kwayar cutar huhu ta wani dangin mai cutar wanda ya yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an sadaukar da ƙoƙari sosai don binciken HCoV.
An ware HCoV-NL63 daga yaro ɗan wata 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cewa ya zama ruwan dare a cikin yara ƙanana, tsofaffi da marasa lafiya masu fama da cututtukan numfashi.
Bayyanawar coryza, conjunctivitis, zazzabi, da bronchiolitis na kowa ne a cikin cutar da HCoV-NL63 ke haifarwa.
Wani binciken mai zaman kansa ya bayyana ware kwayar cutar iri ɗaya daga samfurin hanci daga yaro ɗan wata 8 da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi ne a ƙasar Netherlands, amma a zahiri an rarraba shi a dukan duniya.
An kiyasta cewa HCoV-NL63 yana da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yawan cutarsa yana faruwa a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar laryngitis mai hanawa, wanda kuma aka sani da croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti da ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Baya ga ciwon huhu da kuma cutar sankarar bargo da aka samu a cikin al'umma, an bayar da rahoton cewa HCoV-HKU1 yana da alaƙa da matsanancin ciwon asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk duniya, wanda ke haifar da cututtukan numfashi masu sauƙi.
Duk waɗannan HCoVs huɗu da aka samo daga al'umma sun dace da mutane kuma galibi ba sa iya canzawa don haifar da cututtukan cututtukan cututtuka, kodayake haɗari sun faru ne saboda dalilan da ba a sani ba kamar a cikin mawuyacin hali na mafi ƙarancin cutar HCoV-NL63, wanda kwanan nan aka ba da rahoton haifar da mummunar kamuwa da cutar ƙananan hanyoyin numfashi a China.
Gabaɗaya, lokacin da waɗannan HCoVs suka sami ikon watsawa yadda ya kamata da kuma ci gaba da kasancewa a cikin mutane, suma suna zama marasa cutarwa ko cututtuka.
An fara gano MERS-CoV a shekarar 2012 daga huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da ciwon huhu mai tsanani da kuma ciwon koda a Saudiyya.
Yayin da yawancin shari'o'in da aka tabbatar da su a cikin dakin gwaje-gwaje suka fito ne daga Gabas ta Tsakiya, an ba da rahoton shari'o'in shigowa da wasu lokuta na biyu zuwa kusanci a cikin ƙasashen Turai da Tunisia.
Wani annobar ta biyu ta faru a Koriya ta Kudu a 2015 tare da tabbatar da shari'o'i 186.
Alamun asibiti na MERS suna kama da na SARS, wanda ke nuna ci gaba da ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da MERS suma sun sami ciwon koda mai tsanani, wanda har yanzu ya zama na musamman ga MERS tsakanin cututtukan da HCoV ke haifarwa.
Fiye da 30% na marasa lafiya suna da alamun cututtukan hanji, kamar zawo da amai.
Ya zuwa 14 ga Fabrairu, 2020, an ba da rahoton sama da mutane 2500 da aka tabbatar da su a cikin dakin gwaje-gwaje tare da yawan mutuwar mutum 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta mafi lalacewa da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin marasa lafiyar cutar huhu da aka sani da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar cututtukan numfashi na ƙasa da SARS-CoV-2 ya haifar da gaggawa ta lafiyar jama'a na damuwa ta duniya kuma ta kuma sanya wa cutar sunan COVID-19.
Ya zuwa ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duk duniya, tare da mutuwar mutum 3.4%.
Musamman, yawan mutuwar a Hubei, China ya kai kashi 4.2%, yayin da wanda ke wajen ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da mummunar kamuwa da cuta ta numfashi kamar SARS-CoV da MERS-CoV, wanda aka gabatar da zazzabi, tari da dyspnea.
Ana kuma ganin gudawa a wasu marasa lafiya.
Ciwon huhu yana ɗaya daga cikin cututtuka masu tsanani kuma yana iya ci gaba da sauri zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban homology na jerin nucleotide na 82%, sun haɗu cikin rassa daban-daban a cikin itacen phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da cutar amma yana da saurin yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An bayar da rahoton mutane marasa alamun cutar da SARS-CoV-2 kuma suna iya ba da gudummawa ga saurin yaduwar ta a duniya.
Kwatanta da bambancin SARS-CoV-2 da sauran HCoVs shida sun bayyana kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokacin kamuwa da cutar da kuma tsawon lokacin cutar HCoV suna kama da juna.
A wannan batun, SARS-CoV-2 yana bin yanayin gabaɗaya na sauran HCoVs shida.
Na biyu, tsananin alamun COVID-19 yana tsakanin SARS-CoV da HCoVs huɗu da aka samu a cikin al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 yana nuna halaye waɗanda aka fi gani yayin kamuwa da cutar da HCoVs da aka samu a cikin al'umma, gami da gabatar da alamun da ba na musamman ba, mai sauƙi ko ma babu alamun cutar.
A gefe guda, ana iya ganin ƙananan ƙananan ƙananan cututtukan COVID-19 kamar yadda ake gani a cikin yanayin kamuwa da cutar SARS-CoV, kodayake rabon ya ɗan ƙasa kaɗan.
Na uku, watsa SARS-CoV-2 kuma yana nuna halaye masu ban sha'awa na halayen duka HCoVs da aka samu a cikin al'umma da SARS-CoV.
A gefe guda, yaduwar SARS-CoV-2 yana da girma kamar na HCoVs da aka samu a cikin al'umma.
A gefe guda, har yanzu ba a tabbatar da ko watsawar SARS-CoV-2 ya ragu ba bayan wucewa cikin mutane kamar yadda yake a cikin shari'ar SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfuran ƙwayoyin cuta.
Ko watsawar SARS-CoV-2 ta baki yana taka muhimmiyar rawa kamar yadda yake a cikin SARS-CoV aƙalla a ƙarƙashin wasu yanayi har yanzu ba a bayyana ta binciken gaba ba.
Hakanan yana da matukar sha'awa musamman don ganin ko SARS-CoV-2 na iya nuna yanayi kamar yadda yake a cikin yanayin HCoVs da aka samu a cikin al'umma.
Duk da haka, halayen SARS-CoV-2 gami da watsawa, cututtukan cuta da ci gaba da yaduwa bayan wucewa cikin mutane zai yi tasiri kan ƙarshen ƙarshen barkewar COVID-19.
Dukkanin HCoVs huɗu da aka samo daga al'umma waɗanda ke haifar da alamun rashin lafiya sun dace da mutane.
Daga wani hangen nesa, yana iya zama gaskiya cewa mutane sun dace da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu na iya zama waɗanda suka tsira daga tsoffin cututtukan HCoV.
An kawar da HCoVs waɗanda ke haifar da cututtuka masu tsanani a cikin mutane da mutanen da suka sami cututtukan HCoV masu tsanani.
Don wannan ya faru, HCoVs dole ne su sake maimaitawa a cikin mutane har zuwa isa don ba da damar tarawar juyin halittar da ke magance abubuwan ƙuntatawa na mai masauki.
A wannan ma'anar, tsawon lokacin da barkewar SARS-CoV-2 ke ci gaba da yawaita mutane da ta kamu da su, mafi girman damar da za ta dace da mutane.
Idan ya daidaita da kyau, watsa shi a cikin mutane zai yi wuya a dakatar da shi ta hanyar keɓewa ko wasu matakan kula da kamuwa da cuta.
Shekaru da yawa, CoVs huɗu da aka samo daga al'umma suna yawo a cikin yawan mutane, suna haifar da sanyi a cikin masu rigakafi.
Wadannan ƙwayoyin cuta ba sa buƙatar wani ajiyar dabba.
Sabanin haka, SARS-CoV mai cutarwa sosai da MERS-CoV ba su dace da mutane da kyau ba kuma ba za a iya ci gaba da watsa su a cikin mutane ba.
Suna buƙatar ci gaba da haɓaka a cikin wuraren ajiyar dabbobi kuma suna neman damar da za su iya watsawa ga maƙasudin ɗan adam, mai yiwuwa ta hanyar ɗaya ko fiye da matsakaici da kuma ƙarfafa masu karɓar.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV/MERS-CoV da HCoVs huɗu da aka samo daga al'umma.
Yana da saurin yaduwa kamar HCoVs da aka samu a cikin al'umma, aƙalla a yanzu.
Koyaya, yana da cutar fiye da HCoVs da aka samo daga al'umma kuma ba shi da cutar fiye da SARS-CoV ko MERS-CoV.
Har yanzu ba a san ko zai dace da mutane ba kuma ya yi yawo a cikin mutane ba tare da wani mai riƙe da ruwa ko mai karɓar dabba ba.
Kafin tattauna asalin dabbobi na HCoVs, zai taimaka mana sosai mu tattauna ma'anoni da halaye na juyin halitta, na halitta, mai tanadi, matsakaici da kuma haɓaka masu karɓar HCoVs.
Dabba tana aiki a matsayin mai karɓar baƙi na HCoV idan tana da kakanni masu alaƙa da juna waɗanda ke da babban haɗin kai a matakin jerin nucleotide.
Kwayar cutar ta asali yawanci tana da kyau kuma ba ta haifar da cutar a cikin wannan mai masaukin.
Hakanan, mai riƙe da ajiya yana riƙe da HCoV ci gaba da dogon lokaci.
A cikin duka lamura, masu karɓar baƙi suna da kamuwa da cuta ta halitta kuma sune masu karɓar baƙi na HCoV ko kwayar iyayenta.
Sabanin haka, idan an gabatar da HCoV zuwa wani mai watsa shiri na tsakiya kafin ko kusa da gabatarwar sa ga mutane, ba ya dace da sabon mai watsa shiri kuma sau da yawa yana haifar da cututtuka.
Wannan mai watsa shiri na tsakiya na iya zama tushen cutar ta mutum kuma yana taka rawar mai karɓar bakuncin ta hanyar ba da damar kwayar cutar ta ninka ta ɗan lokaci sannan kuma ya watsa ta ga mutane don ƙara girman kamuwa da cutar ɗan adam.
HCoV na iya kamuwa da kamuwa da cuta idan ba zai iya ci gaba da watsawa a cikin mai watsa shiri na tsakiya ba.
Akasin haka, HCoVs na iya daidaitawa da mai watsa shiri na tsakiya har ma da kafa ƙarancin lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Bayanan cututtukan cututtuka sun nuna cewa yanayin SARS yana da tarihin hulɗa da dabbobin daji.
Binciken cutar da aka yi a baya ya nuna cewa masu cinikin dabbobi suna da yawan cutar anti-SARS-CoV IgG idan aka kwatanta da sauran jama'a.
An fara gano civets na dabino masu rufe fuska (Paguma larvata) da kare racoon a kasuwannin dabbobi masu rai don ɗaukar ƙwayoyin cuta masu kama da SARS-CoV waɗanda kusan iri ɗaya ne da SARS-CoV.
Wannan ya kasance a kaikaice ta hanyar gaskiyar cewa ba a sake ba da rahoton SARS ba bayan kashe dukkan civets a kasuwanni.
Koyaya, an ba da rahoton cewa civets na dabino masu rufe fuska daga daji ko gonaki ba tare da fuskantar kasuwannin dabbobi masu rai ba sun kasance mafi yawa mara kyau ga SARS-CoV, yana ba da shawarar cewa civets na dabino masu rufe fuska na iya zama mai watsa shiri ne kawai amma ba ma'ajiyar halitta ba na SARS-CoV.
Musamman, tunda kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da ƙwayoyin cuta na anti-SARS-CoV, ba za a iya cire yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa da yawa na iya zama masu karɓar bakuncin SARS-CoV ba.
Duk waɗannan suna da alama ba su da mafita ga SARS-CoV.
Binciken da aka yi na dabbobi na SARS-CoV ya nuna wani nau'in CoV na bat da ke da alaƙa da SARS, wanda ake kira SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Wadannan kwari suna da inganci ga kwayoyin anti-SARS-CoV da jerin kwayoyin halittar SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na bera suna da haɗin haɗin nucleotide 88-92% tare da SARS-CoV.
Wadannan binciken sun kafa tushe ga sabon ra'ayi cewa barbashi suna karbar bakuncin cututtukan mutum masu tasowa.
An kuma gano wasu CoVs masu kama da SARS (SL-CoVs) daga jemage, amma babu wanda aka ware a matsayin kwayar cuta mai rai sai dai wanda aka sanya WIV1.
An san cewa enzyme mai canza angiotensin na mutum 2 (ACE2) shine mai karɓar SARS-CoV.
WIV1 wanda aka samo daga samfurin ƙazamar ƙuda na ƙuda ya nuna don amfani da ƙuda, civet da ACE2 na ɗan adam azaman mai karɓar shigarwar kwayar halitta.
Abin sha'awa, ƙwayar ƙwayar cuta na marasa lafiya na SARS da ke warkewa sun iya kawar da WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar magabatan SARS-CoV da ke da alaƙa da ƙwayoyin cuta, suna raba 95% na jerin nucleotide.
Kodayake babban kamani tsakanin waɗannan ƙwayoyin cuta biyu, gabaɗaya ana tsammanin cewa WIV1 ba kwayar cutar mahaifa ce ta SARS-CoV ba kuma bats ba shine mai karɓar bakuncin SARS-CoV ba.
Binciken Phylogenetic yana tattara MERS-CoV zuwa rukuni ɗaya kamar na CoV-HKU4 na bera da CoV-HKU5 na bera.
Bat CoV-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar.
Tsarin RNA polymerase na RNA-dogara na MERS-CoV yana da kusanci da phylogenetically zuwa takwarorinsu a cikin bat beta-CoVs da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a iya samun MERS-CoV mai rai a cikin barbashi na daji ba.
MERS-CoV da danginsa mafi kusa na CoV-HKU25 suna da kashi 87% na jerin abubuwan nucleotide.
Don haka, jemage ba zai iya zama mai karɓar baƙi na MERS-CoV ba.
A gefe guda kuma, nazarin da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuma dromedary suna da ƙwayar cuta don ƙwayoyin cuta na MERS-CoV na musamman, kamar raƙuma na Gabas ta Tsakiya a ƙasashen Afirka da yawa.
An ware MERS-CoV mai rai wanda yayi daidai da kwayar cutar da aka samo a cikin mutane daga swabs na hanci na raƙuma dromedary, wanda ya nuna cewa raƙuma suna aiki a matsayin mai karɓar ajiyar MERS-CoV.
Hakanan yana da mahimmanci a lura cewa gabaɗaya ana lura da alamun rashin lafiya amma ana samun yawan ƙwayar cuta a cikin raƙuma da ke kamuwa da cutar MERS-CoV.
Musamman, raƙuma masu kamuwa da cutar suna zubar da ƙwayoyin cuta ba kawai ta hanyar numfashi ba har ma ta hanyar ƙwayoyin cuta-bakin, wanda kuma shine babban hanyar fitar da ƙwayoyin cuta daga jemage.
Koyaya, har yanzu akwai tambayoyi tunda yawancin mutanen da aka tabbatar da cutar MERS ba su da tarihin tuntuɓar raƙuma kafin bayyanar cututtuka, wanda a bayyane yake ana danganta shi da watsawa daga mutum zuwa mutum ko hanyoyin watsawa da ba a sani ba waɗanda suka shafi nau'ikan dabbobi da ba a san su ba waɗanda ke dauke da MERS-CoV.
SARS-CoV-2 yana da daidaiton nucleotide 96.2% tare da CoV RaTG13 na bera wanda aka ware daga Rhinolophus affinis bats.
Kamar yadda yake a cikin shari'ar SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don sanya alaƙar iyaye.
Wato, kwari ba za su iya zama mai karɓar baƙi na SARS-CoV-2 ba sai dai idan an sami kusan CoVs na kwari a nan gaba.
Da alama, dabbobi masu karɓar SARS-CoV-2 na tsaka-tsaki ya kamata su kasance cikin nau'ikan dabbobin daji da aka sayar da su kuma aka kashe a Kasuwar Kasuwancin Kifi na Huanan, wanda yawancin shari'o'in farko na COVID-19 ke da alaƙa da su, wanda ke nuna yiwuwar yiwuwar cutar daga dabba zuwa mutum.
Yawancin binciken kwanan nan dangane da jerin metagenomic sun ba da shawarar cewa rukunin ƙananan dabbobi masu shayarwa da ke cikin haɗari da aka sani da pangolins (Manis javanica) na iya ɗaukar tsoffin beta-CoVs masu alaƙa da SARS-CoV-2.
Wadannan sabbin kwayoyin halittar pangolin CoV suna da 85-92% na nucleotide jerin homology tare da SARS-CoV-2.
Koyaya, suna da alaƙa da RaTG13 tare da kusan 90% daidaito a matakin jerin nucleotide.
Suna haɗuwa cikin ƙananan ƙwayoyin cuta guda biyu na ƙwayoyin cuta masu kama da SARS-CoV-2 a cikin itacen phylogenetic, ɗayan ɗayan yana da yanki mai kama da mai karɓar mai karɓa (RBD) tare da SARS-CoV-2, tare da 97.4% amino acid jerin ainihi.
Sabanin haka, RBDs na SARS-CoV-2 da RaTG13 sun fi banbanci, kodayake mafi girman digiri na jerin homology a cikin kwayoyin halitta.
Wani binciken da aka yi a baya kan pangolins da ke fama da rashin lafiya ya kuma ba da rahoton gano ƙwayoyin cuta daga samfuran huhu, waɗanda suka bayyana suna da alaƙa da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyi daban-daban na haɗuwa da sarrafawa ta hannu don samar da jerin kwayoyin halittar ɗan adam wanda ya ƙunshi kusan 86.3% na cikakken kwayar cutar kwayar cuta.
Ba za mu iya kawar da yiwuwar cewa pangolin yana ɗaya daga cikin dabbobi masu karɓar bakuncin SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa asalin pangolin kai tsaye na SARS-CoV-2 saboda bambancin tsari tsakanin SARS-CoV-2 da pangolin SARS-CoV-2-da ke da alaƙa da beta-CoVs.
Bugu da ƙari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi ta tsakanin SARS-CoV-2 da pangolin SARS-CoV-2-related beta-CoVs.
Har yanzu ba a tabbatar da hanyar juyin halitta na SARS-CoV-2 a cikin jemage, pangolins da sauran dabbobi masu shayarwa ba.
Yayin da aka sami mafi girman jerin homology a cikin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2-da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da mafi girman jerin jerin homology a cikin kwayoyin halitta.
Yana da matukar zato cewa babban matakin kamanceceniya tsakanin RBDs na pangolin SARS-CoV-2-da ke da alaƙa da beta-CoVs da SARS-CoV-2 ana haifar da shi ta hanyar juyin halitta mai haɗuwa ta hanyar zaɓaɓɓu.
Wani shawarwari na gaba yana goyon bayan sake haɗuwa tsakanin beta-CoV mai alaƙa da SARS-CoV-2 da kuma RaTG13 a cikin nau'in dabba na uku.
A matsayin ƙarfin motsawa a cikin juyin halitta, sake haɗuwa yana yaduwa tsakanin beta-CoVs.
Har yanzu ba a yanke hukunci kan asalin cutar SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa sosai, an kuma yi nazarin asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na bat, yayin da aka sami ƙwayoyin cuta na iyaye na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An bayar da rahoton cewa CoV na bera da ake kira ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin dan damisa mai launin fata na Arewacin Amurka ya nuna alaƙar da ke tsakanin HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da wata ƙwayar CoV ta bat, da ake kira Hipposideros / GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ake zargin camellida a matsayin mai watsa shiri na tsakiya.
Don tsabta, ilimin yanzu game da asalin dabbobi na sanannun HCoVs an taƙaita su a cikin Hoto 1 da Tebur 2.
Binciken phylogenetic ya samar da hujja game da abubuwan watsawa tsakanin jinsuna na HCoVs a cikin tarihi.
Lokacin da HCoV-OC43 ya ƙetare nau'in don ya kamu da mutane daga dabbobin gida a kusa da 1890, an yi rikodin cutar kamuwa da cutar numfashi.
Tarihin watsawa tsakanin jinsuna na HCoV-229E bai bayyana sosai ba.
An gano bat alpha-CoVs da ke da alaƙa da HCoV-229E.
Tsakanin su akwai alpha-CoV na alpaca.
Akwai shaidu da dama da ke nuna cewa kwayar cutar tana yaduwa daga kuraje zuwa mutane kai tsaye.
Na farko, mutane amma ba alpacas ba na iya hulɗa da bat a cikin wani yanki na muhalli.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, alpha-CoVs na bera masu alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin bera, yayin da alpaca alpha-CoV ya haifar da barkewar cutar numfashi a cikin dabbobi masu kamuwa da cuta.
A ƙarshe, ba a sami alpaca alpha-CoV a cikin dabbobin daji ba.
Don haka, ba za a iya cire yiwuwar alpacas su sami alpha-CoV mai alaƙa da HCoV-229E daga mutane ba.
A zahiri, jemage sune tushen kai tsaye na ƙwayoyin cuta masu cutar ɗan adam ciki har da ƙwayar cutar hauka, ƙwayar cutar Ebola, ƙwayar Nipah da ƙwayar cutar Hendra.
Saboda haka ba abin mamaki bane cewa jemage na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, yayin da bat alpha-CoVs ke aiki a matsayin tarin kwayoyin halittar HCoV-229E, alpacas da raƙuma dromedary na iya zama masu watsawa na tsaka-tsaki waɗanda ke watsa ƙwayoyin cuta ga mutane, daidai kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV yana aiki a matsayin kyakkyawan misali na yaduwar jinsuna daga jemage zuwa raƙuma na dromedary kuma daga raƙuma na dromedary zuwa mutane.
Asalin juyin halitta na MERS-CoV daga jemage an san shi a farkon gano shi kuma an kuma ƙarfafa shi ta binciken da aka samu daga baya.
A bayyane yake cewa jemage suna samar da wadataccen nau'in ƙwayoyin cuta don musayar ɓangarorin kwayoyin halitta da watsawa tsakanin jinsuna.
Tsawon rai, yankuna masu yawa, hulɗar zamantakewar jama'a da kuma ƙarfin tashi duk yanayi ne mai kyau ga bats don zama 'mai yaduwar kwayar cutar'.
A gefe guda kuma, an gabatar da MERS-CoV ga raƙuman dromedary shekaru da yawa.
Ya dace da waɗannan raƙuman da suka canza daga mai watsa shiri na tsakiya zuwa mai karɓar ruwa mai ɗorewa da na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙarancin canjin canji a cikin waɗannan dabbobin.
Yaduwar sa zuwa ga mutane ba zato ba tsammani ne kuma mutane suna ci gaba da kasancewa mai karɓar baƙi na MERS-CoV saboda ba za a iya ci gaba da yaduwar sa ba.
Sabanin rawar raƙuma wajen watsa MERS-CoV, rawar pangolins, idan akwai, a cikin watsa SARS-CoV-2 ta bambanta.
Musamman, pangolin beta-CoVs suna da cutarwa sosai a cikin pangolins.
Suna iya zama mahalarta mara kyau ga beta-CoVs masu alaƙa da SARS-CoV-2, kwatankwacin civets a cikin yanayin SARS-CoV.
Akwai yiwuwar da dama na yaduwar SARS-CoV-2 daga dabbobi zuwa mutane a cikin ko kuma a cire su a cikin binciken nan gaba.
Na farko, jemage na iya zama mai riƙe da kwayar cutar da ke da alaƙa da SARS-CoV-2 kusan daidai da SARS-CoV-2.
Mutane na iya raba yanayin muhalli tare da jemage ta hanyar yanka ko hakar ma'adinai.
Na biyu, pangolins na iya zama ɗaya daga cikin matsakaitan masu haɓaka mai watsa shiri wanda sabon kwayar cutar da ke da alaƙa da SARS-CoV-2 aka gabatar da ita.
Mutane suna kamuwa da cutar ta hanyar yanka da cin naman farauta.
Yana yiwuwa dabbobi masu shayarwa da yawa ciki har da dabbobin gida suna da saukin kamuwa da SARS-CoV-2.
Ana buƙatar binciken dabbobi na gida da na daji don ƙwayoyin cuta.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ke da alaƙa da duka bat da pangolins.
Har yanzu ana ci gaba da binciken asalin SARS-CoV-2 daga dabbobi.
Baya ga nau'ikan nau'ikan dabbobi daban-daban, manyan abubuwa uku a gefen kwayar cutar suna da mahimmanci wajen sauƙaƙe CoVs don ƙetare shingen jinsuna.
Da farko dai, yawan canjin halittarsu a cikin kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar canjin canjin CoVs ana iya ɗauka a matsayin  matsakaici  zuwa  mai girma  tare da matsakaicin canjin canji na ~ 10-4 sauyawa a kowace shekara a kowane shafin 2, dangane da matakin daidaitawar CoV zuwa sabbin masu karɓar baƙi.
CoVs suna da exoribonuclease mai karantawa, cirewa wanda ke haifar da canji mai yawa da raguwa ko ma rashin rayuwa.
Abin sha'awa, ana san analogue na nucleotide Remdesivir don hana kwayar cutar CoV ta hanyar hana wannan exoribonuclease da RNA-dogara RNA polymerase.
Remdesivir yana ɗaya daga cikin mafi kyawun magungunan anti-SARS-CoV-2 da za a gwada a cikin gwaji na asibiti.
Duk da haka, yawan canjin CoVs ya fi na masu karɓar su sau miliyan.
Bugu da kari, yawan canjin halitta yakan yi yawa idan CoVs ba su dace da mai gidan ba.
Idan aka kwatanta da SARS-CoV tare da babban canjin canji, canjin canjin SARS-CoV-2 a bayyane ya fi ƙasa, yana nuna matakin daidaitawa da mutane.
Wataƙila, ya riga ya daidaita da wani mai ba da abinci da ke kusa da mutane.
Baya ga SARS-CoV-2, wannan ma ya shafi MERS-CoV, wanda ya dace da raƙuman dromedary.
A ka'idar, ba zai yiwu ba cewa jujjuyawar kwayoyin halitta za ta sa alluran rigakafi da maganin rigakafin cutar SARS-CoV-2 ba su da tasiri da sauri.
Na biyu, babban RNA genome a cikin CoVs yana amfani da ƙarin filastik a cikin gyaran genome don maye gurbi da sake haɗawa, don haka yana ƙaruwa da yiwuwar co-juyin halitta tsakanin jinsuna, wanda ke da fa'ida ga fitowar sabbin CoVs lokacin da yanayi ya dace.
Wannan yana tallafawa ta hanyar ɗakunan karatu na musamman da kuma ayyukan furotin da aka tsara zuwa ƙarshen 3 'na kwayoyin halitta.
Na uku, CoVs bazuwar kuma sau da yawa suna canza samfuran yayin sakewa na RNA ta hanyar tsari na musamman  kwafin-zaɓi.
A cikin mai masaukin da ke aiki a matsayin jirgin ruwa mai haɗawa, sauya zaren yana faruwa sau da yawa yayin rubutun CoV RNA.
RNAs masu cikakken tsayi da kuma subgenomic masu kama da juna zasu iya sake haɗuwa don samar da sababbin CoVs.
An sami shaidar ilimin halitta na sake haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar su bat SL-CoV da batCoV-HKU9.
Hadin gwiwar kwayar cutar da mai masaukin baki dangane da watsawa
Baya ga abubuwan da ke tattare da kwayar cutar guda uku da aka ambata a sama, hulɗar kwayar cutar tare da mai karɓar mai karɓar wani mahimmin abu ne mai tasiri kan watsawa tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zabin tabbatacce yayin abubuwan watsawa tsakanin jinsuna.
Dangane da nazarin kwatancen tsakanin keɓaɓɓu na SARS-CoVs na mutum da civet, ana tsammanin SARS-CoV yana fuskantar saurin daidaitawa a cikin masu watsawa daban-daban, musamman tare da maye gurbi a RBD na furotin S.
Gabaɗaya, RBD a cikin furotin S na CoV yana hulɗa tare da mai karɓar ƙwayoyin cuta kuma ana zaɓar shi sosai ta hanyar amsawar ƙwayoyin cuta.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 akan ɓangaren S1, wanda ke ɗaure da ACE2 na ɗan adam da kuma masu karɓar sa don shigar da kwayar cutar.
RBD na SARS-CoV na iya gane masu karɓar ACE2 na dabbobi daban-daban, gami da bat, civet, linzamin kwamfuta da kare raccoon, yana ba da damar watsa kwayar cutar tsakanin jinsuna.
A zahiri, an lura da ragowar amino acid 6 ne kawai daban da na mutum da na civet virus a cikin RBD kuma 4 daga cikinsu suna cikin abin da ke ɗaure mai karɓar don hulɗa tare da mai karɓar ACE2.
Civet SARS-CoV yana da canjin K479N da S487T a cikin RBD, wanda zai iya haɓaka alaƙar hulɗar furotin mai ƙwanƙwasa tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomin, waɗannan maye gurbin amino acid guda biyu na iya zama mahimmanci ga daidaitawar kwayar cutar ga mutane.
Yana da mahimmanci cewa SARS-CoV-2 yana da masu karɓar ƙwayoyin cuta iri ɗaya da SARS-CoV.
Bambanci 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S protein yana nuna cewa alaƙar haɗin S protein tare da ACE2 na ɗan adam na iya canzawa.
A zahiri, binciken cryo-EM ya nuna kusancin wannan haɗin ya ninka sau 10 zuwa 20 fiye da na tsakanin ACE2 na ɗan adam da furotin SARS-CoV S.
Hakanan zai zama mai ban sha'awa don ƙayyade ko ana buƙatar wani mai karɓar coreceptor don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana ɗaure da ACE2 amma tare da wani ɓangare na S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan zasu iya bayyana nasarar daidaita waɗannan CoVs a cikin mutane bayan watsawa tsakanin jinsuna daga masu karɓar dabbobi.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon watsawar HCoVs tsakanin jinsuna yana kuma ƙarƙashin sauran abubuwan dogaro da ƙuntatawa.
Bambancin waɗannan sunadarai masu karɓar baƙi tsakanin mutane da masu karɓar baƙi na HCoVs na halitta kamar bats, dromedary raƙuma da rodents na iya zama shinge ga watsa tsakanin jinsuna.
HCoVs dole ne su mamaye abubuwan dogaro da mai masauki kuma su kawar da abubuwan ƙuntatawa na mai masauki don samun nasarar watsawa tsakanin jinsuna.
A wannan batun, ƙayyadaddun kwayoyin halitta a cikin wannan muhimmin yanki na hulɗar ƙwayoyin cuta-mai watsa shiri har yanzu ana ganowa da halayyar su.
Binciken da ba shi da son kai na dukkanin kwayoyin halitta na dogara da mai masauki da kuma ƙuntatawa ga SARS-CoV-2 ta amfani da fasahar zamani ta CRISPR na iya zama mai amfani.
Fitowar sabbin HCoVs: komawa zuwa wuri na farko
Bambancin CoVs na bera yana ba da dama mai yawa don fitowar sabbin HCoVs.
A wannan ma'anar, CoVs na bera suna aiki azaman tarin kwayoyin halittar HCoVs.
Bugu da ƙari, sauye-sauye mai sauri da sake haɗuwa da kwayoyin halitta suma suna haifar da juyin halittar HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan aikin.
Misali, saye ko asarar sabbin kwayoyin halittar furotin suna da damar canza yanayin kwayar cutar sosai.
Daga cikin furotin na SARS-CoV, an yi tunanin ORF8 yana da mahimmanci wajen daidaitawa da mutane, kamar yadda aka ware ƙwayoyin cuta na SARS-CoV amma an gano cewa suna ɓoye furotin ORF8 daban.
An gano wani nau'in cirewar nucleotide 29 na SARS-CoVs a cikin nau'ikan da aka ware a farkon annobar ɗan adam.
Wannan cirewa ya raba ORF8 zuwa ORF8a da ORF8b kuma ana tunanin cewa canji ne na daidaitawa wanda ke inganta sauyawar masu masaukin baki.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa tare da zuriyar alpha- da gamma-CoVs, inda aka gano ƙananan ƙananan yankuna a cikin RNA-dogara RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10, da kuma sassan nsp14.
Hakanan, an nuna cewa annobar MERS-CoV ta sami abubuwan haɗuwa tsakanin zuriyoyi daban-daban, wanda ya faru a cikin raƙuman dromedary a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake haɗuwa a cikin sauran HCoVs, wanda HCoVs ke sake haɗuwa tare da sauran CoVs na dabbobi a cikin ƙwayoyin halittar su.
Hakanan yakamata a yi gargadi cewa zabin wucin gadi na iya ba da gudummawa ga canje-canje da ba a so a cikin kwayoyin halittar kwayar cuta, mai yiwuwa sakamakon sauƙaƙe ƙwayoyin cuta daga matsin zaɓin da aka yi, kamar ta tsarin rigakafin mai masaukin.
Misali na waɗannan tasirin shine asarar cikakken ORF4 a cikin samfurin samfurin HCoV-229E, saboda cirewar nucleotide biyu.
Duk da yake ana iya lura da cikakkiyar ORF4 a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, alpha-CoV na alpaca yana nuna shigar da nucleotide guda ɗaya, wanda ke haifar da canjin firam.
A ƙarshe amma ba mafi ƙaranci ba, juyin halitta na sabon HCoVs kuma ana motsa shi ta hanyar matsin zaɓin a cikin masu riƙe da su.
An gano alamun rashin bayyanar cututtuka ko kuma kawai alamu masu sauƙi lokacin da kwari suka kamu da CoVs, wanda ke nuna daidaitawar juna tsakanin CoVs da kwari.
Ya bayyana cewa jemage sun dace da CoVs a zahiri da kuma ilimin lissafi.
Misali, lahani a cikin kunnawar amsawar kumburi a cikin jemage yana rage cututtukan da CoVs ke haifar da su yadda ya kamata.
Bugu da ƙari, aikin ƙwayoyin halitta na halitta a cikin bats an hana shi saboda haɓakar mai karɓar ƙwayar halitta mai kisan kai NKG2/CD94 da ƙananan matakin bayyana manyan kwayoyin halittar ƙwayar cuta na I.
Bugu da ƙari, babban matakin nau'ikan oxygen masu aiki (ROS) da aka samar daga babban aikin metabolism na jemage na iya hana CoV sakewa kuma yana shafar gyara ta hanyar exoribonuclease, don haka samar da matsin lamba don samar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su cikin sabon mai masauki.
Ƙarin ƙwayar CoV mai cutarwa na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko fasalolin sunadarai don daidaitawar mai masauki.
Don haka, ba daidaituwa ba ne cewa sabbin HCoVs uku sun fito a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko haifar da alamun rashin lafiya a cikin masu riƙe da su kamar bats da raƙuma.
Suna yin kwafi sosai ba tare da haifar da amsa mai karfi ba.
A nan ne asirin dalilin da yasa ake ganin masu dauke da cutar ba tare da alamomi ba da kuma abin da ke haifar da mummunan yanayin kamuwa da cutar a cikin mutane.
Manyan alamun galibi saboda yawan aiki ne na amsawar rigakafi da kuma guguwar cytokine inda mafi ƙarfin amsawar rigakafi, mafi tsananin lalacewar huhu.
Sabanin haka, a cikin masu ɗaukar alamun, an cire amsar rigakafi daga maimaita CoV.
Hanyar da ta dace ta cire haɗin maganin rigakafi na iya samun sakamako mai amfani a cikin maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin bat.
Don haka, gudanar da nau'in I interferon aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya zama da amfani.
Bugu da kari, NLRP3 kunnawa mai kumburi a cikin bat yana da lahani.
Ta wannan dalili, hana NLRP3 inflammasome tare da MCC950 na iya zama da amfani a maganin COVID-19.
Fitowar SARS-CoV-2 ya biyo bayan babban jigon da SARS-CoV da MERS-CoV suka taso.
Yayin da aka gano beta-CoV na bera wanda ke da kashi 95% na nucleotide homology tare da SARS-CoV, akwai kuma bat-CoV wanda ke da kashi 96% na nucleotide homology tare da SARS-CoV-2.
Yayin da aka gano civets da sauran dabbobi a kasuwanni suna dauke da ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano masu karɓar bakuncin SARS-CoV-2 ba.
An gano pangolin beta-CoVs masu kama da SARS-CoV-2, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu karɓar baƙi na tsakiya ko pangolin beta-CoVs na iya ba da gudummawar gutsuttsarin kwayoyin halitta zuwa sigar ƙarshe ta SARS-CoV-2.
Kodayake tambayoyi sun kasance, babu wata hujja da ke nuna cewa SARS-CoV-2 mutum ne ya yi shi da gangan ko kuma ba da gangan ba.
CoVs sun dawo cikin hasken haske saboda barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin CoVs a cikin jemage da sauran dabbobi ya canza ra'ayinmu game da mahimmancin asalin dabbobi da wuraren ajiyar dabbobi na HCoVs a cikin watsawa ga mutane.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin bera kuma ana watsa su ga mutane ta hanyar masu watsawa na tsakiya.
Ganin cewa kamuwa da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da civets a kasuwanni, rufe kasuwanni masu ɗumi da kashe civets a can na iya kawo ƙarshen annobar SARS.
Ta wannan dalili, ya kamata a cire pangolins daga kasuwannin rigar don hana yaduwar cutar zoonotic, saboda gano yawancin zuriyar pangolin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa har yanzu ba a bayyana su ba a cikin binciken da za a yi a nan gaba.
A gefe guda, MERS-CoV ya wanzu a cikin raƙuman dromedary na dogon lokaci.
Wadannan raƙuma suna aiki a matsayin muhimmin kayan aiki don sufuri da kuma babban tushen nama, madara, fata da kayayyakin ulu ga mazauna yankin.
An rarraba su ko'ina cikin Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a sadaukar da dukkan raƙuma don sarrafa MERS ba, kamar yadda aka yi a kasuwannin dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar cutar MERS, ya kamata a ɗauki cikakkiyar hanyar haɓaka alluran rigakafi masu tasiri akan MERS-CoV don raƙuma, a hade tare da sauran matakan sarrafa kamuwa da cuta.
Tunda ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sabbin nau'ikan ƙwayoyin cuta na iya fitowa don haifar da barkewar cutar.
Yawancin CoVs masu cutar dabbobi suna yawo a cikin daji.
Musamman, CoVs na bera tare da yuwuwar cutar dabbobi sun bambanta sosai.
Akwai dama da yawa cewa waɗannan CoVs na zoonotic sun samo asali kuma sun sake haɗuwa, wanda ke haifar da fitowar sabbin CoVs waɗanda ke da saurin yaduwa da / ko kisa a cikin mutane a nan gaba.
Dole ne a daina al'adar cin namun daji a wasu wurare na kasar Sin domin rage hulɗar da ba dole ba tsakanin mutane da dabbobi.
Tare da wahalar SARS, MERS da COVID-19, yakamata a sami shiri da shirin amsawa mafi kyau.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniya na dogon lokaci.
Suna zama a cikin tafkunan su na halitta har sai akwai damar yaduwa.
Ko da yake jemage suna da halaye da yawa da ke sa yaduwar ƙwayoyin cuta, ana iya rage damar da mutane za su iya haɗuwa da jemage da sauran dabbobin daji idan an koya wa mutane su guji su.
Ana buƙatar ci gaba da sa ido a cikin dabbobi masu shayarwa don fahimtar yanayin CoVs da masu karɓar su na halitta, wanda zai zama da amfani wajen hana watsawa daga dabba zuwa mutum da ɓarkewar gaba.
A ƙarshe, hanya mafi inganci don hana cutar dabbobi ta hanyar kwayar cutar ita ce mutane su nisanta kansu daga wuraren da ke da alamun halitta na ƙwayoyin cutar.
Har yanzu akwai wasu abubuwa da suka ɓace a cikin wuyar warwarewa game da asalin SARS-CoV-2.
Da farko, idan kwari sun watsa kwayar cutar SARS-CoV-2 ga pangolins, zai zama da ban sha'awa ganin a wane yanayi kwari da pangolins zasu iya raba wuri ɗaya na muhalli.
Na biyu, idan kwari suna taka rawa kai tsaye wajen yaduwar cutar ga mutane, ya kamata a tantance yadda mutane ke hulɗa da kwari.
Na uku, idan dabba mai shayarwa ta uku tana aiki a matsayin mai watsa shiri na gaskiya, yadda yake hulɗa da nau'ikan daban-daban ciki har da mutane, bats da pangolins dole ne a bayyana.
A ƙarshe, tunda dabbobi masu shayarwa da yawa ciki har da dabbobin gida na iya zama masu saukin kamuwa da SARS-CoV-2, yakamata a gudanar da sa ido da kamuwa da cuta na gwaji.
Idan kwaro ne, pangolin ko wani dabba mai shayarwa, ana tsammanin cewa SARS-CoV-2 ko ƙwayoyin cuta na iyayensa waɗanda kusan iri ɗaya ne za a gano su a cikin masu ba da ita na halitta a nan gaba.
Ci gaba da bincike a wannan yanki zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman tasiri a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin bincike na COVID-19 wanda ake zargi da cutar da wanda aka tabbatar da cutar
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganewa da maganin cutar coronavirus ta 2019 (2019-nCoV), kuma wannan jagorar ta ba da kwarewarmu kuma ta zama kyakkyawan tunani don yaƙi da wannan annobar a duk duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, hankalinmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma kwarewar aikin asibiti; saboda haka, dabarun bincike da magani suma ana sabunta su koyaushe.
A cikin wannan wasikar, mun amsa tsokaci guda kan jagorarmu kuma mun samar da sabbin ka'idojin bincike na wanda ake zargi da cutar da wanda aka tabbatar da cutar bisa ga sabuwar Jagorar Ganowa da Kula da COVID-19 (siffa ta bakwai) da Kwamitin Kiwon Lafiyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu aka sanya masa suna a hukumance a matsayin cutar coronavirus ta 2019 (COVID-19) kuma an sanya wa kwayar cutar suna mai tsanani mai tsanani coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don yaƙi da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagorar shawara mai sauri kuma an buga ta kan layi a cikin Binciken Likita na Soja a ranar 06 ga Fabrairu 2020.
An yi amfani da shi sosai tun lokacin da aka buga shi.
Ka lura duk da haka cewa COVID-19 sabuwar cuta ce, wayar da kanmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma kwarewar aikin asibiti; saboda haka, dabarun bincike da magani suma ana sabunta su koyaushe.
Misali, Jagororin Bincike da Kula da COVID-19 da Kwamitin Kiwon Lafiya na Jama'ar Sin (http://www.nhc.gov.cn/) ya bayar, tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, ya fitar da jimlar bugu bakwai tare da wasu mahallin da aka canza sosai.
Yanzu jagorarmu ta sami tsokaci daga Zhou et al., sun gabatar da shawara mai sauƙi bisa ga kwarewarsu ta asibiti.
Aikin su ya kara sabbin shaidu ga jagororinmu kuma ya kuma zama muhimmin tunani ga wannan annoba a duk duniya.
Muna goyon bayan aikinsu mai muhimmanci kuma muna godiya.
Koyaya, aikin su kuma yana buƙatar sabuntawa bisa ga sabon Jagoran Ganowa da Kulawa don COVID-19 (Gwaji na bakwai) da kuma binciken kwanan nan.
A cewar fitowar ta bakwai (3 ga Maris 2020), don tabbatar da yanayin da ake zargi yana buƙatar haɗa kowane abu na tarihin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk:
Tarihin cututtuka: (1) tarihin tafiya ko zama a cikin garin Wuhan da kewayensa, ko wasu al'ummomin da aka ba da rahoton shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin tuntuɓar masu kamuwa da cutar SARS-CoV-2 (tare da gwajin kwayar nucleic acid mai kyau); (3) tarihin tuntuɓar marasa lafiya da zazzabi ko alamun cututtukan numfashi daga garin Wuhan da kewayensa, ko wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) tarihin tuntuɓar rukuni na tabbatar da shari'o'in (≥ 2 shari'o'in da zazzabi da / ko alamun numfashi sun faru a cikin makonni 2 a cikin ƙananan yankuna, kamar gida, ofis, aji na makaranta, da sauransu).
Bayyanar asibiti: (1) zazzabi da / ko alamun numfashi; (2) tare da alamun hoto na kamuwa da cutar COVID-19; (3) yawan adadin farin jini yana nuna al'ada, raguwa, ko rage yawan ƙwayoyin lymphocyte a farkon farkon farawa.
Gano tabbataccen yanayin ya kamata ya dogara da yanayin da ake zargi tare da kowane abu guda na pathogenic ko shaidar serological kamar haka: (1) gwajin PCR na lokaci na ainihi mai kyau don SARS-CoV-2; (2) jerin kwayoyin halittar kwayar cutar gaba ɗaya wanda ke nuna babban daidaituwa ga sanannun sabbin cututtukan coronavirus; (3) tabbatacce ga takamaiman IgM antibody da IgG antibody zuwa SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko canji na takamaiman IgG antibody na SARS-CoV-2 daga mara kyau zuwa tabbatacce, ko titer yana ƙaruwa ≥4 sau a cikin farfadowa sama da na cikin lokacin gaggawa.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin hanyoyin numfashi ko samfuran jini a bugu na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara gano cutar daga samfurin jini a bugu na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan kuma an ƙara shaidar serological a bugu na bakwai.
Waɗannan gyare-gyare dangane da masu binciken sun ci gaba da aiki don bincika mafi kyawun kayan gano nucleic acid don saurin ganewar asali, da kuma samfuran daga hanyoyin numfashi gami da ɗaukar jini, wanda ya haɓaka wadatar samfuran daban-daban, kuma ya tallafawa kawo takamaiman sakamako mai kyau na antibody a cikin ƙa'idodin da aka tabbatar.
Bugu da kari, akwai karin shaidu da ke tunatar da mu mu yi taka tsantsan da marasa lafiya marasa alamun cutar da marasa alamun cutar.
Saboda haka, ya kamata a sabunta jadawalin kwararar Zhou et al., saboda sun rarraba mutumin da ba shi da alamun asibiti a matsayin ƙarancin haɗari.
Hakanan ana buƙatar tabbatar da tsarin ƙimar a cikin ƙarin aikin asibiti da karatu.
A ƙarshe, muna fatan samun ƙarin shaida kai tsaye kuma muna kira ga masu karatu su ba da ra'ayoyinsu.
Don ganewar asali na mutumin da ake zargi da cutar da mutumin da aka tabbatar da cutar, muna ba da shawarar bin diddigin sabbin jagororin ƙasashensu.
Ƙungiyarmu za ta kuma sabunta jagororinmu don bayar da taimako.
Bangladesh ta ba da rahoton sabbin mutuwar biyar saboda COVID-19, mafi girma a kowace rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar mutane biyar sakamakon COVID-19 a ranar.
Wannan shine mafi yawan adadin mutuwar a rana guda saboda kwayar cutar.
A jiya, Cibiyar Kula da Cututtuka da Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton yawan mutanen da suka kamu da cutar sun haɗa da masu aiki 114 da kuma 33 da suka warke waɗanda ke zama a gida.
An samu mutuwar mutane 17.
A wani taron labarai na kan layi, darektan IEDCR, Dokta Meerjady Sabrina Flora, ta ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr Meerjady, mutane biyu sun haura shekaru 60, biyu tsakanin 51 da 60, kuma daya yana da shekaru 41-50.
Ta kuma ce biyu daga cikin wadanda aka kashe daga Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu, cewa daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, darektan Hukumar Yaki da Cin Hanci da Rashawa ta Bengal, wanda aka kula da shi a Asibitin Kuwait Maitree.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufuri da gadaje na Bangladesh Obaidul Quader ya ce za a rufe jigilar jama'a na tsawon lokacin da aka tsara tun farko, har zuwa wannan Asabar mai zuwa.
Wannan rufewar jigilar jama'a da farko ya fara ne a ranar 26 ga Maris kuma an shirya zai ƙare a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu mahimmanci - likitanci, mai da abinci.
Abubuwan farko da aka rubuta game da kamuwa da COVID-19 a Bangladesh sun kasance a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar ɗayansu.
A ranar 19 ga watan Maris, waɗannan uku sun warke.
SARS-CoV-2 ya zarce mutane miliyan daya da suka kamu da cutar a duniya
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus ta SARS-CoV-2 ya zarce miliyan ɗaya a duk duniya, bayanan Jami'ar Johns Hopkins sun nuna.
Akalla mutuwar mutane dubu 52 an danganta su da COVID-19, cutar da cutar coronavirus ke haifarwa.
Wannan muhimmin abu ya zo a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko kuma Zambia ta sami mutuwar farko da ta shafi coronavirus.
Koriya ta Arewa ta yi ikirarin, har zuwa ranar Alhamis, tana ɗaya daga cikin ƙasashe kaɗan da suka rage marasa kamuwa da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da aka tabbatar da cutar, gami da mutane 79,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe agogon Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an yi rikodin sama da mutane dubu 244 da suka kamu da cutar coronavirus, wanda ya danganta da mutuwar mutane akalla 5,900.
CBS News ta ruwaito, tana ambaton bayanan Jami'ar Johns Hopkins, akwai mutuwar Amurka sama da 1,000 a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana cutar yaduwa.
A ranar Alhamis, Sergei Sobyanin, magajin garin Moscow, ya tsawaita dokar kulle birnin har zuwa 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya bayyana cewa za a ci gaba da biyan 'yan Rasha albashi ba tare da sun je aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci ta kasa da kwanaki 15; an amince da kuri'ar da kuri'u 215 a kan, goma sun ki, kuma kuri'a daya ta yi.
Saudiyya ta tsawaita dokar hana fita a biranen alfarma na Makka da Madina don ta ci gaba da aiki a duk rana; a baya, dokar hana fita tana aiki ne kawai tsakanin karfe 3 na yamma da karfe 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin karfe 10 na dare da karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar zaman gida har zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya sun rage iyakar takardar bayan gida a kowane ma'amala
A ranar Lahadi da Asabar da yamma, sarƙoƙin shagunan Australiya Woolworths da Coles sun rage ƙuntatawa kan sayen takarda na bayan gida zuwa fakiti biyu da ɗaya a kowane ma'amala a duk shagunan a matakin ƙasa, bi da bi.
ALDI kuma ta gabatar da iyakar kunshin daya, a ranar Litinin.
An sanya waɗannan ƙuntatawa a matsayin saƙonni a kan rajistan shiga, da kuma shafukan Facebook na sarƙoƙi.
An bayar da rahoton cewa masu siye suna tara kaya saboda tsoron COVID-19 idan mutane suna buƙatar keɓe kansu.
A ranar Laraba, Woolworths kuma ya iyakance sayen takardar bayan gida don isar da gida zuwa fakiti ɗaya a kowane tsari.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na fakitin hudu da aka gabatar da su ta hanyar Woolworths da Coles a ranar 4 da 5 ga Maris.
" Coles, a cikin sanarwar da ta fitar a ranar 8 ga Maris, ta ba da rahoton cewa tare da takunkumin fakitin hudu a wurin, ""shaguna da yawa har yanzu suna sayarwa cikin awa ɗaya bayan isarwa"", kuma ta kira bukatar ""ba a taɓa gani ba"", yayin da ALDI, a cikin rubutun Facebook a ranar Talata, ta kira shi ""ba zato ba tsammani"". "
"Tallace-tallace sun tashi cikin "karin girma" a makon da ya gabata, a cewar mai magana da yawun Woolworths. "
Shagon Costco a Canberra ya kuma iyakance adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don kara rage karancin, Coles ya ba da umarnin manyan fakiti daga masu samarwa da kuma kara yawan isar da kayayyaki, Woolworths ya ba da umarnin karin kaya, yayin da ALDI ta samar da kaya don shirin na ranar Laraba na musamman da wuri.
Russell Zimmerman, darektan ƙungiyar masu sayar da kayayyaki a ƙasar Ostareliya, ya ce masu sayar da kayayyaki suna ƙoƙari su tara kayayyaki, amma dokar da hukumomin yankin suka kafa game da lokacin da za a kai kayayyaki ta sa hakan ya yi wuya.
Yana tsammanin farashin samarwa zai karu, yayin da masu samar da kayayyaki ke kokarin biyan bukatar, kuma ba za a samu karin kayayyaki ba.
A ranar Talata, ALDI ta sanar da cewa bayan sakin kaya da wuri, wasu shagunan ba za su iya gudanar da sadaukarwar Laraba ba.
A wani rahoto da News.com.au ta wallafa, Dr Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shagunan suna cika kaya a kowane dare.
Ya ce takardar wanka abu ne mai girma, wanda ke haifar da karancin adadin kayayyaki, kuma, idan aka sayar, ya bar sararin samaniya a kan ɗakunan ajiya, yana kara jin ƙarancin.
"Coles da Woolworths suna da ra'ayi [cewa] idan akwai abubuwa da yawa a kan shiryayye, idan ana iya [siyar da] kayayyaki kamar takalman bayan gida da tsabtace jiki kuma suna nan da yawa, tabbas za ku rage firgita"" in ji Russell Zimmerman ga ABC News. "
Mai samar da takardar bayan gida mai sake amfani da ita wanda ya ba da shit ya ce a ranar Laraba da ta gabata sun ƙare.
Kimberly-Clark, wanda ke yin Kleenex Toilet Tissue, da Solaris Paper wanda ke yin Sorbent, sun jaddada cewa suna aiki 24/7 don kiyaye wadatar, a cewar rahoton News.com.au.
Domain.com, wani shafin yanar gizon gidaje, ya ruwaito wasu masu siyar da gidaje suna ba da takardar bayan gida kyauta ga mai ba da kyauta na farko a gwanjon a Melbourne, lokacin da aka gudanar da gwanjo kaɗan saboda masu siye suna da hutu a ƙarshen mako mai tsawo na ranar aiki.
A ranar Alhamis, jaridar NT News, da ake bugawa a yau a Darwin, ta haɗa da shafi takwas da aka yi amfani da su a matsayin takardar bayan gida.
Shagunan da farko sun yi jinkirin sanya takunkumi, a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris inda suka ce ba su da shirin sanya takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna da matukar bukata, ciki har da masks, sanitizer, kayan bushewa, wanke hannu da gari.
Hakazalika, a wajen Ostiraliya, a ranar Lahadi da yamma an lura da babban kanti na Burtaniya na Ocado yana iyakance sayayya na takardar bayan gida ta Andres zuwa fakiti biyu na 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19  cutar da cutar coronavirus SARS-CoV-2  ke haifarwa a matsayin annoba.
" Kodayake kalmar ""annoba"" tana nufin kawai yadda cutar ta yadu sosai, ba yadda hatsarin wasu lokuta ke ba, WHO ta lura da buƙatar tura gwamnatoci zuwa aiki: "
"Duk kasashe na iya canza yanayin wannan annoba. "
"Idan kasashe sun gano, gwada, bi da, ware, ganowa da kuma tattara mutanensu a cikin martani,"" in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO. "
"Muna matukar damuwa da yadda cutar ke yaduwa da kuma yadda take da tsanani da kuma yadda ake rashin daukar mataki".
" A cewar Dr. Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Rigakafin Amurka, annobar "ba ta da misali".
Ya ce, a cikin maganganun da CNN ta buga a watan Fabrairu, ""ban da mura, ba a lura da wani kwayar cutar numfashi ba daga fitowar ta zuwa ci gaba da yaduwa a duniya. "" "
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa ""ba mu taɓa ganin annobar da cutar coronavirus ta haifar ba""".
Ya ci gaba, ""kuma ba mu taɓa ganin annobar da za a iya sarrafa ta a lokaci guda ba. """
Sabon matsayin a matsayin annoba ya biyo bayan shawarar WHO a watan Janairu don ayyana barkewar cutar a matsayin gaggawa na lafiyar jama'a na damuwa ta duniya.
" Daraktan Cibiyar Kula da Magungunan Allergy da Cututtuka na Amurka, Dr. Anthony Fauci, ya ce game da barkewar cutar, ""a ƙarshe, zai ƙara muni. "" "
Ya zuwa ranar Alhamis, Associated Press ta ba da rahoton akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duk duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar annobar coronavirus ta 201920 annobar cutar coronavirus ce ta 2019 (COVID-19), wanda ke faruwa ta hanyar cutar coronavirus mai tsanani ta 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta kiwon lafiyar jama'a na damuwa ta duniya a ranar 30 ga Janairu, 2020, kuma an amince da ita a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu 2020, an ba da rahoton kusan mutane miliyan 1.61 na COVID-19 a cikin ƙasashe 210 da yankuna, wanda ya haifar da kusan mutuwar 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar a China ya kai kashi 4%, yayin da a duniya ya kasance daga 13.04% a Aljeriya zuwa .08% a New Zealand.
Alamomin da aka saba gani sun hada da zazzabi, tari da kuma numfashi.
Matsaloli na iya haɗa da ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci daga fallasawa zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma yana iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu wani allurar rigakafi ko magani na musamman na cutar.
Maganin farko shine maganin alamomi da tallafi. Matakan rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe bakin mutum lokacin tari, nisantar wasu mutane, da saka idanu da keɓe kai ga mutanen da suke zargin sun kamu da cutar.
Hukumomi a duk duniya sun amsa ta hanyar aiwatar da ƙuntatawa na tafiya, keɓewa, dokar hana fita, sarrafa haɗarin wurin aiki, da rufe wuraren aiki.
Cutar ta haifar da mummunan rikicewar tattalin arziki da zamantakewar duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma karancin kayayyaki da aka kara ta'azzara ta hanyar sayen firgici.
Makarantu da jami'o'i sun rufe ko dai a duk faɗin ƙasar ko a cikin gida a cikin ƙasashe 193, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Bayanai marasa kyau game da kwayar cutar sun bazu a kan layi, kuma an sami lamura na ƙin baƙi da nuna bambanci ga Sinawa, sauran mutanen Gabas da Kudu maso Gabashin Asiya da bayyanar su, da sauransu daga yankunan da ke da manyan cututtukan cutar.
Saboda rage tafiye-tafiye da rufe masana'antun masana'antu, an sami raguwar gurɓatar iska da fitar da iskar carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin cututtukan ciwon huhu da ba a san dalilin su ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu 2020.
Yawancin lokuta suna da alaƙa da Kasuwar Kasuwancin Kifi na Kifi na Huanan kuma don haka ana tunanin cewa kwayar cutar ta zoonotic ce.
Kwayar cutar da ta haifar da barkewar cutar an san ta da SARS-CoV-2, sabuwar kwayar cutar da aka gano da ke da alaƙa da kwayar cutar coronaviruses, pangolin coronaviruses, da SARS-CoV. An gano daga baya cewa farkon mutumin da aka sani da alamun cutar ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da alaƙa da alamar kasuwa mai zafi.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku an gano cewa suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya nuna cewa wani lamari da aka gano a ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 daga lardin Hubei, na iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da sabbin shari'o'in da aka ruwaito sun ragu a China amma ba zato ba tsammani suka karu a Italiya, Iran, da Koriya ta Kudu, yawan sabbin shari'o'in da ke wajen China ya zarce adadin sabbin shari'o'in da ke cikin China a karon farko.
Akwai yiwuwar rashin yawan rahotanni, musamman a tsakanin wadanda ke da alamun rashin lafiya.
Zuwa 26 ga watan Fabrairu, an samu karancin masu kamuwa da cutar a tsakanin matasa, wadanda shekarunsu 19 zuwa kasa da haka sun kai kashi 2.4% na masu kamuwa da cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin a sami ingantacciyar rigakafin garken.
Yanayi yana nufin yawan mutanen da aka gwada don COVID-19, kuma wanda aka tabbatar da gwajin ya tabbata bisa ga ƙa'idodin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma ƙasashe da yawa suna da manufofin hukuma na ba da gwaji ga waɗanda ke da alamun rashin lafiya kawai, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa a China, har zuwa 23 ga watan Janairu, kimanin kashi 86% na kamuwa da COVID-19 ba a gano su ba, kuma waɗannan kamuwa da cutar da ba a rubuta ba sune tushen kamuwa da cutar ga kashi 79% na shari'o'in da aka rubuta.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa yawan masu kamuwa da cutar a Italiya ya fi yawan wadanda aka ruwaito.
Ƙididdigar farko na ƙididdigar ƙididdigar asali (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka ta wallafa ya kammala cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga waɗanda ba su yi ba, lokacin daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14.
Ya zuwa 10 ga Afrilu 2020, kusan mutuwar 97,000 an danganta su da COVID-19.
A China, ya zuwa ranar 5 ga watan Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin waɗanda suka haura 60, kuma kashi 75% suna da yanayin kiwon lafiya da suka riga sun wanzu ciki har da cututtukan zuciya da ciwon sukari. Lissafin hukuma na mutuwar daga cutar COVID-19 gabaɗaya suna nufin mutanen da suka mutu waɗanda aka gwada su da COVID daidai da ƙa'idodin hukuma.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda ba zai haɗa da mutanen da suka mutu ba tare da gwaji ba - misali a gida, a gidajen kula da tsofaffi, da sauransu.
Bayanai na wani bangare daga Italiya sun gano cewa yawan yawan mutuwar mutane a lokacin annobar ya zarce adadin mutuwar COVID na hukuma da kashi 4-5x.
" Wata mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta yarda da cewa ""Mun san cewa [adadin mutuwar da aka bayyana] rashin kimantawa ne"", wata sanarwa da rahotanni na rashin daidaituwa suka tabbatar da rashin ƙididdigar a Amurka. Irin wannan rashin kimantawa sau da yawa yakan faru a cikin annoba, kamar annobar cutar H1N1 ta 2009. Mutuwar farko da aka tabbatar a Wuhan ne a ranar 9 ga Janairu 2020. "
Mutuwar farko a wajen babban yankin China ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga Fabrairu.
Zuwa 28 ga watan Fabrairu, a wajen babban yankin China, an yi rikodin mutuwar sama da goma sha biyu a Iran, Koriya ta Kudu, da Italiya.
Zuwa 13 ga watan Maris, kasashe da yankuna sama da arba'in sun ba da rahoton mutuwar, a kowace nahiya sai dai Antarctica. Ana amfani da ma'auni da yawa don ƙididdige yawan mutuwa.
Waɗannan lambobin sun bambanta ta yanki da lokaci, kuma suna shafar yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar, da halayen jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Dangane da ƙididdigar Jami'ar Johns Hopkins, adadin mutuwar duniya zuwa shari'ar shine 6.0% (97,039/1,617,204) kamar na 10 ga Afrilu 2020.
Yawan waɗannan mutanen ya bambanta daga yanki zuwa yanki.
A China, ƙididdigar mutuwar-zuwa-halaye ta ragu daga 17.3% (ga waɗanda ke da alamun bayyanar cututtuka 110 Janairu 2020) zuwa 0.7% (ga waɗanda ke da alamun bayyanar cututtuka bayan 1 Fabrairu 2020).Sauran matakan sun haɗa da ƙimar mutuwar shari'a (CFR), wanda ke nuna yawan mutanen da aka gano waɗanda suka mutu daga cuta, da ƙimar mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan masu kamuwa da cuta (wanda aka gano da wanda ba a gano ba) waɗanda suka mutu daga cuta.
Wadannan ƙididdigar ba su da iyakacin lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewar shari'ar.
Masana da yawa sun yi ƙoƙarin lissafin waɗannan lambobin don takamaiman mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan kamuwa da cutar a cikin annobar gaba ɗaya yana tsakanin 0.1% da 0.39%.
Ƙididdigar sama na wannan zangon ya dace da sakamakon gwajin bazuwar farko don COVID-19 a Jamus, da kuma nazarin ƙididdigar nazarin tasirin gwaji akan ƙididdigar CFR.
WHO ta tabbatar da cewa za a iya sarrafa annobar.
Ba a san lokacin da cutar ta fara bullar ba kuma ba ta da tsawo kuma za ta iya bambanta dangane da wurin da ta fito.
" Maciej Boni na Jami'ar Jihar Penn ya bayyana, "" Idan ba a kula da su ba, cututtukan cututtuka galibi suna da yawa sannan kuma suna fara raguwa lokacin da cutar ta ƙare daga masu karɓar baƙi. "
"Amma kusan ba zai yiwu a yi wani kyakkyawan hasashen yanzu game da lokacin da hakan zai kasance ba".
Babban mai ba da shawara kan harkokin lafiya na gwamnatin China Zhong Nanshan ya yi jayayya cewa ""yana iya karewa a watan Yuni"" idan duk ƙasashe za su iya motsawa don bin shawarar WHO kan matakan dakatar da yaduwar cutar. "
" A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magungunan Yankin Guguwa ta London ya bayyana cewa SARS-CoV-2 ""zai yi yawo, mai yiwuwa na shekara ɗaya ko biyu"". "
" A cewar binciken kwalejin Imperial wanda Neil Ferguson ya jagoranta, za a buƙaci nisantar jiki da sauran matakan ""har sai an sami allurar rigakafi (mai yiwuwa watanni 18 ko fiye)"". "
"William Schaffner na Jami'ar Vanderbilt ya bayyana, ""Ina ganin ba zai yiwu wannan coronavirus basaboda yana da saukin yaduwazai ɓace gaba ɗaya"" kuma zai iya zama "cuta ta yanayi, yana dawowa kowace shekara"". "
Rashin cutar na dawowa zai dogara ne akan rigakafin garken da kuma girman maye gurbi.
Alamun COVID-19 na iya zama ba na musamman ba kuma mutanen da ke fama da cutar na iya zama marasa alamun cutar.
Alamomin biyu da suka fi yawa sune zazzabi (88%) da tari mai bushe (68%).
Alamomin da ba a saba gani ba sun haɗa da gajiya, samar da ƙura na numfashi (phlegm), rashin jin ƙamshi, numfashi, tsoka da ciwon haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, vomiting, hemoptysis, zawo, ko cyanosis. WHO ta bayyana cewa kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa kamar wahalar numfashi, ciwon kirji mai ɗorewa ko matsin lamba, rikicewa kwatsam, wahalar farkawa, da fuska ko lebe mai launin shuɗi; ana ba da shawarar kula da likita nan da nan idan waɗannan alamun sun kasance. Ƙarin ci gaban cutar na iya haifar da ciwon huhu mai tsanani, ciwon ƙwayar cuta mai tsanani, sepsis, septic shock da mutuwa.
Wasu daga cikin waɗanda suka kamu da cutar na iya zama ba su da alamun cutar, ba tare da alamun asibiti ba amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda ke da kusanci da mutanen da aka tabbatar da kamuwa da cutar ya kamata a lura da su sosai kuma a bincika su don kawar da kamuwa da cuta.
Tsinkayen kasar Sin na yawan marasa alamun cutar sun kasance daga kadan zuwa 44%.
Lokacin da aka saba da shi (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) ya kasance daga kwana ɗaya zuwa 14; yawanci kwanaki biyar ne. A matsayin misali na rashin tabbas, ƙididdigar yawan mutanen da ke da COVID-19 waɗanda suka rasa ƙamshi da farko ya kasance 30% kuma daga baya ya ragu zuwa 15%.
Har yanzu ana ci gaba da gano wasu bayanai game da yadda cutar ke yaduwa.
Ana tsammanin cutar tana yaduwa ne a lokacin kusanci da ƙananan ɗigon ruwa da aka samar yayin tari, hancin, ko magana; tare da kusanci da ke tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Nazarin ya gano cewa tari da ba a rufe shi ba na iya haifar da saukad da ruwa zuwa mita 4.5 (15 ƙafa) zuwa mita 8.2.
Wasu sun ba da shawarar cewa ana iya watsa kwayar cutar ta ƙananan ɗigon ruwa waɗanda ke kasancewa na tsawon lokaci a cikin iska, waɗanda za a iya samarwa yayin magana. Hakanan ana iya samar da ɗigon numfashi yayin numfashi, gami da lokacin magana, kodayake kwayar cutar ba ta yawan wucewa ta iska.
Ruwa yana iya shiga bakin mutane ko kuma hanci ko kuma ya shiga cikin huhu.
Wasu hanyoyin kiwon lafiya kamar intubation da sake farfado da zuciya (CPR) na iya haifar da ɓoyayyen numfashi don yin iska kuma don haka ya haifar da yaduwar iska.
Hakanan yana iya yaduwa idan mutum ya taɓa wani abu mai ƙazanta, gami da fata, sannan ya taɓa idanunsu, hanci, ko bakinsu.
Duk da cewa akwai damuwa cewa zai iya yaduwa ta hanyar ƙazanta, ana ganin wannan haɗarin yana da ƙanƙanci.
Gwamnatin China ta musanta yiwuwar yaduwar SARS-CoV-2 ta baki-baki. Kwayar cutar tana da saurin kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a matakai na gaba na cutar.
Mutane sun gwada tabbatacce ga cutar har zuwa kwanaki uku kafin bayyanar cututtuka wanda ke nuna yiwuwar yaduwa kafin haɓaka alamun bayyanar cututtuka.
Rahotanni kaɗan ne kawai na alamun rashin alamun da aka tabbatar a cikin dakin gwaje-gwaje, amma an gano watsawar rashin alamun ta wasu ƙasashe yayin binciken gano hulɗa.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta bayyana cewa duk da cewa ba a san yadda cutar ke yaduwa ba, mutum ɗaya yakan kamu da wasu biyu zuwa uku. Kwayar cutar tana rayuwa na awanni zuwa kwanaki a kan farfajiya.
Musamman, an gano cewa ana iya gano kwayar cutar har zuwa kwanaki uku a kan filastik (polypropylene) da 304 bakin karfe, na kwana ɗaya a kan kwali, kuma har zuwa awanni huɗu a kan jan ƙarfe.
Wannan, duk da haka, ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada kwayar cutar ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan tuntuɓar dabbobi, kamar bayan tuntuɓar wasu wurare da mutane masu cutar za su iya taɓa su.
Cutar coronavirus 2 mai tsanani ta numfashi (SARS-CoV-2) wani sabon kwayar cuta ne, wanda aka fara warewa daga mutane uku da cutar huhu da ke da alaƙa da rukunin cututtukan numfashi a Wuhan.
Dukkanin siffofin sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin coronaviruses masu alaƙa a cikin yanayi.A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke narkar da murfin kariya.SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Ana tunanin cewa yana da asalin dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar coronavirus ta haɗu da kwayoyin halitta tare da nau'in Betacoronavirus, a cikin ƙaramin Sarbecovirus (tsarin B) tare da nau'ikan nau'ikan biyu da aka samo daga bat.
Ya kasance daidai da kashi 96% a matakin kwayoyin halitta tare da sauran samfuran coronavirus na bat (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci amino acid guda daya ne kawai a wasu sassan jerin kwayoyin halittar mutum tsakanin ƙwayoyin cuta daga pangolins da waɗanda suke daga mutane.
Kwatanta dukkanin kwayoyin halitta har zuwa yau ya gano aƙalla kashi 92% na kayan kwayoyin halitta da aka raba tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da pangolins a matsayin mai watsa shiri na tsakiya ba.
Ana iya gano kamuwa da cutar ta hanyar cutar ta hanyar alamomi, kodayake tabbaci a ƙarshe ta hanyar jujjuyawar polymerase chain reaction (rRT-PCR) na ɓoyayyun cututtukan ko CT imaging.
Wani binciken da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR hankali sosai, kodayake ba shi da ƙayyadaddun bayani, tare da yawancin fasalulluka na hoto da ke haɗuwa da sauran ciwon huhu da hanyoyin cututtuka.
" Tun daga watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""Ba za a yi amfani da CT don tantancewa ko a matsayin gwajin layi na farko don gano COVID-19 ba"". "
WHO ta buga wasu hanyoyin gwajin RNA don SARS-CoV-2, tare da na farko da aka bayar a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin akan numfashi ko samfurin jini.
Sakamakon yawanci ana samunsa cikin 'yan sa'o'i zuwa kwanaki.
Gabaɗaya ana yin wannan gwajin akan swab na nasopharyngeal kodayake ana iya amfani da swab na makogwaro. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwaje-gwajen serological, waɗanda ke gano ƙwayoyin cuta.
Ya zuwa 6 ga Afrilu 2020, babu ɗayan waɗannan da aka tabbatar da cewa daidai ne don yarda da amfani da shi sosai.
A Amurka an amince da gwajin serological wanda Cellex ya haɓaka don amfani da gaggawa ta hanyar dakunan gwaje-gwaje masu izini kawai.
Abubuwan da ke nuna alamun hoto akan radiographs da CT na mutane waɗanda ke da alamun cututtuka sun haɗa da rashin daidaituwa na gilashin gilashin da ba a taɓa gani ba da kuma rashin zubar da jini.
Radiologicalungiyar Radiology ta Italiya tana tattara bayanan kan layi na duniya na binciken hoto don tabbatar da shari'o'in.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, ɗaukar hoto ba tare da tabbatarwa ta PCR ba yana da iyakantaccen ƙayyadaddun abu wajen gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa kodayake daukar hoto bai da takamaiman cutar, amma ya fi sauri da kuma saukin kamuwa da cutar, wanda ke nuna cewa ana iya la'akari da shi a matsayin kayan aikin tantancewa a yankunan da annoba ta barke.
An haɓaka cibiyoyin sadarwa na jijiyoyin jiki na wucin gadi don gano fasalin hoto na kwayar cutar tare da duka radiography da CT.
Dabaru don hana yaduwar cutar sun haɗa da kiyaye tsabtace jiki gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannayen da ba a wanke ba, da tari ko hancin cikin nama da sanya nama kai tsaye cikin kwandon shara.
An shawarci waɗanda ke da cutar da su sa'ad da suke cikin jama'a su sanya abin rufe fuska.
Ana kuma ba da shawarar kiyaye nesa don hana yaduwa. Gwamnatoci da yawa sun hana ko kuma sun ba da shawarar duk balaguron da ba dole ba zuwa da daga ƙasashe da yankunan da cutar ta shafa.
Koyaya, kwayar cutar ta kai matakin yaduwar al'umma a yawancin sassan duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'ummomi, kuma wasu membobin al'umma ba su san inda ko yadda suka kamu ba. Ana ba da shawarar masu ba da kiwon lafiya da ke kula da wani wanda zai iya kamuwa da cutar su yi amfani da ƙa'idodin kariya, kiyayewa na tuntuɓar, da kariya ta ido. Binciken tuntuɓar hanya ce mai mahimmanci ga hukumomin kiwon lafiya don ƙayyade tushen kamuwa da cuta da hana ƙarin yaduwa.
Amfani da bayanan wurin da wayoyin hannu ke amfani da su don wannan dalili ya haifar da damuwar sirri, tare da Amnesty International da sama da wasu kungiyoyi 100 da suka fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen wayoyin hannu daban-daban ko kuma an ba da shawarar don amfani da son rai, kuma har zuwa 7 ga Afrilu, 2020, sama da ƙungiyoyin masana goma sha biyu suna aiki kan hanyoyin magance sirrin sirri, kamar amfani da Bluetooth don yin rajistar kusanci da mai amfani da wasu wayoyin hannu.
Masu amfani sannan suna karɓar saƙo idan sun kasance kusa da wani wanda ya gwada tabbatacce ga COVID-19. Ra'ayoyin da ba daidai ba suna yawo game da yadda za a hana kamuwa da cuta; misali, wanke hanci da yin gargling tare da bakin bakin ba su da tasiri.
Babu allurar rigakafin COVID-19, kodayake ƙungiyoyi da yawa suna aiki don haɓaka ɗaya.
Ana bada shawarar wanke hannu don hana yaduwar cutar.
Hukumar CDC ta bada shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla dakika ashirin, musamman bayan sun je bayan gida ko kuma idan hannayensu sun yi datti sosai; kafin su ci abinci; da kuma bayan sun hura hanci, tari, ko hancin mutum.
Wannan domin a waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke fashe da kumburin kariya.
CDC ta kuma ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na hannu da ke da giya da aƙalla kashi 60% na giya ta hanyar girma lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane da su guji taɓa idanu, hanci, ko baki da hannaye marasa wanka.
Za'a iya kawar da farfajiyoyi tare da wasu mafita (a cikin minti daya na fallasa maganin kashe cuta don farfajiyar bakin karfe), ciki har da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Wasu magunguna, kamar su benzalkonium chloride da chrohexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin ko tabbatar da cutar COVID a wani wuri kamar ofis ko kula da rana, duk wuraren kamar ofisoshi, dakunan wanka, wuraren gama gari, kayan aikin lantarki da aka raba kamar allunan, allon taɓawa, mabuɗan rubutu, sarrafawa ta nesa, da injunan ATM da marasa lafiya ke amfani da su, ya kamata a kashe su.
Ƙungiyoyin kiwon lafiya sun ce idan mutum yana tari ko hancinsa, ya rufe bakinsa da hancinsa da ƙafarsa ko kuma ya rufe shi da tawul kuma ya zubar da tawul ɗin nan da nan.
Ana ba da shawarar rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya rage girma da nisan tafiyar ɗigon numfashi da ke warwatsewa yayin magana, hancin, da tari.
WHO ta bayar da umarni kan lokacin da yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin kwayar cuta a Jami'ar Leeds, "Sanya abin rufe fuska na iya rage son mutane su taba fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba. "An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da wanda ke da cutar. "
WHO ta ba da shawarar sanya abin rufe fuska ta lafiyayyun mutane kawai idan suna cikin haɗari, kamar waɗanda ke kula da mutum mai COVID-19, kodayake sun kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara karfafa amfani da abin rufe fuska daga jama'a.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na likita wanda ba na masana'anta ba. China ta ba da shawarar musamman amfani da abin rufe fuska na likita da za a iya amfani da shi ta hanyar lafiyayyun mutane, musamman lokacin da suke kusanci da mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska lokacin da ke ɗaukar jigilar jama'a ko zama a wuraren da jama'a ke yawa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi abin rufe fuska na masana'anta a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita a fili ba tare da sanya abin rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta nemi kowa ya sanya abin rufe fuska lokacin da yake zuwa wuraren jama'a don kare kansa da wasu.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga kantin sayar da kayan masarufi dole ne ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna kasar da su sanya takunkumin rufe fuska idan suna waje.
Taiwan, wacce ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjoji a jiragen kasa da bas na tsakanin birane su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta sanya wajibi a sanya abin rufe fuska a duk lokacin da za a fita waje, yayin da kuma ta ba da shawarar yin abin rufe fuska na gida ga waɗanda ba za su iya siyan abin rufe fuska ba.
Hakanan an yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nisa tsakanin jama'a (wanda kuma aka sani da nesa ta jiki) ya haɗa da ayyukan sarrafa kamuwa da cuta da nufin rage saurin yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun haɗa da keɓewa; ƙuntatawa na tafiya; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, ko cibiyoyin cin kasuwa.
Mutane na iya amfani da hanyoyin nisantar zamantakewa ta hanyar kasancewa a gida, iyakance tafiya, guje wa wuraren taron jama'a, amfani da gaisuwa ba tare da tuntuɓar juna ba, da nisantar da kansu daga wasu.
Gwamnatoci da yawa yanzu suna ba da umarni ko ba da shawarar nisantar zamantakewa a yankunan da cutar ta shafa.
Matsakaicin girman taron da hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka suka ba da shawarar an rage shi da sauri daga mutane 250 (idan babu sanannen yaduwar COVID-19 a wani yanki) zuwa mutane 50, kuma daga baya zuwa mutane 10.
"A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane sama da biyu.Manya da waɗanda ke da yanayin kiwon lafiya kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma tsarin garkuwar jiki da aka lalata suna fuskantar haɗarin kamuwa da cututtuka da rikitarwa kuma CDC ta shawarce su da su zauna a gida gwargwadon iko a wuraren da cutar ta bulla.A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "nisanci na zamantakewa" da "nisanci na zahiri", don bayyana cewa makasudin shine rage hulɗar jiki yayin kiyaye alaƙar zamantakewa, ko dai a zahiri ko a nesa. "
" Amfani da kalmar ""nisanci na zamantakewa"" ya haifar da ma'anar cewa mutane su shiga cikin cikakken keɓewar zamantakewa, maimakon ƙarfafa su su ci gaba da tuntuɓar wasu ta hanyar madadin. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i don amfani da su yayin annobar. "
Wadannan sun hada da shawarwari don yin jima'i kawai tare da wanda kuke zaune tare, wanda ba shi da kwayar cutar ko alamun cutar.
An ba da shawarar keɓewa a gida ga waɗanda aka gano suna da COVID-19 da waɗanda suke zargin sun kamu da cutar.
Hukumomin kiwon lafiya sun bayar da cikakkun bayanai game da keɓe kai yadda ya kamata. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar keɓe kai ga dukan mutanen da ke zaune a yankunan da cutar ta shafa.
An bayar da umarnin keɓe kai mafi ƙarfi ga waɗanda ke cikin manyan ƙungiyoyin haɗari.
Wadanda suka iya kamuwa da wani da ke dauke da COVID-19 da wadanda suka yi tafiya kwanan nan zuwa wata kasa ko yanki da ke da yaduwar yaduwar an shawarce su da su killace kansu na kwanaki 14 daga lokacin da suka kamu da cutar.
Dabaru wajen dakile barkewar cutar sune hana ko hanawa, da ragewa.
Ana gudanar da hana yaduwar cutar a farkon lokacin barkewar cutar kuma ana nufin ganowa da ware wadanda suka kamu da cutar da kuma gabatar da wasu matakan kula da kamuwa da cuta da allurar rigakafi don dakatar da yaduwar cutar ga sauran jama'a.
Idan ba za a iya dakile yaduwar cutar ba, sai a koma matakin rage yaduwar cutar: ana daukar matakan rage yaduwar cutar da rage tasirin ta a kan tsarin kiwon lafiya da al'umma.
Za a iya yin haɗuwa da matakan hanawa da ragewa a lokaci guda.
Tashin hankali yana buƙatar ƙarin matakan matsananci don juyar da cutar ta hanyar rage yawan haifuwa zuwa ƙasa da 1. Wani ɓangare na sarrafa barkewar cutar mai yaduwa shine ƙoƙarin rage ƙimar cutar, wanda aka sani da daidaitawar yanayin cutar.
Wannan yana rage hadarin ayyukan kiwon lafiya da ke cike da mutane kuma yana ba da ƙarin lokaci don samar da alluran rigakafi da magunguna.
Hanyoyin da ba na magunguna ba waɗanda za su iya magance barkewar cutar sun haɗa da matakan rigakafin mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓe kai; matakan al'umma da nufin nisantar jiki kamar rufe makarantu da soke taron jama'a; haɗin gwiwar al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan matakan; da kuma matakan muhalli kamar tsabtace farfajiya. An ɗauki ƙarin tsauraran matakai don ƙuntata barkewar cutar a China da zarar tsananin barkewar cutar ya bayyana, kamar keɓewa da keɓaɓɓun birane da kuma sanya takunkumin hana tafiya.
Sauran ƙasashe ma sun ɗauki matakai daban-daban da nufin iyakance yaduwar cutar.
Koriya ta Kudu ta gabatar da tantancewar jama'a da keɓewar wuri, kuma ta ba da faɗakarwa game da motsin mutane masu kamuwa da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda ke da cutar waɗanda suka keɓe kansu kuma sun ɗora manyan tarar waɗanda suka kasa yin hakan.
Taiwan ta kara samar da abin rufe fuska da kuma hukunta tara kayan aikin likita.Gasar kwaikwayo ga Burtaniya da Amurka sun nuna cewa ragewa (ragewa amma ba dakatar da yaduwar annoba) da dakile (juyawa ci gaban annoba) suna da manyan kalubale.
Manufofin rage cututtuka masu kyau na iya rage yawan buƙatun kiwon lafiya da kashi biyu bisa uku da mutuwar rabin, amma har yanzu yana haifar da dubban daruruwan mutuwar da tsarin kiwon lafiya da ke fama da wahala.
Za a iya fifita hanawa amma ana buƙatar ci gaba da har sai kwayar cutar ta kewaya a cikin yawan mutane (ko har sai an sami allurar rigakafi, idan hakan ta fara faruwa), saboda watsawa zai sake dawowa da sauri idan an sassauta matakan.
Matakan da aka dauka na dogon lokaci don dakile annobar na haifar da tsadar zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar da aka amince da su don COVID-19, amma ana ci gaba da ƙoƙarin haɓaka, gami da gwajin magungunan da ke akwai.
Shan magungunan sanyi da ba a ba da takardar sayan magani ba, shan ruwa, da kuma hutawa zai iya taimaka wajen rage alamun.
Dangane da tsananin cutar, ana iya bukatar maganin oxygen, ruwa cikin jijiya, da taimakon numfashi.
Yin amfani da kwayoyin steroid na iya ƙara muni.
Ana binciken wasu mahaɗan da aka amince da su a baya don maganin wasu cututtukan ƙwayoyin cuta don amfani da su wajen magance COVID-19.
" WHO ta kuma bayyana cewa wasu "magungunan gargajiya da na gida" na iya samar da sauki ga alamun da SARS-CoV-19 ya haifar. "
Ƙara iya aiki da daidaita kiwon lafiya don bukatun marasa lafiya na COVID-19 an bayyana ta WHO a matsayin muhimmin matakin amsawa ga barkewar cutar.
ECDC da ofishin yanki na Turai na WHO sun ba da jagorori ga asibitoci da sabis na kula da lafiyar farko don sauya albarkatu a matakai da yawa, gami da mai da hankali kan sabis na dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓi a duk lokacin da zai yiwu, warewa da keɓe marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan masu numfashi da gadaje da ke akwai.
Akwai dabaru daban-daban game da inda farkon yanayin (wanda ake kira mai haƙuri zero) na iya samo asali.
Ana iya gano farkon sanannen cutar coronavirus na farko zuwa 1 ga Disamba 2019 a Wuhan, Hubei, China.
A cikin wata guda, yawan masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Waɗannan galibi suna da alaƙa da Kasuwar Kasuwancin Abinci na Tekun Huanan, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'idar ita ce kwayar cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko, a wasu kalmomin, yana da asalin dabbobi. An lura da tarin cutar huhu da ba a san dalilin ba a ranar 26 ga Disamba kuma likita Zhang Jixian ya kula da shi a Asibitin Lardin Hubei, wanda ya sanar da CDC na Wuhan Jianghan a ranar 27 ga Disamba.
" A ranar 30 ga Disamba, wasu likitoci a asibitin Wuhan na tsakiya sun gargadi abokan aikinsu game da ""coronavirus mai kama da SARS"". "
Likitoci takwas daga cikin wadannan, ciki har da Li Wenliang, 'yan sanda sun yi musu gargaɗi don yada jita-jita na ƙarya, kuma wani, Ai Fen, shugabanninta sun tsawata mata don tayar da ƙararrawa.
Daga baya Hukumar Kiwon Lafiyar Birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An bayar da rahoton isassun cututtukan ciwon huhu da ba a sani ba ga hukumomin kiwon lafiya a Wuhan don haifar da bincike a farkon watan Janairu. A farkon lokacin barkewar cutar, yawan masu cutar ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, kwayar cutar ta yadu zuwa wasu lardunan China, wanda aka taimaka ta hanyar ƙaurawar Sabuwar Shekarar China da Wuhan kasancewar cibiyar sufuri da babbar hanyar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 a rana daya, ciki har da mutane biyu a Beijing da daya a Shenzhen.
Bayanai na hukuma na baya-bayan nan sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar a ranar 20 ga Janairu, 2020.Zuwa 26 ga Maris, Amurka ta zarce China da Italiya tare da mafi yawan adadin mutanen da aka tabbatar da cutar a duniya.Zuwa 9 ga Afrilu, 2020, an samu sama da mutane miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kimanin kasashe da yankuna 200 sun sami akalla mutum daya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa a cikin Yankin Schengen sun takaita motsi da kafa kulawar kan iyaka.
Haɗin gwiwar ƙasa sun haɗa da matakan hanawa kamar keɓewa (wanda aka sani da umarnin zama a gida, umarnin mafaka a wuri, ko kullewa) da dokar hana fita.Ya zuwa 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna ƙarƙashin wasu nau'ikan kullewa a Amurka, sama da mutane miliyan 50 suna cikin kullewa a Philippines, kusan mutane miliyan 59 suna cikin kullewa a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin kullewa a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin wasu nau'ikan kulle-kulle, wanda ya karu zuwa mutane biliyan 2.6 bayan kwana biyukusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon yanayin tabbatar da COVID-19 zuwa 1 ga Disamba 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna farkon yanayin ya kasance a ranar 17 ga Nuwamba.
Likita Zhang Jixian ta lura da tarin cututtukan ciwon huhu da ba a san dalilin su ba a ranar 26 ga Disamba, wanda asibitin ta ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin kwayoyin halitta na farko na samfuran marasa lafiya a ranar 27 ga Disamba 2019 ya nuna kasancewar kwayar cutar coronavirus mai kama da SARS.
Hukumar Kiwon Lafiyar Birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
" Yayin da waɗannan sanarwar suka faru, likitocin Wuhan sun yi gargadi daga 'yan sanda don " yada jita-jita " game da barkewar cutar. "
" Hukumar Lafiya ta Kasa ta kasar Sin da farko ta yi ikirarin cewa babu "bayyanannen shaida" na yaduwar mutum zuwa mutum. "
A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da kamfen mai tsattsauran ra'ayi wanda daga baya babban sakataren Jam'iyyar Kwaminis ta China Xi Jinping ya bayyana a matsayin "yaƙin mutane" don hana yaduwar cutar.
" A cikin abin da aka bayyana a matsayin ""mafi girman keɓewa a tarihin ɗan adam"", an sanar da dokar hana fita daga Wuhan a ranar 23 ga Janairu, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane kusan miliyan 57. "
An haramta amfani da motocin mutane a birnin.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibiti na wucin gadi, Asibitin Huoshenshan, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti bayan haka, Asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, China ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta kafa ƙarin matakan hana barkewar COVID-19, gami da bayar da sanarwar kiwon lafiya ga matafiya da tsawaita hutun bikin bazara.
Jami'o'i da makarantu a duk fadin kasar ma an rufe su.
Yankunan Hong Kong da Macau sun kafa wasu matakai, musamman game da makarantu da jami'o'i.
An kafa matakan aiki na nesa a yankuna da dama na kasar Sin.
An sanya takunkumin hana tafiya a ciki da wajen Hubei.
An gyara hanyar sufuri ta jama'a, kuma an rufe gidajen tarihi a dukan ƙasar Sin na ɗan lokaci.
" An yi amfani da kula da motsi na jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan ƙuntatawa a waje. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana kwayar cutar daga "shigowa" daga wasu ƙasashe. "
Misali, Beijing ta sanya dokar killacewa ta kwanaki 14 ga duk matafiya na kasa da kasa da ke shiga birnin. A ranar 23 ga watan Maris, kasar Sin ta babban yankin mutum daya ne kawai ya kamu da cutar a cikin gida a cikin kwanaki biyar da suka gabata, a wannan yanayin ta hanyar matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an toshe yaduwar cututtukan da aka yada a cikin gida kuma an sarrafa barkewar cutar a China.
A wannan ranar an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan an kafa dokar kulle. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigarwa ga masu biza ko izinin zama daga 28 ga Maris, ba tare da wani takamaiman bayani game da lokacin da wannan manufar za ta ƙare ba.
Wadanda suke son shiga kasar Sin za su nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, kuma ta samar da kayan tallafi na kudi ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki da za ta fara da minti uku na shiru a ranar 10:00 4 ga Afrilu, daidai da bikin Qingming, kodayake gwamnatin tsakiya ta nemi iyalai su yi biyayya ta yanar gizo don kiyaye nesa ta jiki don kauce wa sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu 2020 daga China.
Hukumar kiwon lafiya ta kasar ta ba da rahoton ƙaruwar ƙaruwar ƙaruwar ƙaruwar ƙaruwar a ranar 20 ga Fabrairu, wanda galibi ana danganta shi ne ga taron da aka yi a Daegu na sabon motsi na addini da aka sani da Shincheonji Church of Jesus.
Ana zargin masu bautar Shincheonji da ke ziyartar Daegu daga Wuhan da asalin barkewar cutar.
Ya zuwa 22 ga Fabrairu, daga cikin mabiya 9,336 na cocin, 1,261 ko kusan 13% sun ba da rahoton alamun.Koriya ta Kudu ta ayyana matakin faɗakarwa mafi girma a ranar 23 ga Fabrairu 2020.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da gwaje-gwaje suka tabbatar da cewa sojoji uku sun kamu da cutar.
Hakanan an shafi jadawalin jiragen sama kuma saboda haka an canza su.Koriya ta Kudu ta gabatar da abin da aka ɗauka mafi girma kuma mafi kyawun tsari a duniya don bincika yawan jama'a don cutar, da ware duk mutanen da suka kamu da cutar da kuma ganowa da keɓe waɗanda suka tuntube su.
Hanyoyin tantancewa sun haɗa da tilastawa sabbin masu shigowa ƙasashen duniya su ba da rahoton alamun cutar ta hanyar aikace-aikacen wayar hannu, gwajin tuki don cutar tare da sakamakon da ke samuwa a washegari, da haɓaka ƙarfin gwaji don ba da damar gwada mutane 20,000 kowace rana.
Ana ganin shirin Koriya ta Kudu ya yi nasara wajen dakile barkewar cutar duk da cewa ba a killace dukkan biranen ba. Da farko al'ummar Koriya ta Kudu sun rabu biyu game da yadda Shugaba Moon Jae-in ya amsa wannan rikici.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman ko dai a tsige Moon saboda abin da suka yi iƙirarin shi ne rashin kulawar gwamnati game da barkewar cutar, ko kuma yabon yadda ya amsa.
A ranar 23 ga Maris, an bayar da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin adadin masu cutar a cikin mako huɗu.
A ranar 29 ga Maris an ba da rahoton cewa farawa daga 1 ga Afrilu duk sabbin masu shigowa daga ƙasashen waje za a keɓe su na makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatun taimako don gwajin kwayar cutar daga ƙasashe daban-daban 121.
Iran ta ba da rahoton farkon tabbacin kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu daga baya a wannan ranar.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da sauran al'adu, wasanni, da addu'o'in Juma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware Riyal tiriliyan biyar domin yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kuma mutane ne kawai za a killace su.
An sanar da tsare-tsaren iyakance zirga-zirga tsakanin biranen a watan Maris, kodayake yawan zirga-zirgar ababen hawa tsakanin biranen kafin Sabuwar Shekarar Farisa Nowruz ya ci gaba.
Wuraren ibada na Shi'a a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris 2020.Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A yayin da ake zargin cewa an rufe yawan cutar a Iran, sama da kasashe goma sun gano cewa akwai masu cutar a Iran a ranar 28 ga watan Fabrairu, wanda ke nuna cewa yawan cutar na iya zama mafi muni fiye da mutane 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, tare da 23 daga cikin mambobi 290 da aka ba da rahoton sun gwada tabbatacce ga kwayar cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkukun Iran da su saki masu kare hakkin bil adama da aka tsare saboda rashin amincewarsu, da kuma sakin dukkan fursunonin da suka cancanci.
Ya bayyana cewa akwai babban hadarin yaduwar kwayar cutar a cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, wadanda kuma basu da isasshen kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, mafi yawa da aka rubuta a ƙasar tun lokacin da cutar ta fara.
Akalla 'yan siyasa 12 na Iran da jami'an gwamnati sun mutu daga cutar a ranar 17 ga Maris.
A ranar 23 ga watan Maris, Iran tana fuskantar sabbin mutane 50 a kowace awa da kuma sabon mutuwa a kowane minti goma saboda coronavirus.
A cewar wani jami'in WHO, akwai yiwuwar akwai karin mutane biyar da suka kamu da cutar a Iran fiye da yadda ake bayar da rahoton.
An kuma nuna cewa takunkumin da Amurka ta kakaba wa Iran na iya shafar karfin tattalin arzikin kasar wajen magance cutar.
Babban Kwamishinan Majalisar Dinkin Duniya na Kare Hakkin Dan Adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar zuwa Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido' yan China biyu suka gwada tabbatacce ga SARS-CoV-2 a Rome.
Yanayin ya fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da dawowa daga China kuma ta ayyana dokar ta baci.
Daga baya an gano tarin marasa alaƙa na COVID-19 lokuta, farawa da tabbatar da shari'o'i 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon doka don hana barkewar cutar, gami da keɓe mutane sama da 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan da cutar ta bulla, ba za a ba da izinin shiga da fita ba. "
An riga an ba da umarnin dakatar da ayyukan aiki da abubuwan wasanni a waɗannan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta kai mutuwar 100".
Duk manyan abubuwan wasanni, gami da wasannin kwallon kafa na Serie A, za a gudanar da su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiya na Anesthesia, Analgesia, Resuscitation da Kulawa mai tsanani (SIAARTI) ta buga shawarwarin ɗabi'ar likita game da hanyoyin rarrabuwa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta wuce China a matsayin ƙasa da ta fi yawan mutuwar da ke da nasaba da cutar coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 daga cutar.
A ranar 22 ga Maris, an ba da rahoton cewa Rasha ta aika da jiragen sama na soja tara tare da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da cutar, 15,887 da suka mutu, da kuma 21,815 da suka warke a Italiya, tare da yawancin waɗannan cututtukan da ke faruwa a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffin mutanen Italiya da rashin iya gwada duk waɗanda ke da kwayar cutar har zuwa yau na iya ba da gudummawa ga yawan mutuwar.
Amsar da Burtaniya ta bayar ga kwayar cutar ta fara fitowa a matsayin daya daga cikin ƙasashe masu nutsuwa, kuma har zuwa 18 ga Maris 2020, gwamnatin Burtaniya ba ta sanya kowane nau'in nisantar zamantakewa ko matakan killace jama'a ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta sami suka saboda rashin saurin da ake ganin ba shi da ƙarfi a cikin martani ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawara game da duk balaguron da ba dole ba da kuma hulɗar zamantakewa, yana ba da shawarar mutane su yi aiki daga gida idan ya yiwu kuma su guji wurare kamar mashaya, gidajen abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da wuraren motsa jiki za su rufe da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata har zuwa iyakar £ 2,500 a kowane wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewa, hana tarurruka na mutane sama da biyu da kuma iyakance tafiya da ayyukan waje zuwa abin da aka ɗauka ya zama dole.
Ba kamar matakan da suka gabata ba, 'yan sanda sun tilasta wa wadannan takunkumi ta hanyar ba da tarurruka da kuma tarwatsa tarurruka.
" An umarci yawancin kasuwancin su rufe, ban da kasuwancin da aka ɗauka ""muhimmanci"", gami da manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, tashoshin mai, da gareji. "
A ranar 20 ga Janairu, an tabbatar da sanannen shari'ar farko ta COVID-19 a jihar Washington da ke Arewa maso Yammacin Pacific a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa Rukunin Ayyukan Coronavirus na Fadar White House a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, kuma ta sanya takunkumi kan shiga ga matafiya daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtukababbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurkata sanar da cewa sun haɓaka kayan gwajin kansu.
Duk da haka, Amurka ta yi jinkirin farawa a cikin gwaji, wanda ya ɓoye ainihin yaduwar cutar a lokacin.
Gwajin ya lalace saboda kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta masana kimiyya, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙuntatawa ga mutane don cancanta don gwaji har zuwa farkon Maris (ana buƙatar umarnin likita bayan haka).
Zuwa 27 ga watan Fabrairu, The Washington Post ta ruwaito an gudanar da gwaje-gwaje kasa da 4,000 a Amurka.
Zuwa 13 ga watan Maris, The Atlantic ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamomi da umarnin likita sun jira awanni ko kwanaki don gwaji. "Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, matakin da wasu jihohi suka bi ba da daɗewa ba. "
Makarantu a yankin Seattle sun soke azuzuwan a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, an shawarci Amurka game da hasashen tasirin sabon coronavirus a ƙasar ta ƙungiyar masana cututtukan cututtuka a Kwalejin Imperial ta London.
A wannan ranar Shugaba Trump ya rattaba hannu kan Dokar Shirye-shiryen Coronavirus da Amsawa da Ƙarin Kuɗaɗen Kuɗi, wanda ya samar da dala biliyan 8.3 a cikin kuɗin gaggawa don hukumomin tarayya don amsa cutar.
Kamfanoni sun sanya takunkumin tafiye-tafiye ga ma'aikata, sun soke taro, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke abubuwan wasanni da yanayi. A ranar 11 ga Maris, Trump ya sanar da takunkumin hana tafiye-tafiye ga yawancin Turai, ban da Burtaniya, na kwanaki 30, wanda ya fara aiki a ranar 13 ga Maris.
Kashegari, ya faɗaɗa ƙuntatawa don haɗa da Burtaniya da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya samar da kudaden tarayya don amsa rikicin.
Farawa daga 15 ga Maris, yawancin kasuwancin sun rufe ko rage sa'o'i a duk faɗin Amurka don ƙoƙarin rage yaduwar kwayar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a jihohi 50 da kuma gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa New York City tana da mutane 10,700 da suka kamu da cutar coronavirus, fiye da jimlar adadin masu cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce nisantar zamantakewar jama'a kamar tana aiki, yayin da ƙididdigar ninki biyu na lokuta ta ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Ya zuwa ranar 28 ga watan Maris, an samu mutane 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga watan Maris, an bayar da rahoton cewa Amurka tana da mutane da yawa da suka kamu da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya. Ya zuwa ranar 8 ga Afrilu, an samu mutane 400,335 da suka kamu da cutar a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ƙa'idodin nisantar zamantakewa har zuwa 30 ga Afrilu.
A wannan ranar, jirgin ruwan asibiti mai ɗauke da gadaje 1,000 mai suna USNS Comfort ya kafa kafa a birnin New York.
A ranar 3 ga Afrilu, Amurka ta sami adadin mutuwar 884 saboda cutar coronavirus a cikin awanni 24.
A jihar New York, masu kamuwa da cutar sun zarce mutane 100,000 a ranar 3 ga Afrilu. An soki Fadar White House saboda rage girman barazanar da kuma sarrafa saƙon ta hanyar umarci jami'an kiwon lafiya da masana kimiyya da su daidaita maganganun jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin Mataimakin Shugaban Mike Pence.
Gabaɗaya amincewa da yadda Trump ke kula da rikicin ya kasance mai rarrabuwa a cikin ƙungiyoyi.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayan aiki masu mahimmanci, gami da kayan aikin likita masu mahimmanci, daga China.
An yi amfani da nazarin tsarin tafiye-tafiyen jirgin sama don tsarawa da tsinkayar yanayin yaduwa kuma an buga shi a cikin Jaridar Magungunan Balaguro a tsakiyar Janairu 2020.
Dangane da bayanan 2018 daga Transportungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei suna da mafi yawan matafiya daga Wuhan.
An kuma bayar da rahoton cewa Dubai, Sydney, da Melbourne sanannun wurare ne ga mutanen da ke tafiya daga Wuhan.
Bali an ba da rahoton cewa ita ce mafi ƙarancin iyawa a cikin biranen 20 da aka fi so a cikin shirye-shirye, yayin da biranen Ostiraliya aka ɗauka mafi iyawa. Ostiraliya ta fitar da Tsarin Amsar Gaggawa don Sabon Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa har yanzu ba a gano abubuwa da yawa game da COVID-19 ba, kuma cewa Ostiraliya za ta jaddada kula da kan iyakoki da sadarwa a cikin martani ga cutar.
A ranar 21 ga Maris, an ayyana gaggawa na lafiyar ɗan adam a Ostiraliya.
Saboda keɓewar sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa sun shirya kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, musamman ta hanyar jiragen haya na ƙasar, tare da hukumomin China suna ba da izini.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostareliya, Faransa, Argentina, Jamus, da Thailand suna cikin na farko da suka shirya fitar da 'yan kasarsu.
Pakistan ta ce ba za ta kwashe wani dan kasar ta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da 'yan Poland hudu, wani dan kasar Sin, da kuma dan kasar Indiya.
'Yan ƙasar Poland, China, da Indiya sun sauka a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da hanyarsa zuwa Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a wani sansanin soji kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko, da 39 daga jirgin sama na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama na 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun kwashe 'yan ƙasa 277 a ranakun 3 da 4 ga watan Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake amfani da shi a matsayin cibiyar killacewa, inda suka kasance na kwanaki 14.
Jirgin saukar da mutanen New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (gami da wasu daga Ostiraliya da Pacific) an killace su a sansanin sojan ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa a cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama dauke da fasinjojin Kanada 129 da aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta yi haya ya dawo da' yan Afirka ta Kudu 112.
An gudanar da gwajin likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu waɗanda ke nuna alamun coronavirus a baya don rage haɗarin.
'Yan Afirka ta Kudu ne kawai aka dawo da su da gwajin su ya nuna ba su da lafiya.
Sakamakon gwajin ya tabbatar da cewa dukkan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin jin kai, waɗanda, a matsayin matakin kariya, duk sun kasance a ƙarƙashin lura da keɓewa na tsawon kwanaki 14 a The Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen aika taimako zuwa sassan kasar Sin da cutar ta shafa, tare da wani rukuni na hadin gwiwa a yankin Chicago da aka bayar da rahoton sun samu nasarar aika da abin rufe fuska N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agajin jin kai ta Direct Relief, tare da hadin gwiwa da FedEx, ta aika da abin rufe fuska 200,000 tare da sauran kayan kariya na mutum, gami da safar hannu da riguna, ta hanyar jirgin gaggawa zuwa Asibitin Tarayyar Wuhan kafin 30 ga Janairu.
" A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da ƙoƙarin magani tare da kare ""al'ummomin da ke cikin haɗari a Afirka da Kudancin Asiya"". "
Interaksyon ta ruwaito cewa gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta aika da tallafin da ya kai dala miliyan 2.26 ga kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayayyakin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu na kiwon lafiya miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya daban-daban da suka hada da rigunan Hazmat 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayayyakin kiwon lafiya ga China kuma ta yi alkawarin karin dala miliyan 100 a matsayin tallafin kudi ga kasashen da cutar ta shafa. Bayan da lamura a China suka bayyana sun daidaita, kasar ta aika da taimako ga kasashe daban-daban da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da masana don taimakawa Italiya wajen magance annobar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da rigunan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi 5 zuwa Panama.
Ma ya kuma bayar da kayayyakin kiwon lafiya ga Kanada. Kasashen Netherlands, Spain, Turkey, Georgia, da Czech Republic sun nuna damuwarsu game da abin rufe fuska da kayan gwajin da aka yi a China.
Misali, Spain ta janye kayan gwajin coronavirus 58,000 da aka yi a China tare da daidaito na kashi 30% kawai, a halin yanzu, Netherlands ta dawo da abin rufe fuska 600,000 na Sinawa waɗanda ke da lahani.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, wanda ake tsammanin daga China ne, amma a zahiri daga Colombia ne.
A gefe guda kuma, an yi maraba da taimakon da kasar Sin ta bayar a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da ayyukan tallafi na gaggawa ga kasashe masu tasowa.
WHO ta yaba da kokarin da hukumomin kasar Sin ke yi wajen sarrafawa da kuma dakile annobar.
"WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002 zuwa 2004, inda aka zargi hukumomin China da yin sirri wanda ya hana rigakafi da kokarin hanawa, da rikicin yanzu inda gwamnatin tsakiya ""ta samar da sabuntawa na yau da kullun don kauce wa firgici kafin hutun Sabuwar Shekarar Lunar"". "
A ranar 23 ga watan Janairu, a matsayin martani ga shawarar hukumomin tsakiya na aiwatar da haramcin zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya lura cewa yayin da "ba lallai ba ne shawarar da WHO ta bayar ba", amma kuma "alamu ne masu mahimmanci na jajircewar hana annobar a wurin da ta fi karkata" kuma ya kira ta "marasa misali a tarihin lafiyar jama'a".A ranar 30 ga Janairu, bayan tabbatar da yaduwar mutum zuwa mutum a wajen China da kuma karuwar adadin masu cutar a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a na damuwa ta duniya (PHEIC), PHEIC na shida tun lokacin da aka fara amfani da matakin a lokacin annobar mura ta 2009. "
Darakta Janar na WHO Tedros Adhanom ya ce PHEIC ya faru ne saboda "hadarin yaduwar duniya, musamman ga ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba. "
" A cikin martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa ""babu wani dalili na matakan da ke tsoma baki ba dole ba tare da tafiye-tafiye da cinikayya na duniya"" kuma cewa ""WHO ba ta ba da shawarar iyakance kasuwanci da motsi ba""".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya don bayar da gudummawar dala miliyan 675 don tallafawa shirye-shiryen dabarun a cikin ƙasashe masu ƙarancin kuɗi, tana mai nuna gaggawa don tallafawa waɗancan ƙasashe waɗanda "ba su da tsarin da za su gano mutanen da suka kamu da cutar, koda kuwa za ta fito".
Tedros ya ci gaba da yin jawabai yana mai cewa ""mu ne kawai masu ƙarfi kamar yadda mafi rauni mu ke"" kuma ya bukaci al'ummar duniya su "zuba jari a yau ko biya ƙarin daga baya"".A ranar 11 ga Fabrairu, WHO a cikin taron manema labarai ta kafa COVID-19 a matsayin sunan cutar. "
A wannan ranar, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince da samar da "ikon dukkan tsarin Majalisar Dinkin Duniya a cikin martani".
" An kunna ƙungiyar kula da rikice-rikice ta Majalisar Dinkin Duniya sakamakon haka, wanda ya ba da damar daidaita dukkan amsar Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar ""mayar da hankali kan amsar kiwon lafiya yayin da sauran hukumomin za su iya ba da ƙwarewar su don ɗaukar tasirin zamantakewar jama'a, tattalin arziki da ci gaban cutar"". "
" A ranar 14 ga watan Fabrairu, an kunna wata ƙungiyar haɗin gwiwa ta WHO tare da China don samar da ƙwararrun ƙasashen duniya da WHO a ƙasa a China don taimakawa cikin kulawar cikin gida da kimantawa ""tsananin cutar da yaduwar cutar"" ta hanyar karɓar bita da tarurruka tare da manyan cibiyoyin matakin ƙasa da gudanar da ziyarar filin don kimantawa ""tasirin ayyukan ba da amsa a matakan lardi da gundumar, gami da birane da yankunan karkara"".A ranar 25 ga Fabrairu, WHO ta bayyana cewa ""duniya ta kamata ta yi ƙarin shiri don yiwuwar annobar coronavirus, "" tana mai cewa duk da cewa har yanzu ba a fara kiran ta annobar ba, ƙasashe duk da haka ya kamata su kasance ""a cikin matakin shiri"". "
" A sakamakon barkewar cutar a Iran, WHO ta aika da tawagar hadin gwiwa don tantance lamarin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara kimanta barazanar coronavirus a matakin duniya daga ""mai girma"" zuwa ""mai girma sosai"", matakin da ya fi dacewa na faɗakarwa da kimanta haɗari. "
Mike Ryan, darektan zartarwa na shirin gaggawa na lafiya na WHO, ya yi gargadi a cikin wata sanarwa cewa ""Wannan gwaji ne na gaskiya ga kowace gwamnati a duniya: Ku farka. "
"Wannan kwayar cutar na iya zuwa kuma kuna buƙatar kasancewa a shirye, "" yana ba da shawarar cewa matakan amsawa daidai na iya taimaka wa duniya kauce wa ""mafi munin shi"". "
Ryan ya ci gaba da bayyana cewa bayanan na yanzu ba su ba jami'an kiwon lafiyar jama'a damar ayyana cutar ta duniya ba, yana mai cewa irin wannan sanarwar na nufin ""muna yarda da cewa kowane dan Adam a doron kasa zai kamu da wannan kwayar cutar""".
A ranar 11 ga Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO tana "da matukar damuwa da yadda ake yada cutar da kuma yadda take da tsanani, da kuma yadda ake rashin daukar mataki". WHO ta fuskanci zargi mai tsanani saboda yadda ake ganin ba ta kula da cutar yadda ya kamata ba, ciki har da sanarwar gaggawa ta lafiyar jama'a da kuma rarraba kwayar cutar a matsayin annoba. "
Sakamakon ya hada da takardar neman izinin babban daraktan WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil'adama na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar masana ta ce kowa na da hakkin yin aikin ceto rai kuma gwamnati ce ke da wannan hakkin.
Kungiyar ta jaddada cewa rashin kudi ko inshorar lafiya bai kamata ya zama dalilin nuna bambanci ga wata kungiya ba.
Masana sun jaddada cewa kowane mutum na da hakkin samun lafiya, gami da nakasassu, na kananan kungiyoyi, tsofaffi, mutanen da suka rasa muhallansu, marasa gida, wadanda ke rayuwa cikin mawuyacin hali, mutanen da ke tsare, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana ba wadanda ke bukatar tallafin gwamnati.
Kungiyoyin gwamnati na kasa da kasa suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwa da raya tattalin arziki ta kaddamar da wani dandamali domin samar da cikakken bayani kan yadda kasashen duniya ke amsawa, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya don magance tasirin kulle-kulle da ƙuntatawa kan balaguro, cibiyar dijital ta haɗa da Mai Kula da Manufofin Kasashe, kuma tana da nufin taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Gwamnatin China ta sha suka daga Amurka, Ministan Ofishin Ma'aikatar Burtaniya Michael Gove, da dan Shugaban Brazil Jair Bolsonaro Eduardo Bolsonaro saboda yadda ta kula da cutar, wacce ta fara a lardin Hubei na kasar Sin.
An kori wasu jami'an gwamnatin lardin na jam'iyyar kwaminis ta kasar Sin (CPC) saboda yadda suka gudanar da ayyukan killace mutane a tsakiyar kasar Sin, wata alama ce ta rashin jin dadin yadda siyasa ta mayar da martani ga barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan matakin an yi shi ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, misali Zhao Lijian sun yi watsi da amincewar da aka yi a baya game da barkewar cutar coronavirus da ta fara a Wuhan, don goyon bayan ka'idodin makirci game da COVID-19 da ya samo asali daga Amurka ko Italiya.
Gwamnatin Amurka ta Donald Trump ta kira coronavirus da ""Covid-19 na China"" ko ""Covid-19 na Wuhan"" tana mai cewa "ta'addancin da China ta yi ya kara kwayar cutar da ta zama annoba ta duniya", wanda wasu masu sukar suka soki a matsayin wariyar launin fata da kuma "distracting daga gazawar gwamnatinsa wajen dakile cutar".
" Daily Beast ta samu wata takardar gwamnatin Amurka da ke bayyana wata dabarar sadarwa da ta fito daga Majalisar Tsaro ta Kasa, tare da ambaton dabarar a matsayin ""Dukkanin game da China ne. "
" Ana gaya mana mu yi kokarin fitar da wannan sakon ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma bayyana a talabijin. " "Masu wallafa labarai kamar su Politico, Foreign Policy, da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na aika taimako ga kasashen da cutar ta shafa wani bangare ne na yakin neman tasirin duniya. "
"Shugaban manufofin kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa da ya hada da gwagwarmayar samun tasiri ta hanyar juyawa da kuma 'siyasa ta karimci.'"
"Borrell ya kuma ce ""China tana tura sakon da karfi cewa, sabanin Amurka, ita abokiyar zama ce mai alhakin abin dogaro. """
Kasar Sin ta kuma yi kira ga Amurka da ta janye takunkumin da ta kakaba wa kasashen Syria, Venezuela da Iran, yayin da rahotanni ke cewa ta aika da tallafi ga kasashen biyu na karshe.
An toshe kyautar Jack Ma na masks 100,000 zuwa Cuba ta takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da taimakon da aka yi niyyar ba wasu kasashe zuwa kasarsu.
Kuma an bayar da rahoton rikice-rikice da suka shafi abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin numfashi da aka nufa zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai da Italiya da cutar coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a EU, ya ce "Kasar Sin ce kawai ta amsa ta bangarorin biyu. "
"Tabbas, wannan ba alama ce mai kyau ba ta hadin kan Turai.
A ranar 22 ga Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su aika da likitocin soja, motocin kashe ƙwayoyin cuta na musamman, da sauran kayan aikin likita zuwa Italiya.
" Jaridar La Stampa ta Italiya ta ambaci wani "tushen siyasa mai girma" wanda ba a san shi ba cewa kashi 80 cikin dari na taimakon Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya". "
" Majiyar ta zargi Rasha da fara wani "geopolitical da diplomatic" charm offensive. "
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin sama mai dauke da kayan aikin likita zuwa Amurka.
" Kakakin Kremlin Dmitry Peskov ya ce ""lokacin da yake ba da taimako ga abokan aikinsa na Amurka, [Putin] ya ɗauka cewa lokacin da masana'antun Amurka na kayan aikin likita da kayan aiki suka sami ƙarfi, su ma za su iya amsawa idan ya cancanta. "" "
"Gudanar da sojin NATO da aka shirya a Jamus, Poland, da kuma ƙasashen Baltic, mafi girman atisayen yaƙin NATO tun ƙarshen Yakin Cacar Baki, za a gudanar da shi a ƙaramin sikelin. "
Babban sakataren Kamfen na Yaki da Makaman Nukiliya Kate Hudson ya soki atisayen Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana barazanar rayukan ba kawai sojojin Amurka da kasashen Turai da yawa da ke halarta ba amma mazaunan kasashen da suke aiki. "Gwamnatin Iran ta yi fama da cutar sosai, tare da kusan 'yan majalisa ashirin da biyu da suka kamu da cutar da kuma wasu mutane goma sha biyar na yanzu ko tsoffin siyasa. "
Shugaban Iran Hassan Rouhani ya rubuta wasiƙar jama'a ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana cewa ƙasarsa tana gwagwarmaya don yaƙar annobar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin da Amurka ta sanya wa Iran. Annobar ta haifar da kira ga Amurka da ta ɗauki manufofin zamantakewar da aka saba a wasu ƙasashe masu arziki, gami da kula da lafiyar duniya, kula da yara na duniya, izinin iyali da aka biya, da kuma ƙarin matakan kuɗi don lafiyar jama'a.
Masu nazarin siyasa sun yi tsammanin hakan na iya shafar damar da Donald Trump zai sake samu a zaben shugaban kasa na 2020. Dangantaka ta diflomasiyya tsakanin Japan da Koriya ta Kudu ta tabarbare saboda annobar.
"Koriya ta Kudu ta soki "ƙoƙarin keɓewa da keɓaɓɓu da na Japan" bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a sanya shi cikin keɓewa na makonni biyu a wuraren da gwamnati ta tsara. "
Da farko dai al'ummar Koriya ta Kudu sun rabu biyu a kan yadda Shugaba Moon Jae-in ya amsa wannan rikici.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman ko dai a tsige Moon saboda abin da suka yi iƙirarin cewa gwamnati ta yi amfani da cutar ba daidai ba, ko kuma ya yaba da martani. Cutar ta ba da damar ƙasashe su zartar da dokar ta baci don amsawa.
Wasu masu sharhi sun nuna damuwa cewa zai iya ba gwamnatoci damar ƙarfafa ikon su.
A Hungary, majalisar ta kada kuri'ar ba da izinin firaminista, Viktor Orbán, ya yi mulki ta hanyar doka har abada, dakatar da majalisar da kuma zabuka da kuma hukunta waɗanda aka ɗauka sun yada bayanan karya game da kwayar cutar da kuma yadda gwamnati ke magance rikicin.
An zargi barkewar cutar coronavirus da yawan rashin wadatar kayayyaki, wanda ya samo asali ne daga karuwar amfani da kayan aiki a duniya don yaƙar barkewar cutar, sayen firgici, da katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da ƙarancin magunguna da kayan aikin likita saboda ƙaruwar buƙatun mabukaci da katsewar masu samarwa.
Wuraren da dama kuma sun ga fargabar sayayya wanda ya haifar da share ɗakunan ajiya na kayan masarufi kamar abinci, takardar bayan gida, da ruwan kwalba, wanda ke haifar da ƙarancin wadata.
Musamman masana'antar fasaha ta yi gargadi game da jinkiri ga jigilar kayayyakin lantarki.
A cewar babban darektan WHO Tedros Adhanom, bukatar kayan kariya ta mutum ta ƙaru sau 100.
Wannan bukatar ta haifar da karin farashin har sau ashirin fiye da farashin al'ada kuma ya haifar da jinkiri a kan samar da kayayyakin kiwon lafiya na watanni hudu zuwa shida.
Ya kuma haifar da karancin kayan kariya na mutum a duk duniya, tare da WHO da ke gargadin cewa wannan zai kawo haɗari ga ma'aikatan kiwon lafiya.
A Ostiraliya, annobar ta samar da sabuwar dama ga masu siyayya daigou don sayar da kayayyakin Ostiraliya zuwa China.
Wannan aikin ya haifar da karancin abinci na yara a wasu manyan kantuna kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan masu cutar COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma yawan buƙatun kayayyakin abinci, an ceci yankuna biyu daga matsanancin karancin abinci.
Matakan da China da Italiya suka dauka na yaki da tara kayan abinci da kuma cinikin da ba a yarda da su ba sun yi nasara, ta yadda aka kauce wa karancin abinci da ake tsammani a Turai da kuma Arewacin Amirka.
Arewacin Italiya da yawan amfanin gona bai samu raguwa ba, amma farashin na iya ƙaruwa a cewar wakilan masana'antar.
An sami rafin abinci mara amfani na ɗan lokaci ne kawai, har ma a birnin Wuhan, yayin da jami'an gwamnatin China suka saki ajiyar naman alade don tabbatar da wadataccen abinci ga jama'a.
Akwai irin waɗannan dokoki a ƙasar Italiya da ke bukatar masu samar da abinci su adana kayayyaki don irin wannan gaggawa.
An ji lahani ga tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin China ya sha wahala sosai a cikin watanni biyu na farko na 2020 saboda matakan da gwamnati ta ɗauka don rage yaduwar cutar, kuma tallace-tallace na siyarwa ya faɗi da kashi 20.5%.
Kamar yadda babban yankin kasar Sin babban cibiyar tattalin arziki da masana'antu ne, an ga barkewar cutar ta haifar da babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ta yi hasashen cewa kasuwanni za su ci gaba da zama masu saurin canzawa har sai an sami cikakken hoto game da sakamakon da ake iya samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin annobar kan ci gaban duniya na iya wuce na barkewar cutar SARS ta 20022004.
Wani ƙididdiga daga wani gwani a Jami'ar Washington a St. Louis ya ba da $ 300 + biliyan tasiri a kan sarkar samar da kayayyaki na duniya wanda zai iya wucewa har zuwa shekaru biyu.
"Kungiyar Kasashen Fetur da ke Fitar da Man Fetur (OPEC) ta ce ta "ci karo da matsalar" bayan faduwar farashin man fetur saboda karancin bukatar da kasar Sin ke yi".
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, alamun hannun jari daban-daban na Amurka ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun buga raguwar su mafi girma tun 2008, tare da Dow ya faɗi maki 1,191, raguwar rana ɗaya mafi girma tun rikicin kuɗi na 200708.
Dukkanin alamun uku sun ƙare makon da ya ragu da fiye da 10%.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta tabbatar da darajar darajar darajar kasar Sin, amma ta ci gaba da kasancewa da mummunan hangen nesa.
Hannun jari sun sake faɗuwa bisa tsoron coronavirus, mafi girman faɗuwa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai koma baya.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa na bankunan tsakiya da na jihohi.
Bankunan tsakiya suna amsawa da sauri fiye da yadda suka yi wa matsalar kudi ta 2008.
Yawon shakatawa yana ɗaya daga cikin ɓangarorin da suka fi fama da cutar saboda haramcin tafiya, rufe wuraren jama'a gami da abubuwan jan hankali na balaguro, da kuma shawarar gwamnatoci game da duk wani tafiya a duk faɗin duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirgar jiragen sama saboda karancin bukatar, gami da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na yankin Burtaniya Flybe ya rushe.
Tasirin da aka yi wa masana'antar jiragen ruwa na jirgin ruwa ya kasance a matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da yawa.
Cutar ta zo daidai da Chunyun, babban lokacin tafiya da ke da alaƙa da hutun Sabuwar Shekarar China.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da suka shafi manyan jama'a, gami da bukukuwan Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu da kansu suna rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
Yawancin abubuwan Sabuwar Shekarar Lunar da wuraren yawon bude ido an rufe su don hana taron jama'a, gami da Haramtaccen Birni a Beijing da bikin haikalin gargajiya.
A larduna 24, da kananan hukumomi da yankuna 31 na kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara zuwa 10 ga watan Fabrairu, suna ba da umarnin yawancin wuraren aiki kada su sake buɗewa har zuwa wannan ranar.
Wadannan yankuna sun wakilci 80% na GDP na kasar da 90% na fitarwa.
Hong Kong ta kara yawan cututtukan da ke kamuwa da cuta zuwa mafi girma kuma ta ayyana dokar ta baci, rufe makarantu har zuwa watan Maris da soke bikin Sabuwar Shekara. An yi tasiri a duniya a fannin sayar da kayayyaki, tare da rage lokutan shaguna ko rufewa na wucin gadi.
Ziyarci kantunan sayar da kayayyaki a Turai da Latin Amurka ya ragu da kashi 40%.
Kasuwancin Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar 50-60%.
Wannan kuma ya haifar da raguwar 3343% a cikin zirga-zirgar tafiya zuwa cibiyoyin cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duk duniya sun sanya ƙarin matakan, kamar ƙara tsaftacewa, shigar da na'urorin bincike na zafi don bincika zafin jiki na masu siye, da soke abubuwan da suka faru.Dangane da ƙididdigar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan da annobar ta haifar na iya barin tsakanin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda za su kasance a wannan halin ba tare da annobar ba.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta kai kololuwa a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Da yawa daga cikin kusan ma'aikatan karkara miliyan 300 na kasar Sin sun makale a gida a lardunan cikin gida ko kuma sun makale a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar coronavirus na iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar Babban Bankin Tarayya na St. Louis.Kullewar a Indiya ta bar miliyoyin ma'aikatan baƙi na Indiya (waɗanda ake biyan su ta hanyar albashi na yau da kullun) ba su da aiki.Binciken daga Cibiyar Angus Reid ya gano cewa kashi 44% na gidajen Kanada sun sami wani nau'in rashin aikin yi.Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka shiga cikin kulle a tsakiyar Maris 2020.
A rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi biyan alawus din rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Birtaniya sun nemi tsarin bashi na kowa. Kusan kamfanoni miliyan biyar a Jamus sun tura ma'aikatansu a tsarin aikin gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbeit.
Faransa da Birtaniya sun karɓi tsarin biyan diyya na ɗan gajeren lokaci na Jamus.
Masana'antar wasan kwaikwayo da al'adun al'adu sun sami mummunan tasiri ta hanyar cutar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutaneduka ma'aikata da masu zaman kansua duniya.
Kungiyoyin fannin fasaha da al'adu sun yi ƙoƙarin ci gaba da aikin su (sau da yawa ana tallafawa jama'a) don samar da damar samun al'adun al'adu ga al'umma, kula da lafiyar ma'aikatansu da jama'a, da tallafawa masu fasaha a duk lokacin da zai yiwu.
Zuwa Maris 2020, a duk faɗin duniya kuma zuwa matakai daban-daban, an rufe gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu har abada tare da soke ko jinkirta baje kolin su, abubuwan da suka faru da wasan kwaikwayon su.
A sakamakon haka an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Wani sakamakon cutar da ke saurin haɓaka shi ne soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide da wake-wake, taron fasaha, da nunin kayan kwalliya.
Har ila yau, masana'antar fim ma ta sami matsala. Vatican ta sanar da cewa an soke bukukuwan mako mai tsarki a Rome, wanda ke faruwa a makon karshe na lokacin tuba na Kirista na Lent.
Diocese da yawa sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin yayin da wasu ke ba da sabis na mota.
Tare da Roman Katolika Diocese na Rome rufe majami'un da chapels da St. Peter ta Square komai daga Kirista mahajjata, sauran addinai kungiyoyi ma soke sabis da iyakance jama'a taro a majami'u, masallatai, majami'u, temples da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga baya an rufe wuraren ibada, yayin da Saudiyya ta hana shiga baƙi da mazaunanta zuwa wuraren tsarki a Makka da Madina.
Cutar ta haifar da babbar matsala ga kalandar wasanni a duk duniya tun bayan Yaƙin Duniya na Biyu.
Yawancin manyan abubuwan wasanni an soke su ko an jinkirta su, gami da gasar Zakarun Turai ta 2019 20, Premier League ta 2019 20, UEFA Euro 2020, kakar NBA ta 2019 20, da kakar NHL ta 2019 20.
" Cutar ta katse shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka shirya fara a ƙarshen Yuli; Kwamitin Wasannin Olympics na Duniya ya ba da sanarwar a ranar 24 ga Maris cewa za a "" sake tsara taron zuwa ranar da ta wuce 2020 amma ba daga baya ba a lokacin bazara na 2021"". An rufe gidajen caca da sauran wuraren wasan caca a duk duniya kuma an jinkirta ko kuma an soke wasannin karta kai tsaye. "
Wannan ya sa 'yan caca da yawa suka koma kan layi, tare da shafukan caca da yawa na yanar gizo suna ba da rahoton ƙaruwa mai yawa a cikin ƙimar sabbin rajista. Har ila yau, masana'antar nishaɗi ta sami matsala, tare da ƙungiyoyin kiɗa daban-daban da ke dakatar ko soke rangadin kide kide.
Yawancin manyan gidajen wasan kwaikwayo kamar waɗanda ke Broadway suma sun dakatar da duk wasan kwaikwayon.
" Wasu masu fasaha sun bincika hanyoyin da za su ci gaba da samarwa da raba aiki ta hanyar intanet a matsayin madadin wasan kwaikwayon raye na gargajiya, kamar raye-raye na raye-raye ko ƙirƙirar "bikin" na yanar gizo don masu fasaha suyi, rarraba, da kuma tallata aikinsu. "
A kan layi, yawancin abubuwan da ke cikin yanar gizo game da coronavirus sun bazu yayin da mutane da yawa ke juyawa zuwa raha da shagala a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da ƙiyayya, ƙin baƙi, da wariyar launin fata ga mutanen da ke da asalin ƙasar Sin da Gabashin Asiya, da kuma mutanen da ke fitowa daga wuraren zafi a Turai, Amurka da sauran ƙasashe.
An lura da tsoro, tuhuma, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da yankin Asiya da Fasifik.
Rahotanni daga watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ke cikin China) sun rubuta ra'ayoyin wariyar launin fata da aka bayyana a cikin ƙungiyoyi daban-daban a duniya na Sinawa da suka cancanci cutar ko karɓar abin da aka yi iƙirarin cewa daidai ne.
Wasu kasashe a Afirka ma sun ga karuwar nuna adawa da kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci bisa asalin yankin su.
An sami tallafi ga Sinawa, a ciki da wajen layi, da kuma waɗanda ke cikin yankunan da cutar ta shafa.
Bayan ci gaban annobar zuwa sabbin ƙasashe masu zafi, mutane daga Italiya, ƙasa ta farko a Turai da ta fara fuskantar mummunar annobar COVID-19, suma za su iya fuskantar tuhuma da ƙiyayya da baƙi. 'Yan ƙasa a ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore, da Koriya ta Kudu da farko sun sanya hannu kan takardun neman izinin hana Sinawa shiga ƙasashensu a ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
Sinawa da sauran 'yan Asiya a Burtaniya da Amurka sun ba da rahoton karuwar cin zarafin wariyar launin fata, da kuma hare-hare.
"Shugaban Amurka Donald Trump ya fuskanci suka saboda ambaton coronavirus a matsayin ""Covid na China"", kalmar da masu sukar ke ganin wariyar launin fata ce da kuma adawa da Sinawa. "
Masu zanga-zanga a Ukraine sun kai hari kan bas din da ke dauke da 'yan kasar Ukraine da na kasashen waje da aka kwashe daga Wuhan zuwa Novi Sanzhary.
Daliban da suka fito daga Arewa maso Gabashin Indiya, wanda ke da iyaka da China, kuma suna karatu a manyan biranen Indiya an ba da rahoton sun fuskanci tsangwama da ke da alaƙa da barkewar cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata na jihar a West Bengal Dilip Ghosh ya bayyana cewa Sinawa sun lalata yanayi kuma "saboda haka ne Allah ya rama musu".
" Daga baya ofishin jakadancin kasar Sin da ke Kolkata ya yi Allah wadai da wannan magana, yana mai cewa "kuskure ne".A kasar Sin, cutar ta kara tsananta wa 'yan kasashen waje da nuna wariyar launin fata ga mutanen da ba Sinawa ba, inda aka bayyana 'yan kasashen waje a matsayin "sharar gida" kuma ana nufin "kashe su". "
Yawancin jaridu tare da bangon biya sun cire su don wasu ko duk ɗaukar hoto na coronavirus.
Yawancin masu wallafa kimiyya sun sanya takardun kimiyya da suka danganci barkewar cutar a buɗe.
Wasu masana kimiyya sun zaɓi raba sakamakon su da sauri akan sabobin bugawa kamar bioRxiv.
Cutar cututtuka mai tasowa  Cutar cututtuka na sabon kwayar cuta, sau da yawa sabon abu a cikin yanayin fashewa ko hanyar watsawa
Duniya da cututtuka  Bayani kan duniya da kuma yaduwar cututtuka
Jerin cututtuka da annoba  Jerin mutuwar da aka yi sanadiyar cututtuka masu yaduwa
Kasuwancin dabbobi da dabbobi  Hadarin kiwon lafiya da ke tattare da cinikin dabbobi masu ban mamaki
Gwajin dakin gwaje-gwaje don cutar coronavirus na numfashi 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa ya haɗa da hanyoyin da ke gano kasancewar kwayar cutar da waɗanda ke gano ƙwayoyin cuta da aka samar don amsa kamuwa da cuta.
Ana tabbatar da kasancewar ƙwayoyin cuta a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin takamaiman ne kuma an tsara shi ne don gano RNA na kwayar cutar SARS-CoV-2 kawai.
Ana amfani dashi don tabbatar da cututtukan cututtuka na kwanan nan ko masu aiki.
Ana iya amfani da gano kwayoyin cutar (serology) don tantancewa da kuma lura da yawan jama'a.
Gwaje-gwajen rigakafi suna nuna mutane nawa suka kamu da cutar, gami da waɗanda alamun su ba su da yawa don bayar da rahoto ko waɗanda ba su da alamun cutar.
Za a iya ƙayyade ainihin mutuwar cutar da matakin rigakafin garken a cikin yawan jama'a daga sakamakon wannan gwajin.
Saboda iyakancewar gwaji, har zuwa watan Maris na 2020 babu wata ƙasa da ke da ingantaccen bayani game da yaduwar cutar a cikin jama'arsu.
Zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arta, kuma akwai bambance-bambance masu yawa a yawan gwajin da aka yi a tsakanin ƙasashe.
Wannan canjin yana iya yin tasiri sosai ga ƙimar mutuwar da aka ruwaito, wanda zai iya zama mai yawa a cikin wasu ƙasashe.
Ta amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR) ana iya yin gwajin akan samfuran numfashi da aka samo ta hanyoyi daban-daban, gami da swab na nasopharyngeal ko samfurin sputum.
Sakamakon yawanci ana samun su cikin 'yan sa'o'i zuwa kwanaki 2.
Gwajin RT-PCR da aka yi da swabs na makogwaro yana da tabbaci ne kawai a makon farko na cutar.
Daga baya kwayar cutar na iya ɓacewa a cikin makogwaro yayin da take ci gaba da yawaita a cikin huhu.
Ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, a madadin haka za a iya ɗaukar samfurin samfurin daga zurfin hanyoyin numfashi ta hanyar tsotsa catheter ko kuma a yi amfani da kayan tari (scum).
An haɓaka ɗayan gwajin PCR na farko a Charité a Berlin a cikin Janairu 2020 ta amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR), kuma ya zama tushen kayan aiki 250,000 don rarrabawa ta Hukumar Lafiya ta Duniya (WHO).
Ƙasar Ingila ta kuma samar da gwaji a ranar 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya haɓaka kayan aikin gano SARS-CoV-2 na PCR na asibiti (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
" Yana neman kwayar halitta ""E"" da dukkan beta coronaviruses ke rabawa, da kuma kwayar halitta ta RdRp da ta dace da SARS-CoV-2.A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka karɓi amincewar amfani da gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China don kayan gano SARS-CoV-2 na PCR.A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin (CDC) suna rarraba kwamitin bincikensa na 2019-Novel Coronavirus (2019-nCoV) na RT-PCR na Lokaci na Gaskiya zuwa dakunan gwaje-gwajen kiwon lafiyar jama'a ta hanyar Tushen Reagent na Duniya. "
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin juzu'in kayan gwajin ya haifar da sakamakon da ba shi da tabbas saboda magungunan da ba daidai ba, da kuma matsalar gwaji a CDC a Atlanta; wannan ya haifar da matsakaicin ƙananan samfura 100 a rana da aka sarrafa cikin nasara a cikin dukan Fabrairu 2020.
Ba a tabbatar da gwaje-gwajen da ke amfani da abubuwa biyu da za su iya dogaro ba har zuwa 28 ga Fabrairu, 2020, kuma ba sai lokacin da aka ba da izinin dakunan gwaje-gwaje na jihohi da na gida su fara gwaji ba.
Hukumar Kula da Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin Amfani da Gaggawa. Dakunan gwaje-gwaje na kasuwanci na Amurka sun fara gwaji a farkon Maris 2020.
Ya zuwa 5 ga Maris 2020 LabCorp ta sanar da wadatar COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Quest Diagnostics kuma ya samar da gwajin COVID-19 a duk faɗin ƙasar kamar yadda aka samu a ranar 9 ga Maris 2020.
Babu iyakance adadin da aka sanar; dole ne a yi tattara samfurin da sarrafa shi daidai da bukatun CDC.
A Rasha, Cibiyar Nazarin Virology da Biotechnology VECTOR ta ƙasa ce ta haɓaka da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin.A ranar 12 ga Maris, 2020, an ba da rahoton Mayo Clinic ta haɓaka gwajin don gano kamuwa da COVID-19.A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin babban girma, don haka ba da damar na'ura ɗaya don yin kimanin gwaje-gwaje 4,128 a cikin awa 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Laboratories na Abbott don gwaji akan tsarin m2000 na Abbott; FDA ta riga ta ba da irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta karɓi EUA daga FDA don gwajin da ke ɗaukar kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar kara ƙarfin isothermal nucleic acid maimakon PCR.
Tun da yake wannan ba ya bukatar jerin sauye-sauye na zafin jiki, wannan hanyar tana iya ba da sakamako mai kyau a cikin minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan injunan a Amurka kuma Abbott yana tsammanin haɓaka masana'antu don samar da gwaje-gwaje 50,000 a kowace rana. Ana haɓaka gwaji wanda ke amfani da kwayar cutar monoclonal wacce ke ɗaure takamaiman kwayar nucleocapsid (N protein) na sabon coronavirus a Taiwan, tare da fatan zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin mura mai sauri.
"Binciken wallafe-wallafen Maris 2020 ya kammala cewa ""radiographs na kirji ba su da ƙimar bincike a farkon matakan, yayin da CT [komputa tomography] binciken na iya kasancewa tun kafin bayyanar cututtuka. "" "
Abubuwan da ke faruwa a CT sun haɗa da filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen
Dominance na subpleural, hauka mai hauka da ƙarfafawa suna haɓaka yayin da cutar ke ci gaba.
Wani binciken da ya kwatanta PCR da CT a Wuhan a wurin da cutar ta fara ya nuna cewa CT ya fi PCR hankali sosai, kodayake ba shi da ƙayyadaddun bayani, tare da yawancin fasalulluka na hoto da ke haɗuwa da sauran cututtukan huhu da hanyoyin cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""Ba za a yi amfani da CT don tantancewa ko a matsayin gwajin farko don gano COVID-19 ba"".A watan Maris na 2020, CDC ta ba da shawarar PCR don tantancewa na farko. "
Wani ɓangare na amsar rigakafi ga kamuwa da cuta shine samar da ƙwayoyin cuta ciki har da IgM da IgG.
Ana iya amfani da waɗannan don gano kamuwa da cuta a cikin mutane da ke farawa kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma sa ido kan yawan jama'a. Ana iya yin gwaje-gwaje a cikin ɗakunan gwaje-gwaje na tsakiya (CLT) ko ta hanyar gwajin wurin kulawa (PoCT).
Tsarin sarrafa kansa mai ƙarfi a cikin dakunan gwaje-gwaje da yawa na asibiti zasu iya yin waɗannan gwaje-gwajen amma kasancewar su zai dogara da ƙimar samarwa ga kowane tsarin.
Don CLT ana amfani da samfurin jini guda ɗaya, kodayake ana iya amfani da samfuran jerin don bin diddigin amsar rigakafi.
Don PoCT ana samun samfurin jini guda ɗaya ta hanyar huda fata.
Ba kamar hanyoyin PCR ba ana buƙatar matakin cirewa kafin gwaji.A ranar 26 ga Maris, 2020, FDA ta ambaci ƙungiyoyi 29 waɗanda suka ba da sanarwar ga hukumar kamar yadda ake buƙata kuma yanzu haka suna iya rarraba gwajin rigakafin su.
Ya zuwa 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, wanda zai iya gano IgG da IgA antibodies akan kwayar cutar a cikin samfuran jini.
Testingarfin gwaji shine ɗaruruwan samfuran a cikin awanni kuma sabili da haka ya fi sauri fiye da gwajin PCR na al'ada na RNA na kwayar cuta.
Ana iya gano kwayoyin cutar bayan kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu ɗayan kayan gwajin kwayoyin cutar da ta saya da suka isa amfani da su.
" Hong Kong ta kafa wani shiri inda marasa lafiya da ake zargi za su iya zama a gida, ""sashen gaggawa zai ba da bututun samfurin ga mai haƙuri"", za su tofa a ciki, su mayar da shi kuma su sami sakamakon gwajin bayan ɗan lokaci. Hukumar Kula da Lafiya ta Burtaniya ta sanar da cewa tana gwajin wani shiri don gwada masu cutar a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu idan sun zo asibiti ko kuma dole ne a kashe cutar ta hanyar motar asibiti idan an yi amfani da ita.A cikin gwajin tuki don COVID-19 don masu cutar da ake zargi, ƙwararren likita yana ɗaukar samfurin ta amfani da matakan kariya masu dacewa. "
Cibiyoyin da ke ba da kaya sun taimaka wa Koriya ta Kudu yin wasu daga cikin gwaje-gwaje mafi sauri, mafi yawa na kowace ƙasa. A Jamus, Associationungiyar Likitocin Inshorar Lafiya ta Dokokin Lafiya ta ce a ranar 2 ga Maris, tana da damar yin gwaje-gwaje kusan 12,000 a kowace rana a cikin yanayin asibiti kuma an gwada 10,700 a makon da ya gabata.
Idan likita ne ya ba da umarnin yin gwajin, inshorar lafiya ce ke biyan kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da damar yin gwaje-gwaje 160,000 a kowane mako.
Tun daga ranar 19 ga watan Maris, an fara gwajin tuki a manyan birane da dama.
Ya zuwa 26 ga Maris na 2020 ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda sakamako mai kyau ne kawai aka bayar da rahoto.
"Binciken dakin gwaje-gwaje na farko ya nuna cewa a cikin makon kalandar 12/2020 an gwada aƙalla samfura 483,295 har zuwa da kuma ciki har da makon 12/2020 kuma an gwada samfura 33,491 (6.9%) masu inganci don SARS-CoV-2.A Isra'ila, masu bincike a Technion da Asibitin Rambam sun haɓaka kuma sun gwada hanyar gwajin samfura daga marasa lafiya 64 a lokaci guda, ta hanyar tara samfurori da ƙarin gwaji kawai idan an sami samfurin hadewa mai kyau.A Wuhan an buɗe dakin gwaje-gwaje na gaggawa na murabba'in mita 2000 mai suna ""Huo-Yan"" (Sinanci: 火眼, ko ""Fire Eye"" a Turanci) a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya sarrafa sama da samfura 10,000 a rana. "
Tare da ginin da mai kafa BGI Wang Jian ya kula da shi kuma yana ɗaukar kwanaki 5, samfurin ya nuna cewa shari'o'in a Hubei zai kasance 47% mafi girma kuma farashin da ya dace na magance keɓewar zai ninka idan wannan ƙarfin gwajin bai zo kan layi ba.
An bi dakin gwaje-gwaje na Wuhan da sauri ta hanyar dakin gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk faɗin China.
Zuwa 4 ga Maris 2020 jimlar gwajin yau da kullun ya kai 50,000 a kowace rana. An saki tushen buɗewa, ƙirar da aka haɗa ta Origami Assays wanda zai iya gwada samfuran marasa lafiya 1122 don COVID19 ta amfani da gwaje-gwaje 93 kawai. Ana iya gudanar da waɗannan ƙirar daidaitaccen a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar masu sarrafa ruwa na robotic ba.
A watan Maris, karancin da karancin adadin kayan aiki ya zama abin toshewa ga gwajin taro a EU da Burtaniya da Amurka.
Wannan ya sa wasu marubuta su bincika hanyoyin shirya samfurin wanda ya shafi dumama samfuran a 98 °C (208 °F) na mintuna 5 don sakin kwayoyin RNA don ƙarin gwaji.A ranar 31 ga Maris an sanar da cewa Hadaddiyar Daular Larabawa yanzu tana gwada yawancin jama'arta don Coronavirus a kowane mutum fiye da kowace ƙasa, kuma tana kan hanya don haɓaka matakin gwaji don isa ga yawancin jama'a.
"Wannan ya kasance ta hanyar haɗuwa da damar tuki, da siyan dakin gwaje-gwaje mai yawan jama'a daga Group 42 da BGI (bisa ga "Huo-Yan" dakin gwaje-gwajen gaggawa na gaggawa a China). "
An gina shi cikin kwanaki 14, dakin gwaje-gwajen na iya gudanar da dubun dubatan gwaje-gwajen RT-PCR a kowace rana kuma shine na farko a duniya a wannan sikelin da zai fara aiki a wajen China.
An samar da hanyoyin gwaji daban-daban da suka shafi sassa daban-daban na bayanan halittar kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta bi tsarin Jamus na yin kayan aiki da ake tura wa ƙasashe masu ƙarancin kuɗi ba tare da samun damar yin nasu ba.
An buga girke-girke na Jamusanci a ranar 17 ga Janairun 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba ta samuwa har zuwa 28 ga Janairu, jinkirta gwajin da ake da shi a Amurka.China da Amurka suna da matsaloli game da amincin kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin don biyan buƙatu da shawarwari don gwaji ta masana kiwon lafiya ba.
Akasin haka, masana sun ce yawan gwajin da Koriya ta Kudu ke yi ya taimaka wajen rage yaduwar sabon kwayar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina ƙarfin gwaji, galibi a cikin dakunan gwaje-gwaje na kamfanoni masu zaman kansu, tsawon shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen gwaji a matsayin hanya mafi kyau don rage ci gaban cutar COVID-19. Babban buƙata don gwaji saboda yaduwar kwayar cutar ya haifar da jinkirin ɗaruruwan dubban gwaje-gwaje a dakunan gwaje-gwaje na Amurka masu zaman kansu, kuma samar da swabs da reagents na sinadarai ya zama matsi.
A watan Maris na shekarar 2020 kasar Sin ta bayar da rahoton matsaloli game da daidaito a cikin kayan gwajin su.
" A Amurka, kayan gwajin da CDC ta haɓaka suna da ""kurakurai;"" sannan gwamnati ta cire shingen hukuma wanda ya hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin China na Shenzhen Bioeasy Biotechnology Co Ltd, amma ta gano cewa sakamakon ba daidai bane. "
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon rashin tattara samfurori ko amfani da kayan aikin daidai.
Ma'aikatar ta Spain ta ce za ta janye kayan aikin da suka dawo da sakamakon da ba daidai ba, kuma za ta maye gurbinsu da wani kayan gwajin daban wanda Shenzhen Bioeasy ya bayar. 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon da ba daidai ba. Slovakia ta sayi kayan gwajin miliyan 1.2 daga China wanda aka gano ba daidai ba.
Firayim Minista Matovič ya ba da shawarar a zubar da wadannan a cikin Danube.Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskuren kuskure" kuma ba ta "shigar da su cikin amfani ba". "Birtaniya ta sayi kayan gwajin miliyan 3.5 daga China amma a farkon Afrilu 2020 ta sanar da cewa ba za a iya amfani da su ba. "
Gwajin, sannan tare da keɓe waɗanda aka gwada masu kyau da kuma bin sawun waɗanda masu cutar SARS-CoV-2 suka taɓa saduwa da su, ya haifar da sakamako mai kyau.
Masu bincike da ke aiki a garin Vò na Italiya, wurin da aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da zagaye biyu na gwaji a kan dukan mutane kusan 3,400, tsakanin kwanaki goma.
Kimanin rabin mutanen da suka gwada tabbatacce ba su da alamomi, kuma duk waɗanda aka gano an keɓe su.
Tare da takunkumin tafiya zuwa garin, wannan ya kawar da sabbin cututtuka gaba daya.
Tare da bin diddigin tuntuɓar haɗuwa, ƙuntatawa na balaguron shiga, gwaji, da keɓewa, annobar coronavirus ta 2020 a Singapore ta ci gaba da jinkirin yawa fiye da sauran ƙasashe masu tasowa, amma ba tare da matsanancin ƙuntatawa kamar tilasta rufe gidajen abinci da wuraren sayar da kayayyaki ba.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawara ga mazauna su zauna a gida a ranar 28 ga Maris, amma an sake buɗe makarantu a kan lokaci bayan hutun hutu a ranar 23 ga Maris.
Wasu ƙasashe da yawa sun kuma kula da annobar ta hanyar bin diddigin tuntuɓar, ƙuntatawa na balaguron shiga, gwaji, da keɓewa, amma tare da ƙuntatawa da ba ta da ƙarfi, kamar Iceland da Koriya ta Kudu.
Wani binciken kididdiga ya gano cewa ƙasashen da suka gwada ƙarin, dangane da yawan mutuwar, suna da ƙananan adadin mutuwar, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano waɗanda ke da ƙananan alamomi ko babu alamomi.
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da ƙarfin gwaji da dakunan gwaje-gwaje na ƙasa tare da ƙarancin ƙwarewa kan COVID-19 aika da samfuran COVID-19 biyar na farko da na farko goma marasa kyau zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Ostiraliya.
A cikin jadawalin da ke ƙasa, shafi Positive as % of tests yana ƙarƙashin tasirin manufofin gwaji na ƙasar.
Kasar da kawai ke gwada mutanen da aka kwantar a asibitoci za ta sami mafi girman sakamako mai kyau a matsayin kashi na gwaje-gwaje fiye da ƙasar da ke gwada dukkan 'yan ƙasa, ko suna nuna alamomi ko a'a, sauran abubuwa daidai ne.
Wanke hannu (ko wanke hannu), wanda kuma aka sani da tsabtace hannu, shine aikin wanke hannuwan mutum don cire datti, mai, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
" Wanke hannu da sabulu koyaushe a wasu "lokaci masu mahimmanci" a cikin rana yana hana yaduwar cututtuka da yawa, misali gudawa da kwalara, waɗanda ake watsawa ta hanyar fecaloral. "
Hakanan mutane na iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko bakinsu (watau mucous membranes).
Abubuwa biyar masu mahimmanci a rana inda wanke hannu da sabulu ke da mahimmanci sun haɗa da: kafin da bayan bayan bayan, bayan tsabtace ƙasan yaro ko canza diapers, kafin ciyar da yaro, kafin cin abinci da kafin da bayan shirya abinci ko sarrafa nama, kifi, ko kaji.
Idan babu ruwa da sabulu, za a iya wanke hannaye da toka.Kungiyar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin ka dafa abinci, sa'ad da kake dafa abinci da kuma bayan ka gama.
Kafin ka kula da marar lafiya da kuma bayan ka gama.
Bayan ka canja fensir ko kuma ka tsabtace wani yaro da ya je bayan gida.
Bayan ka hura hanci, tari ko hancin.
Bayan ka taɓa dabba ko abincin dabbobi ko kuma ƙura.
Lafiyar hannu ta likita tana nufin ayyukan tsabtace jiki da suka shafi hanyoyin likita.
Wanke hannu kafin a ba da magani ko kulawar likita na iya hana ko rage yaduwar cuta.
Babban manufar aikin wanke hannu shine wanke hannu daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da zasu iya haifar da cuta) da sinadarai waɗanda zasu iya haifar da lahani ko cuta.
Wannan yana da mahimmanci musamman ga mutanen da ke sarrafa abinci ko aiki a fannin kiwon lafiya, amma kuma muhimmiyar hanya ce ga jama'a.
Wanke hannu yana da fa'idodi da yawa ga lafiya, gami da rage yaduwar mura, coronavirus, da sauran cututtukan cututtuka; hana cututtukan cututtukan cututtukan cututtuka na zawo; rage kamuwa da cututtukan numfashi;
da rage yawan mutuwar jarirai a lokacin haihuwar gida.
Wani bincike da aka yi a 2013 ya nuna cewa inganta hanyoyin wanke hannu na iya haifar da ƙaramin ci gaba a cikin tsayin yara a cikin yara 'yan ƙasa da shekaru biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke da nasaba da cututtukan numfashi da zawo ta hanyar gabatar da sauye-sauyen halayya masu sauƙi, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwar waɗannan cututtuka da kusan kashi 50%.
Matakan da ke inganta wanke hannu na iya rage cututtukan guda uku, kuma wannan yana kama da samar da ruwa mai tsafta a yankunan da ba su da kuɗi.
48% na raguwar cututtukan gudawa na iya kasancewa tare da wanke hannu da sabulu. Wanke hannu da sabulu ita ce hanya mafi inganci da arha don hana gudawa da cututtukan cututtukan numfashi (ARI), kamar yadda ake yin ta atomatik a gidaje, makarantu, da al'ummomi a duk duniya.
Ciwon huhu, babban ciwon ARI, shi ne sanadin mutuwa mafi yawa a tsakanin yara 'yan kasa da shekara biyar, yana kashe yara miliyan 1.8 a kowace shekara.
Ciwon gudawa da ciwon huhu suna kashe yara kusan miliyan 3.5 kowace shekara.
A cewar UNICEF, yin wanke hannu da sabulu kafin cin abinci da kuma bayan yin amfani da bayan gida zai iya ceton rayuka fiye da allurar riga-kafi ko kuma maganin da ake yi, kuma hakan zai rage mutuwar masu zazzaɓin jini da kusan rabin kuma ya rage mutuwar masu kamuwa da cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana yawan hada wanke hannu tare da sauran ayyukan tsaftacewa a matsayin wani bangare na shirye-shiryen ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu yana karewa daga impetigo wanda ake watsawa ta hanyar hulɗa ta jiki kai tsaye.
Wani ɗan mummunan sakamako na wanke hannu shine cewa wanke hannu da yawa na iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken Danish na 2012 ya gano cewa yawan wanke hannuwa na iya haifar da ciwon fata mai ƙaiƙayi, mai ƙyalli da aka sani da eczema na hannu ko cututtukan fata na hannu, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin wanke hannu sau da yawa a matsayin ɗaya daga cikin alamun cuta ta obsessive-compulsive disorder (OCD).
Akwai lokuta biyar masu mahimmanci a rana inda wanke hannu da sabulu yana da mahimmanci don rage yaduwar cututtuka ta hanyar fure-bakin: bayan amfani da gidan wanka (yin fitsari, ƙazantawa), bayan tsabtace ƙasan yaro (canza diapers), kafin ciyar da yaro, kafin cin abinci da kafin / bayan shirya abinci ko sarrafa nama mai laushi, kifi, ko kaji.
Sauran lokutan da ya kamata a yi wanka da hannu yadda ya dace don hana yaduwar cuta sun haɗa da kafin da kuma bayan kula da rauni ko rauni; bayan yin fitsari, tari, ko hura hanci; bayan taɓa ƙazamar dabba ko sarrafa dabbobi; da kuma bayan taɓa shara.
A ƙasashe da dama, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita, kashi 38.7% na gidaje suna wanke hannu da sabulu.Binciken na 2014 ya nuna cewa Saudiyya tana da mafi girman kashi 97 cikin dari; Amurka kusa da tsakiyar tare da kashi 77 cikin dari; da China tare da mafi karancin kashi 23 cikin dari.Yanzu akwai hanyoyin sauya dabi'u da yawa don kara karbar dabi'ar wanke hannu da sabulu a lokuta masu mahimmanci.Tsabtace hannu a rukuni ga yaran makaranta a wasu lokutan rana wani zaɓi ne a cikin kasashe masu tasowa don saka wanke hannu a cikin halayen yara.
" Shirin kula da lafiyar da ma'aikatar ilimi ta aiwatar a Philippines misali ne na aiki mai yawa don inganta lafiyar yara da ilimi. "
Kariya daga tsutsotsi sau biyu a shekara, tare da wanke hannuwan yau da kullun da sabulu, goge haƙori yau da kullun tare da fluoride, shine ainihin wannan shirin na ƙasa.
An kuma samu nasarar aiwatar da shi a Indonesia.
Ana kawar da ƙwayoyin cuta daga fata ta hanyar ƙara sabulu ko kayan wanki zuwa ruwa.
Babban aikin sabulu da kayan wanki shine rage shinge ga narkewa, da haɓaka narkewa.
Ruwa kaɗai ba ya tsabtace fata sosai domin kitse da furotin da ke cikin ƙasa ba sa narkewa cikin ruwa.
Amma, tsaftacewa tana da amfani idan akwai ruwa mai yawa.
Sabulu mai ƙarfi, domin ana iya sake amfani da shi, zai iya riƙe ƙwayoyin cuta da aka samu daga amfani da shi a baya.
Karamin adadin binciken da suka kalli canja wurin kwayoyin cuta daga sabulu mai gurbataccen abu sun kammala cewa canja wurin ba zai yiwu ba saboda ana wanke kwayoyin cuta da kumfa.
" CDC har yanzu ta ce ""sabulu mai ruwa tare da sarrafa hannu kyauta don rarrabawa ya fi dacewa"".
An yi wa sabulu na maganin ƙwayoyin cuta wa'azi sosai ga jama'a masu kula da lafiyarsu.
Har zuwa yau, babu wata hujja da ke nuna cewa amfani da maganin kashe ƙwayoyin cuta ko maganin kashe ƙwayoyin cuta yana zaɓar kwayoyin da ke jure maganin rigakafi a cikin yanayi.
Koyaya, sabulu na antibacterial suna ƙunshe da magungunan antibacterial na yau da kullun kamar triclosan, wanda ke da jerin jerin ƙwayoyin cuta masu jurewa.
Don haka, ko da ba a zaɓa nau'ikan maganin rigakafi ba ta hanyar sabulu na antibacterial, ba za su iya zama masu tasiri kamar yadda aka tallata su ba.
Baya ga surfactant da wakilin kare fata, ƙwararrun ƙirar na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, acid benzoic mai aiki da ƙwayoyin cuta da ƙarin kayan kwalliyar fata (aloe vera, bitamin, menthol, tsire-tsire masu tsire-tsire).Binciken da aka yi daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun suna da tasiri kamar sabulu na anti-bacteria na masu amfani da ke dauke da triclosan wajen hana cututtuka da cire kwayoyin cuta daga hannaye.
Ruwan zafi da ke da kyau don wanke hannu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 ° C).
Amma, ruwan sabulu mai ɗumi ya fi ruwan sanyi tasiri wajen kawar da man fetur da ke ɗauke da ƙura da ƙwayoyin cuta.
Akasin abin da mutane da yawa suke tunani, binciken kimiyya ya nuna cewa amfani da ruwan dumi ba ya rage yawan ƙwayoyin cuta a hannaye.
Mai tsabtace hannu ko maganin kashe ƙwayoyin cuta na hannu shine wakili mai tsabtace hannu wanda ba ya dogara da ruwa.
A ƙarshen shekarun 1990 da farkon farkon karni na 21, barasa rub ba ruwa-tushen kayan tsabtace hannu (wanda kuma aka sani da rubs na hannu na barasa, rubs na hannu na antiseptic, ko masu tsabtace hannu) sun fara samun karbuwa.
Yawancin suna dogara ne akan isopropyl barasa ko ethanol wanda aka tsara tare da wakili mai kauri kamar Carbomer (polymer na acrylic acid) a cikin gel, ko humictant kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da rage tasirin bushewar barasa.
Ƙara hydrogen-peroxide mai narkewa yana ƙara haɓaka aikin antimicrobial. Masu tsabtace hannu waɗanda ke ƙunshe da aƙalla kashi 60 zuwa 95% na barasa sune ƙwayoyin cuta masu kashe ƙwayoyin cuta.
Magungunan kashe kwayoyin cuta da ke dauke da barasa suna kashe kwayoyin cuta, kwayoyin cuta masu jurewa da magunguna da yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, mura, da hepatitis) da fungi.
Magungunan tsabtace hannu da ke dauke da kashi 70% na barasa suna kashe kashi 99.97% (ragewar log 3.5 , kwatankwacin rage decibel 35) na ƙwayoyin cuta a hannaye daƙiƙa 30 bayan aikace-aikacen da kuma kashi 99.99% zuwa 99.999% (ragewar log 4-5) na ƙwayoyin cuta a hannaye minti 1 bayan aikace-aikacen. Masu tsabtace hannu suna da tasiri sosai kan ƙwayoyin cuta kuma ba su da tasiri sosai kan wasu ƙwayoyin cuta.
Masu tsabtace hannu da ke da barasa kusan ba su da tasiri sosai a kan ƙwayoyin cuta irin su norovirus (ko Norwalk), sanadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututut
Ana shafa gaban da bayan hannayen biyu da tsakanin da kuma ƙarshen yatsunsu na kimanin dakika 30 har sai ruwa, kumfa ko gel ya bushe.
Dole ne a wanke yatsun yatsunsu sosai, shafa su a cikin dabino biyu. Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar wanke hannu a kan shafawa da tsabtace hannu, musamman idan hannaye suna da datti sosai.
Yawan amfani da wadannan magunguna ya dogara ne da sauƙin amfani da su da kuma saurin kashe ayyukan da ke kashe ƙwayoyin cuta; duk da haka, bai kamata su zama madadin wanke hannu ba sai dai idan sabulu da ruwa basu samuwa.
Amfani da kayan tsabtace hannu na giya sau da yawa na iya haifar da bushewar fata sai dai idan an ƙara emollients da / ko moisturizers na fata a cikin tsari.
Za a iya rage ko kawar da tasirin bushewar barasa ta hanyar ƙara glycerin da/ko wasu emollients zuwa ga tsari.
A cikin gwajin asibiti, masu tsabtace hannu na giya waɗanda ke ɗauke da abubuwan sanyaya jiki suna haifar da ƙarancin ƙonewa da bushewar fata fiye da sabulu ko kayan wanke ƙwayoyin cuta.
Allergic contact dermatitis, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ƙananan ƙarancin haifar da cututtukan cututtukan cututtukan cututtuka ya zama abin jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da ingancinsu, magungunan da ba na ruwa ba suna wanke hannaye daga kayan ƙwayoyin halitta, amma kawai suna kashe su.
Wannan shine dalilin da ya sa masu tsabtace hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cututtuka da yawa, tunda har yanzu cututtukan cututtukan suna kan hannaye.
Ingancin maganin kashe ƙwayoyin cuta na hannu ba tare da barasa ba ya dogara da sinadarai da tsari, kuma a tarihi yana da ƙarancin tasiri da giya da rubs na giya.
Kwanan nan, an nuna cewa magungunan da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimicrobial bayan aikace-aikacen, ba kamar barasa ba, wanda aka nuna cewa yana raguwa a cikin tasiri bayan maimaita amfani, mai yiwuwa saboda ci gaba da mummunan halayen fata.
Mutane da yawa a cikin ƙauyuka masu ƙarancin kuɗi ba za su iya sayen sabulu ba kuma suna amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙasa na iya zama mafi tasiri fiye da ruwa kadai, amma yana iya zama ƙasa da tasiri fiye da sabulu.
Wani abin damuwa shi ne idan ƙasa ko toka ta ƙazantu da ƙwayoyin cuta hakan zai iya sa cututtuka su yaɗu maimakon su rage.
Kamar sabulu, toka tana kashe ƙwayoyin cuta domin idan ta taɓa ruwa, tana zama ruwan gishiri.
Hukumar Lafiya ta Duniya ta ce idan babu sabulu, a yi amfani da toka ko yashi maimakon sabulu.
Daidaitaccen hanyar wanke hannu da Cibiyoyin Kula da Cututtuka na Amurka ke ba da shawarar don hana yaduwar cuta ya haɗa da waɗannan matakan:
Ruwa mai zafi ko ruwan sanyi ya yi ruwa a hannayenka.
Ana ba da shawarar a yi amfani da ruwa mai gudana domin ana iya gurɓata wuraren wanka da ke tsaye, kuma yanayin ruwan ba ya saɓa da yanayin.
Ka wanke hannayenka da sabulu mai yawa, har da bayan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannayensu sosai idan ana amfani da sabulu maimakon ruwa kawai.
Gogewa na akalla dakika 20.
Gogewa tana sa a yi taɓawa, kuma hakan yana kawar da ƙwayoyin cuta daga fata.
Ka wanke shi da kyau da ruwa mai gudu.
Wanke hannu da kwano zai iya sake gurɓata hannu.
Ka bushe da tawul mai tsabta ko ka bar iska ta bushe.
Hannun rigar da rigar suna sake kamuwa da cutar cikin sauki. Yankunan da aka fi rasa su sune babban yatsa, wuyan hannu, yankunan tsakanin yatsunsu, da ƙarƙashin kusoshi.
Ƙwararrun ƙusa da kuma ƙusa mai ƙusa na iya ɗauke da ƙwayoyin cuta.
Ana ba da shawarar ruwan shafa mai laushi don kiyaye hannayen daga bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
" Za a iya yin zaɓuɓɓuka daban-daban masu arha don sauƙaƙe wanke hannu inda ba a samun ruwan famfo da / ko sabulu, misali zuba ruwa daga wani mai rataye ko kabewa tare da ramuka masu dacewa da / ko amfani da toka idan ya cancanta a ƙasashe masu tasowa.A cikin yanayi tare da iyakance samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin kiyaye ruwa, kamar ""tippy-tap"" da sauran zaɓuɓɓuka masu arha. "
Tipy-tap fasaha ce mai sauƙi ta amfani da kwalba da aka rataye ta igiya, da kuma ƙafafun kafa don zuba ruwa kaɗan a kan hannaye da sandar sabulu.
Goge hannaye yadda ya kamata wani muhimmin bangare ne na tsaftace hannu, amma akwai wasu muhawara game da mafi ingancin bushewa a wuraren wanka na jama'a.
Bincike da ke ƙaruwa ya nuna cewa tawul na takarda sun fi tsabtace jiki fiye da na'urar busar hannu da ake samu a ɗakunan wanka da yawa.
A shekara ta 2008, Jami'ar Westminster, London, ta gudanar da wani bincike, kuma masana'antar takarda ta tallafawa taron Turai na Tissue, don kwatanta matakan tsabtace jiki da takarda takarda, bushewar hannu mai zafi da na zamani na jet-air.
Bayan wankewa da bushe hannuwan da na'urar busar iska mai dumi, an gano cewa yawan kwayoyin sun karu a matsakaita a kan yatsunsu da kashi 194% kuma a kan dabino da kashi 254%.
Drying tare da jet-air dryer ya haifar da karuwar yawan adadin kwayoyin cuta a kan yatsunsu da kashi 42% da kuma a kan dabino da kashi 15%.
Bayan wankewa da bushe hannu da tawul na takarda, yawan adadin kwayoyin cuta ya ragu a matsakaita har zuwa kashi 76% a kan yatsunsu da har zuwa kashi 77%.Masana kimiyya sun kuma gudanar da gwaje-gwaje don tabbatar da ko akwai yiwuwar gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka sakamakon kowane nau'in bushewa.
Jirgin bushe-bushe, wanda ke busa iska daga cikin naúrar a cikin saurin da aka yi ikirarin 180 m / s (650 km / h; 400 mph), ya iya busa ƙwayoyin cuta daga hannaye da naúrar kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Amfani da na'urar busar hannu mai iska mai zafi yana yada ƙwayoyin cuta har zuwa mita 0.25 daga na'urar busar.
Takaddun takarda ba su nuna yaduwar ƙwayoyin cuta ba.A cikin 2005, a cikin binciken da TÜV Produkt und Umwelt ya gudanar, an kimanta hanyoyin bushe hannu daban-daban.
An lura da wadannan canje-canje a cikin ƙididdigar ƙwayoyin cuta bayan bushe hannayen:
Akwai masana'antun bushewa na hannu daban-daban, kuma an kwatanta bushewar hannu da bushewa da tawul ɗin takarda.
Wanke hannu ta amfani da tawul din tsabtace hannu wani zaɓi ne yayin tafiya idan babu sabulu da ruwa.
Sanitizer na hannu mai tushen giya ya kamata ya ƙunshi aƙalla kashi 60% na barasa.
Wanke hannu ya zama tilas ne tun bayan likitan Hungary Ignaz Semmelweis ya gano ingancinsa (a 1846) wajen hana cututtuka a asibiti.
Akwai na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano rage yawan kamuwa da cuta tare da amfani da su.
Wanke hannu na likita shine na aƙalla dakika 15, ta amfani da sabulu da ruwa ko gel mai yawa don busawa da shafa kowane ɓangaren hannaye.
Ya kamata a shafa hannaye tare da yatsunsu suna haɗuwa.
Idan akwai tarkace a ƙarƙashin ƙusa, za a iya cire shi da goga.
Tun da ƙwayoyin cuta za su iya kasancewa a cikin ruwa a kan hannuwan, yana da muhimmanci a wanke hannu da kyau kuma a goge su da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul ɗin takarda don kashe ruwa (kuma buɗe kofar fita idan ya cancanta).
Wannan yana hana sake gurɓata hannaye daga waɗancan farfajiyoyin.
"Manufar wanke hannu a wuraren kiwon lafiya shine cire ƙwayoyin cuta masu cutarwa (""kwayoyin cuta"") da kuma guje wa watsa su. "
Jaridar New England Journal of Medicine ta ba da rahoton cewa rashin wanke hannu ya kasance a matakan da ba za a iya karɓa ba a yawancin wuraren kiwon lafiya, tare da yawancin likitoci da ma'aikatan jinya da ke mantawa da wanke hannayensu kafin su taɓa marasa lafiya, don haka suna watsa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran hanyoyin sauki na iya rage yawan kamuwa da cututtukan jini da ke da alaƙa da catheter da kashi 66.
Hakanan za'a iya samun tsarin jagorar tsabtace hannu ta kungiyar a shafin yanar gizon ta don sharhin jama'a.
Whitby et al. sun gudanar da wani bita mai dacewa.
Na'urorin kasuwanci na iya auna da tabbatar da tsabtace hannu, idan ana buƙatar nuna bin ƙa'idodi.
"Kungiyar Lafiya ta Duniya tana da "Lokaci Biyar" don wanke hannu: "
bayan an nuna shi ga jini/ruwan jiki
kafin aikin aseptic, kuma
" bayan kulawar mai haƙuri. Ƙara sunadarai masu maganin cututtuka zuwa sabulu (""magunguna"" ko "antibacterial"" sabulu) yana ba da aikin kisa ga mai wanke hannu. "
Irin wannan kashewa na iya zama abin so kafin yin tiyata ko a cikin saitunan da kwayoyin cuta masu jurewa da maganin rigakafi ke yaduwa.Don 'shafe' hannayen mutum don aikin tiyata, ya zama dole a sami famfo wanda za'a iya kunnawa da kashewa ba tare da taɓa shi da hannaye ba, wasu chlorhexidine ko iodine wanka, tawul ɗin da ba a tsabtace su don bushe hannayen bayan wanka, da goga mai tsabta don shafawa da wani kayan aiki mai tsabta don tsabtace ƙarƙashin kusoshi.
Ya kamata a cire duk kayan ado.
Wannan aikin yana buƙatar wanke hannu da makamai har zuwa gwiwar hannu, yawanci minti 26.
Ba a buƙatar tsawon lokacin gogewa (10 minti).
Lokacin wankewa, dole ne a hana ruwa a kan makamai daga komawa hannun.
Bayan an gama wanke hannu, sai a bushe hannuwan da zane mai tsabta kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da marar lafiya.
Don sarrafa cututtukan staphylococcal a asibitoci an gano cewa mafi girman fa'ida daga tsabtace hannu ya fito ne daga kashi 20% na wankewa, kuma cewa an sami ƙarin fa'ida kaɗan lokacin da aka ƙara yawan tsabtace hannu sama da 35%.
Wankewa da sabulu na yau da kullun yana haifar da fiye da sau uku na yawan cututtukan cututtukan cututtukan da ke kamuwa da cuta da ke yaduwa zuwa abinci idan aka kwatanta da wankewa da sabulu mai maganin ƙwayoyin cuta. Kwatanta shafa hannu da maganin da ke da barasa tare da wanke hannu da sabulu mai maganin ƙwayoyin cuta na matsakaicin lokaci na dakika 30 kowane ya nuna cewa shafa hannu da barasa ya rage gurɓatar ƙwayoyin cuta da kashi 26% fiye da sabulu mai maganin ƙwayoyin cuta.
Amma sabulu da ruwa sun fi tasiri fiye da shafa hannu da ke da barasa don rage kwayar cutar H1N1 ta cutar mura A da kuma ƙwayoyin Clostridium difficile daga hannaye. Matsaloli don inganta tsabtace hannu a wuraren kiwon lafiya na iya haɗawa da ilimantar da ma'aikata kan wanke hannu, ƙara samun maganin shafa hannu da ke da barasa, da tunatarwa ta rubutu da magana ga ma'aikata.
Akwai bukatar karin bincike kan wanne daga cikin wadannan hanyoyin da suka fi tasiri a bangarorin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu an gane shi azaman mai araha, kayan aiki mai mahimmanci don cimma kyakkyawan lafiya, har ma da abinci mai gina jiki.
Koyaya, rashin amintaccen samar da ruwa, sabulu ko wuraren wanke hannu a gidajen mutane, a makarantu da wuraren aiki yana sanya ƙalubale don cimma halayen wanke hannu na duniya.
Misali, a yawancin yankunan karkara na Afirka, famfunan wanke hannu kusa da kowane bayan gida na masu zaman kansu ko na jama'a ba su da yawa, duk da cewa akwai wasu hanyoyin da ba su da tsada don gina tashoshin wanke hannu.
Koyaya, ƙananan yawan wanke hannu na iya zama sakamakon halayen da aka kafa maimakon saboda rashin sabulu ko ruwa.
Tallafawa da kuma bayar da shawarwari game da wanke hannu da sabulu na iya tasiri kan yanke shawara na siyasa, wayar da kan jama'a game da fa'idodin wanke hannu da haifar da canjin halayyar jama'a na dogon lokaci.
Don wannan ya yi aiki yadda ya kamata, ana bukatar sa ido da kuma kimantawa.
"Binciken da aka yi na nazari 70 ya gano cewa hanyoyin da al'umma ke amfani da su suna da tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen din tallatawa na zamantakewa ba shi da tasiri. Misali daya na inganta wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" ta UNICEF wanda ke karfafa makarantu su dauki matakai masu sauki, marasa tsada don tabbatar da cewa dalibai sun wanke hannayensu da sabulu, a tsakanin sauran bukatun tsafta. "
Idan aka cimma ƙa'idodin ƙaƙƙarfan ƙa'idodi, makarantu na iya motsawa daga tauraro ɗaya zuwa ƙarshe taurari uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na inganta wanke hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke kokarin cimma canjin hali. Sakamakon annobar coronavirus ta 2019-20, UNICEF ta inganta amfani da emojis na wanke hannu.
Karamin bincike ya yi la'akari da tasirin kuɗin wanke hannu a cikin ƙasashe masu tasowa dangane da DALYs da aka kauce wa.
Koyaya, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi tsada fiye da sauran hanyoyin ruwa da tsaftacewa.
" Muhimmancin wanke hannu don lafiyar ɗan adam  musamman ga mutanen da ke cikin mawuyacin hali kamar uwaye waɗanda suka haihu ko sojoji da aka ji rauni a asibitoci  an fara gane su a tsakiyar karni na 19 ta hanyar majagaba biyu na tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, Ingilishi ""mai kafa aikin jinya na zamani"". "
A lokacin, mutane da yawa suna ganin cewa ƙamshi ne ke jawo cututtuka.
A cikin shekarun 1980, barkewar cututtukan da ke tattare da abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su inganta tsabtace hannu a matsayin muhimmiyar hanya don hana yaduwar kamuwa da cuta.
Cutar mura ta alade a shekarar 2009 da kuma annobar COVID-19 a shekarar 2020 sun haifar da kara wayar da kan mutane a kasashe da dama kan muhimmancin wanke hannu da sabulu don kare kansu daga irin wadannan cututtuka masu yaduwa.
" Misali, an rataye allon talla tare da "daidaitaccen hanyoyin wanke hannu" kusa da wankin wanke hannu a cikin dakunan wanka na jama'a da kuma a cikin dakunan wanka na gine-ginen ofis da filayen jirgin sama a Jamus. "
"Furucin nan "wanke hannuwan mutum daga" wani abu, yana nufin bayyana rashin son kaiwa ga alhakin abu ko kuma shiga cikin sa. "
Ya samo asali ne daga nassi na littafi mai tsarki a cikin Matta inda Pontius Bilatus ya wanke hannayensa daga shawarar gicciye Yesu Kristi, amma ya zama magana tare da amfani da yawa a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a hankali don ƙoƙarin wanke wani tabo na tunanin, yana wakiltar lamirinta na laifi game da laifukan da ta aikata kuma ta sa mijinta ya aikata.
An kuma gano cewa mutane, bayan sun tuna ko tunanin ayyukan da ba na ɗabi'a ba, suna yawan wanke hannu sau da yawa fiye da wasu, kuma suna da ƙimar kayan aikin wanke hannu.
" Bugu da ƙari, waɗanda aka ba su izinin wanke hannayensu bayan irin wannan tunani ba su da damar shiga cikin wasu ayyukan "tsabtace" masu biyan kuɗi, kamar aikin sa kai. "
Addinai suna ba da umarnin wanke hannu don dalilai na tsabta da na alama.Wasu addinai suna ba da umarnin wanke hannu da ruwa amma ba sabulu ba don wanke hannu, wani ɓangare ne na al'adar wanke hannu da aka nuna a addinai da yawa, gami da Baha'i Faith, Hindu, tevilah da netilat yadayim a addinin Yahudanci, Lavabo a Kristanci, da Wudhu a Musulunci. Addinai kuma suna ba da umarnin wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun umurci wanke hannu bayan amfani da bayan gida.
Kuma, addinin Hindu, Buddha, Sikhism, Yahudanci da Musulunci sun umurci wanke hannu kafin da kuma bayan kowane abinci.
Kula da haɗarin COVID-19 a wuraren aiki
Kula da haɗarin aiki don COVID-19 shine aikace-aikacen hanyoyin aminci da kiwon lafiya na aiki don kula da haɗari don hana cutar coronavirus 2019 (COVID-19).
Kula da haɗari da ya dace a wurin aiki ya dogara da wurin aiki da aikin aiki, bisa la'akari da ƙimar haɗarin tushen haɗari, tsananin cutar a cikin al'umma, da abubuwan haɗarin ma'aikata na mutum waɗanda zasu iya zama masu saurin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari mafi ƙaranci suna da iyakantaccen hulɗa da jama'a da sauran abokan aiki, wanda ake ba da shawarar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ladabi na numfashi, da kiyaye tsaftacewa da kashe ƙwayoyin cuta na yau da kullun na yanayin aiki.
Matsakaicin haɗarin haɗari ya haɗa da waɗanda ke buƙatar hulɗa sau da yawa ko kusanci da mutanen da ba a san su ba ko ake zargi da COVID-19, amma suna iya kamuwa da cutar saboda ci gaba da watsawa a cikin al'umma ko balaguron ƙasa da ƙasa.
Wannan ya hada da ma'aikatan da ke hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a, da wasu wuraren sayar da kayayyaki masu yawa.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali, sun haɗa da iska ta amfani da matattarar iska mai inganci, masu kare hancin, da samun kayan kariya na mutum idan an sami mutum tare da COVID-19.
OSHA ta ɗauki ma'aikatan kiwon lafiya da ma'aikatan gawa da ke fuskantar sanannen ko wanda ake zargi da cutar COVID-19 a matsayin masu haɗarin haɗari, wanda ke ƙaruwa zuwa haɗarin haɗari sosai idan ma'aikata suka yi ayyukan samar da iska a kan, ko tattara ko sarrafa samfuran daga, sanannen ko wanda ake zargi da cutar COVID-19.
Kula da haɗari da ya dace da waɗannan ma'aikata sun haɗa da kula da aikin injiniya kamar ɗakunan iska mai matsin lamba, da kayan kariya na mutum da suka dace da aikin.
Cutar COVID-19 na iya haifar da sakamako da yawa a wurin aiki.
Ma'aikata suna iya yin rashin aiki domin suna rashin lafiya, suna bukatar su kula da wasu, ko kuma suna tsoron haɗari.
Hanyoyin kasuwanci na iya canzawa, duka dangane da abin da ake buƙata, da kuma hanyoyin da za a samu waɗannan kaya (kamar sayayya a lokacin da ba a kan lokaci ba ko ta hanyar aikawa ko sabis na tuki).
A ƙarshe, jigilar kayayyaki daga yankunan ƙasa waɗanda COVID-19 ya shafa sosai na iya katsewa. Za a iya amfani da shirye-shiryen cututtukan cututtuka da shirin amsawa don jagorantar ayyukan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wuraren aiki daban-daban da ayyukan aiki, gami da tushen haɗari, abubuwan haɗari da ke tasowa daga gida da yanayin al'umma, da abubuwan haɗari na ma'aikata na mutum kamar tsufa ko yanayin rashin lafiya.
Sun kuma bayyana matakan da ake bukata don magance wadannan kasada, da kuma tsare-tsaren gaggawa ga yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen shirye-shiryen cututtuka da shirye-shiryen magance cututtuka na iya zama batun shawarwari na ƙasa ko na ƙasa.
Manufofin magance barkewar cutar sun haɗa da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke cikin haɗarin haɗari ga mummunan cututtukan lafiya, kiyaye ayyukan kasuwanci, da rage tasirin sakamako mai illa ga sauran ƙungiyoyi a cikin sarƙoƙin samar da su.
Matsayin cutar a cikin al'umma inda kasuwancin yake yana shafar martani da aka ɗauka.
Tsarin tsarin kula da haɗari tsari ne da ake amfani dashi sosai a cikin aminci da lafiya na aiki don rukuni na kula da haɗari ta hanyar tasiri.
Inda ba za a iya kawar da haɗarin COVID-19 ba, ingantattun hanyoyin sarrafawa sune sarrafa injiniya, sannan sarrafawa na gudanarwa, kuma a ƙarshe kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin da ke tattare da aiki ba tare da dogaro da halayyar ma'aikaci ba, kuma yana iya zama mafita mafi inganci don aiwatarwa.
Kulawa na gudanarwa canje-canje ne a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Kayan kariya na mutum (PPE) ana ɗaukar su da ƙarancin tasiri fiye da injin injiniya da kulawar gudanarwa, amma na iya taimakawa hana wasu fallasa.
Dole ne a zabi dukkan nau'ikan PPE bisa la'akari da haɗarin da ke tattare da ma'aikaci, an saka su yadda ya kamata (misali, na'urorin numfashi), ana sawa koyaushe kuma yadda ya kamata, ana bincika su akai-akai, ana kiyaye su, kuma ana maye gurbinsu, kamar yadda ya cancanta, kuma ana cire su yadda ya kamata, ana tsabtace su, kuma ana adana su ko kuma a zubar da su don kauce wa gurɓata.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari ba su da haɗari sosai ga jama'a da sauran abokan aiki.
Matakan farko na rigakafin kamuwa da cuta da aka ba da shawarar ga dukkan wuraren aiki sun haɗa da wanke hannuwa akai-akai da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ladabi na numfashi gami da rufe tari da hancin, samar da kayan shafawa da kwandon shara, shirya aikin nesa ko sauye sauye idan ya cancanta, hana ma'aikata amfani da kayan aikin wasu da kayan aiki, da kiyaye tsaftacewa da kashe ƙwayoyin cuta na yau da kullun na yanayin aiki.
Gano da kuma ware mutanen da za su iya kamuwa da cutar da wuri mataki ne mai muhimmanci wajen kāre ma'aikata, abokan ciniki, baƙi, da wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikatan da ke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai sun sami sauƙi daga zazzabi, alamun zazzabi, da duk wasu alamun aƙalla awanni 24 ba tare da amfani da rage zazzabi ko wasu magunguna masu canza alamun ba, kuma cewa manufofin hutu na rashin lafiya suna da sassauƙa, suna ba ma'aikata damar zama a gida don kula da wani dangin da ke rashin lafiya, kuma cewa ma'aikata sun san waɗannan manufofin.
A cewar OSHA, ayyukan haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar hulɗa sau da yawa ko kusanci a cikin ƙafa shida (1.8 m) na mutanen da ba a san su ba ko waɗanda ake zargi da marasa lafiya na COVID-19, amma suna iya kamuwa da SARS-CoV-2 saboda ci gaba da yaduwar al'umma a kusa da wurin kasuwancin, ko saboda mutumin yana da kwanan nan tafiya ta duniya zuwa wani wuri tare da yaduwar yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a, da wasu wuraren sayar da kayayyaki masu yawa.Gudanar da aikin injiniya don wannan da manyan rukunin haɗarin ya haɗa da shigar da matatun iska masu inganci, haɓaka ƙimar iska, shigar da shinge na zahiri kamar masu kare filastik masu haske, da shigar da taga don sabis na abokin ciniki.Gudanar da gudanarwa don wannan da manyan rukunin haɗarin ya haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, maye gurbin tarurruka na fuska da fuska da sadarwa ta kama-da-wane, kafa canji, dakatar da balaguron da ba dole ba zuwa wuraren da ke fama da cutar COVID-19, haɓaka shirye-shiryen gaggawa gami da amsa damuwar ma'aikata, samar da ilimi na yau da kullun da horo kan abubuwan haɗarin COVID-19 da abin rufe fuska da kayan kariya, waɗanda ke buƙatar ma'aikata su yi amfani da tufafin kariya da yadda ake amfani da shi, samar da yanayin aiki mai haɗari da haɗari.Dole ne a haɗa da masu aiki tare da kayan aikin COVID-19, masu buƙatar yin aiki tare da hannuwan hannu ko wasu hanyoyin sadarwa, da ke buƙatar aƙalla wasu hanyoyin sadarwa na sirri da keɓaɓɓu, da ke buƙatar masu aiki su yi aiki tare da masu amfani da kayan aikin COVID-19, masu buƙatar yin aiki tare da takalma ko kayan aiki na musamman, da kuma samar da wasu alamun aiki na musamman da ke buƙatar auna.
Ma'aikata a cikin wannan rukunin haɗarin da wuya suna buƙatar amfani da kayan numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da raba mai ciwo daga wasu ta nesa da ƙafa 6, sanya memba ɗaya na ma'aikatan jirgin don yi wa mai ciwo hidima, da ba da abin rufe fuska ga mai ciwo ko tambayar mai ciwo ya rufe bakinsa da hanci da kayan ɗamara lokacin tari ko hancinsa.
Ma'aikatan jirgin ya kamata su sa safar hannu na likita da za a iya amfani da su sau ɗaya idan suna kula da matafiyi mara lafiya ko taɓa ruwa na jiki ko abubuwan da za su iya gurɓata, kuma wataƙila ƙarin kayan kariya na mutum idan matafiyin mara lafiya yana da zazzabi, tari mai ɗorewa, ko wahalar numfashi.
Ya kamata a zubar da safar hannu da sauran abubuwa masu amfani da su a cikin jakar haɗarin halittu, kuma ya kamata a tsabtace da kuma kashe ƙwayoyin cuta a bayan haka. Don jigilar kayayyaki na kasuwanci, gami da jiragen ruwa na yawon shakatawa da sauran jiragen fasinja, kula da haɗari sun haɗa da jinkirta tafiya lokacin da ba su da lafiya, da keɓe kai da sanar da cibiyar likitancin jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamomi yayin jirgin.
Da kyau, bin likita ya kamata ya faru a cikin ɗakin mutum mai keɓewa. Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsabtace ko kashe ƙwayoyin cuta idan mutum mai cutar ya kasance a cikin ginin makaranta ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙananan zuwa matsakaiciyar yaduwar al'umma, ana iya aiwatar da dabarun nisantar zamantakewa kamar soke tafiye-tafiye, taro, da sauran manyan tarurruka kamar ilimin motsa jiki ko azuzuwan mawaƙa ko abinci a cikin kantin abinci, ƙara sarari tsakanin tebur, jinkirta isowa da lokacin sallama, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓen wurin ofishin kiwon lafiya don yara masu alamun mura.
Lokacin da akwai yaduwar yaduwa a cikin al'ummar yankin, ban da dabarun nisantar zamantakewa, ana iya yin la'akari da dakatar da makarantu. Ga ma'aikatan tilasta yin doka da ke yin ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiyar nan da nan da ƙarancin.
Ana ba da shawarar jami'an tilasta yin doka waɗanda dole ne su tuntuɓi mutane da aka tabbatar ko ake zargi da samun COVID-19 su bi ƙa'idodin da masu fasaha na gaggawa, gami da kayan kariya na sirri masu dacewa.
Idan an yi kusanci da su yayin kama su, ma'aikata su tsabtace da kuma kashe ƙwayoyin cuta da belin aiki da kayan aiki kafin sake amfani da su ta amfani da fesa tsabtace gida ko gogewa, kuma su bi ƙa'idodin aiki don ƙuntatawa da zubar da PPE da aka yi amfani da su da kuma riƙewa da wanke tufafi.
OSHA ta yi la'akari da wasu ma'aikatan kiwon lafiya da masu aikin gawa suna cikin manyan ko manyan nau'ikan haɗarin haɗari.
Ayyukan haɗarin haɗari sun haɗa da isar da kiwon lafiya, tallafi, dakin gwaje-gwaje, da ma'aikatan jigilar kayayyakin kiwon lafiya waɗanda ke fuskantar sanannun ko masu cutar COVID-19.
Waɗannan suna zama haɗarin haɗari sosai idan ma'aikata suka yi ayyukan samar da aerosol akan, ko tattara ko sarrafa samfuran daga, sanannun ko masu cutar COVID-19.
Hanyoyin samar da iska sun hada da intubation, hanyoyin haifar da tari, bronchoscopy, wasu hanyoyin hakori da gwaje-gwaje, ko karɓar samfurin ƙwayar cuta.
Ayyukan gidan gawa da ke da haɗarin haɗari sun haɗa da ma'aikatan da ke cikin shirya gawarwakin mutanen da suka san ko ake zargin suna da cutar COVID-19 a lokacin mutuwarsu; waɗannan sun zama haɗarin haɗari sosai idan sun yi autopsy. Ƙarin sarrafa injiniya don waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don marasa lafiya da aka sani ko ake zargin COVID-19, gami da lokacin da ake aiwatar da hanyoyin samar da iska.
Hanyoyin iska na musamman na iya zama dacewa a wasu wuraren kiwon lafiya da kuma wuraren ajiyar gawa.
Ya kamata a yi amfani da samfurori tare da matakan kariya na Biosafety Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a raba marasa lafiya masu shigowa zuwa yankunan jira daban-daban dangane da ko sun kasance masu zargin COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar kayan aikin numfashi ga waɗanda ke aiki a cikin ƙafa 6 na marasa lafiya da aka sani, ko ake zargin, sun kamu da SARS-CoV-2, da waɗanda ke yin hanyoyin samar da iska.
A Amurka, dole ne a yi amfani da N95 mai tace fuskar fuska ko mafi kyau da NIOSH ta amince da shi a cikin mahallin cikakken, rubutaccen shirin kare numfashi wanda ya haɗa da gwajin dacewa, horo, da gwajin likita.
Sauran nau'ikan na'urorin numfashi na iya samar da kariya mafi girma da inganta jin daɗin ma'aikata. WHO ba ta ba da shawarar sutura ba, saboda COVID-19 cuta ce ta numfashi maimakon watsawa ta hanyar ruwan jiki.
WHO ta ba da shawarar kawai rufe fuska don aikin tantancewa a wuraren shiga.
Ga waɗanda ke tattara samfuran numfashi daga, kula, ko jigilar marasa lafiyar COVID-19 ba tare da kowane aikin samar da iska ba, WHO ta ba da shawarar rufe fuska, tabarau, ko garkuwar fuska, riguna, da safar hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2 respirator.
Ganin cewa wadatar PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatun PPE ta hanyar telemedicine, shinge na zahiri kamar windows mai haske, ba da izinin waɗanda ke da hannu cikin kulawa kai tsaye kawai su shiga ɗaki tare da mai haƙuri na COVID-19, amfani da PPE kawai da ake buƙata don takamaiman aiki, ci gaba da amfani da respirator ɗin guda ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da PPE, da hana amfani da masks ga mutane marasa alamomi.
Daga: Katherine Maher, Shugaba na Wikimedia Foundation
TO: Duk ma'aikatan Gidauniyar Wikimedia
LINE MAI TSARA: [Covid-19] Sauƙaƙa kaya da shirya don nan gaba
Ranar aikawa: 14 ga Maris, 2020, 00:24 UTC
LITTAFI: CC0: Babu haƙƙoƙin da aka tanada
Mun sami kanmu cikin yanayi mai ban mamaki wannan watan.
Cutar COVID-19 wani abu ne da ke nuna alakarmu ta duniya da alhakin da muke da shi ga juna.
Ba mu da misali ga kalubalen da yake fuskanta, amma mun san cewa mafi kyawun amsarmu ta dogara ne da irin jinƙai na duniya, haɗin kai, da gina al'umma wanda ke tsakiyar wannan ƙungiyar.
Abokan hulda da kulawa da muka gani tsakanin dukkan abokan aikinmu ta hanyar imel, kira, da hira shine tabbaci mai ban mamaki na mutane masu ban mamaki da muke da sa'a don aiki tare.
Ba zan iya zama mai godiya da alfahari ba da na kirga ku duka a matsayin abokan aiki.
A makon da ya gabata, wani ya nuna godiya ga aikinmu.
Sun tunatar da ni yadda ma'ana yake ga duniya ta iya juya zuwa Wikipedia a yanzu, da kuma yadda alama ce mai ƙarfi don wannan mahimmin kayan aiki ya kasance a kan layi kuma yana samuwa ga kowa.
Aikinku ya sa wannan ya yiwu, ko kuna kiyaye wuraren ci gaba ko abokan aikinmu suna biya ko kuma al'ummominmu suna lafiya.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne wanda ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa a ciki, za mu yi wasu canje-canje masu mahimmanci ga yadda muke aiki tare, farawa a wannan makon mai zuwa.
Canje-canje a aikinmu da kuma jadawalinmu
Kamar yadda Robyn ta ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muke ganin zai zama amsa mai dacewa ga abin da muke fuskanta da kuma hanya mafi kyau don kiyaye ƙungiyar mai dorewa a wannan lokacin.
Mafi yawanci muna so mu kawar da damuwa da kuma tallafawa aikinmu na dogon lokaci.
Idan kana bukatar ka sake kira, ba matsala.
Ga dukan ma'aikata, 'yan kwangila, da ma'aikatan kwangila:
tsammaninmu na aiki na yau da kullun zai zama kimanin awanni 4 a rana, ko awanni 20 a mako har sai an sake ba da umarni.
Ba ma sanar da hutu - idan kuna iya yin aiki fiye da yadda kuke yi, aikin na iya amfani da ku.
Amma, duniya ba ta da tabbas a yanzu, kuma ko kana bukatar kula da ƙaunatattunka, sayen kaya, ko zuwa wurin likita, lafiyarka ita ce ta fi muhimmanci a gare mu.
Ba ma bin sa'arku.
Idan kana rashin lafiya, kada ka yi aiki.
Wannan ya kamata ya zama ba tare da faɗi ba, amma muna faɗar hakan.
Babu ranar rashin lafiya ko PTO da ake buƙata - kawai gaya wa manajan ku kuma ku taimaka wa ƙungiyar ku sake nazarin kalandarku da jadawalin don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan an gano cewa kana da cutar COVID-19, don Allah ka sanar da Bryan a cikin T&amp;C Ops don T&amp;C ta taimaka tare da tallafi da tabbatar da halin da kake ciki ya sami kulawa ta dace daga gudanarwa).
Za a biya mutanen da suke aiki a sa'a ɗaya.
Mun riga mun ce, kuma muna sake yin alkawarin girmama alkawuranmu ga masu aikin kwangila da abokan aikinmu na sa'a.
Za a biya kowa bisa yawan sa'o'in da ya yi a cikin al'ada.
Wannan ya haɗa da idan kana rashin lafiya kuma ba za ka iya aiki ba.
Idan kana son aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aikinsu don su kawar da alhini.
Abin da muke yi zai iya zama da amfani sosai, musamman a irin wannan lokaci.
Har yanzu, wannan game da kulawarka ne.
Muna son ka yi magana da shugabanka don mu san abin da za ka yi tsammani kuma mu daidaita yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole ne mu ci gaba da yi.
SRE, HR Ops, Amincewa &amp; Safety, da kuma Tattara Kuɗi ƙungiyoyi (a tsakanin wasu) suna yin aiki mai mahimmanci wanda zai buƙaci ƙarin tallafi.
Za mu fara aiki tare da dukkan ma'aikatu don tantance manufofinmu na yanzu da kuma mayar da hankalinmu kan tallafawa abin da ke da muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za mu yi, amma za mu mai da hankali kan ayyukan da suka fi muhimmanci.
Sanya hankali yanzu ba zai cutar da baya ba.
Ba mu da shirin tafiya sau biyu don kamawa  da zarar annobar ta wuce.
Ba za a bukaci ka yi aiki na tsawon lokaci ba don ka cika jadawalin da aka ba ka.
Mun amince da cewa yanayi ya sauya, kuma za mu yi aiki don kafa sabbin manufofi da jadawalin lokacin da ya dace.
Me zai faru da shirin shekara-shekara?
Don daidaitawa da sabon gaskiyarmu da tsammanin lokutan aiki na yau da kullun, muna da niyyar daidaita jadawalin isar da shirinmu na shekara-shekara na 2020-2021.
Nufinmu shine mu ba da shawarar tsawaita shirinmu na 2019-2020 wanda ke ba da ƙarin lokaci don tsara kasafin kuɗi don ba ma'aikata damar ba da fifiko ga aiki mai mahimmanci, kula da kansu, da kula da ƙaunatattun su yayin da suke biyan waɗanda ke buƙatar ko son yin aiki a rage jadawalin a cikin makonni masu zuwa.
Wannan tsawaita lokaci yana rage yawan aikin tsarawa da matsin lamba a cikin dukan ƙungiyar.
Za mu gabatar da shawararmu ga kwamitin mako mai zuwa kuma za mu sanar da wakilai da kungiyoyi kan matakai na gaba da zaran mun sami tabbaci.
Na gode wa kungiyar APP saboda jagorancin ku a wannan.
Matsayin ofishi, bayyanuwa, da tsaftacewa
A makon da ya gabata, mun koyi cewa ɗaya daga cikin abokan aikinmu da ke SF na iya kamuwa da cutar COVID-19.
Amma, don mu mai da hankali sosai, mun yi amfani da ƙungiyar tsabtace ƙwayoyin cuta don kashe ƙwayoyin cuta a dukan wurare a ofishin San Francisco.
Sun yi amfani da maganin rigakafin kwayar cutar asibiti don kashe ƙwayoyin cuta a kowane wuri, da kuma harabar da kuma ɗaga-hawan da ke shiga bene.
Ginin yana amfani da tsarin kula da kansa ta amfani da kayayyakin da ke tallafawa lafiyar masu haya.
Muna farin ciki cewa za a shirya ofishin sosai sa'ad da muka sake komawa.
Ofishinmu na DC yana cikin WeWork, wanda ya raba mana da dukkan ma'aikatan DC yarjejeniyar COVID-19.
Tun a makon da ya gabata, ofishinmu na DC ya koma wurin da aka kafa ta nesa daidai da jagororin da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu da ke birnin New York suka sani, mun kuma tattauna batun hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa zai iya zama daidaitawa, kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon taron zuwa awa ɗaya ko biyu.
Idan ana bukatar a yi nazari na tsawon lokaci, ka yi la'akari da yadda za a iya raba su a cikin kwanaki da yawa.
Ka bayyana abin da za a yi a taron, ka tsara jadawalin taron, kuma ka aika da littattafan da za ka karanta tun da wuri.
Ka sanya bidiyo a matsayin tsoho, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗi kai tsaye.
Ka kasance da jagora don sauƙaƙe kowane taro, wani don saka idanu kan hira don tambayoyi da bin jerin masu magana, kuma wani don taimakawa yin rubutu (ko yin rubutu tare).
Aika da imel zuwa goyon bayan fasaha idan kana bukatar wani m lasifika.
Ka yi amfani da kuɗin da aka ba ka don cin abinci.
Shiga cikin #remoties tashar a Slack don magana da abokan aiki game da rarraba aiki
Rukunin Ayyukan HR yana neman jagororin ergonomics na yanar gizo don tallafawa karuwar aikin da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma da su soke abubuwan da Wikimedia ke tallafawa jama'a, kamar su edithons, har sai WHO ta ayyana cutar ta ƙare.
Mun sanar da su cewa mun fahimci cewa buƙatarmu don sokewa da sauran ƙuntatawa na iya sa ba zai yiwu a kammala ayyukan tallafin da aka amince da su ba kuma ba za a hukunta kowa ba don jinkirta ko gyara waɗannan manufofin.
A mako mai zuwa za mu ci gaba da ƙarin jagorori kan Wikimania da sauran taron yanki da na al'ada.
Babban motsin zuciyar jama'ar duniya kamar bakin ciki ne game da rushewa amma jin dadi game da tsabta da ikon mayar da hankali ga al'ummomin su, Wikimedia da sauransu.
A gaba, CRT tana aiki don kafa shafi a Meta-Wiki don samar da sarari ga al'umma don lura da tasirin da kuma bin hanyoyin sadarwa da su.
Kasancewa cikin hulɗa game da batutuwan da suka shafi COVID-19
Za mu aika gayyata zuwa kalandarku don Alhamis mai zuwa, 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku da kuma ciyar da ɗan lokaci don haɗawa da juna.
Muna cikin wannan tare kuma muna nan don taimakawa yadda za mu iya.
A halin yanzu, za ku iya ci gaba da samun bayanan daga wannan imel ɗin, da duk sauran mahimman bayanai masu alaƙa da COVID-19, akan Wiki na Office.
CRT za ta ci gaba da sabunta waɗannan shafuka da kuma duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatan da ke zaune a ƙasashen da ke fama da cutar.
Idan kuna da wasu tambayoyi game da tafiya, abubuwan da suka faru, babban aiki, ko ƙalubalen ɗaukar hoto, ko wani abu da kuke buƙatar taimako da shi, don Allah kada ku yi jinkirin sanar da aiki tare da CRT.
Muna nan don taimakawa wajen samar da tallafi da kuma sadarwa idan ya cancanta.
Idan kana da wani sirri ko m al'amari, don Allah aika da email Bryan Judan - Daraktan HR International Global Operations.
Bai kamata mu ɗauki waɗannan canje-canjen a matsayin barin aikinmu da kuma hakkokinmu ba.
Maimakon haka, sun nuna cewa a wannan lokacin, aikinmu da kuma hakkokinmu za su bukaci su daidaita a hanyar da ba mu taɓa yi ba a dā.
Waɗannan su ne matakan da muka yi imanin wajibi ne don tallafawa wannan juna domin mu ci gaba da aiki, samar da mu motsi da goyon baya da suke bukata, da kuma duniya da sabis da suka dogara da.
Ayyukanmu da muka shirya za su kasance a wurin suna jiranmu sa'ad da lokacin ya yi.
Amma yanzu, lokaci ya yi da za mu tallafa wa juna kuma mu yi aiki mai muhimmanci da za mu yi a makonni da wata-wata masu zuwa.
Muna bukatar ku duka don tabbatar da hakan, don haka muna bukatar ku duka ku kula da kanku da iyalanku don ku kasance cikin mafi kyawunku lokacin da buƙata ta taso.
Yanzu, don Allah - wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin-converting enzyme 2 (ACE2) enzyme ne wanda ke haɗe da farfajiyar waje (ƙwayoyin sel) na ƙwayoyin cuta a cikin huhu, jijiyoyi, zuciya, koda, da hanji.
ACE2 yana magance aikin enzyme mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da haɓaka Ang ((1-7) yana mai da shi kyakkyawan maƙasudin magani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin wurin shiga cikin sel don wasu coronaviruses.
Ana kiran sigar ɗan adam na enzyme da hACE2.
Angiotensin-converting enzyme 2 wani zinc ne mai dauke da metalloenzyme wanda yake a saman endothelial da sauran kwayoyin.
Protein ACE2 ya ƙunshi wani yanki na N-terminal peptidase M2 da kuma yankin C-terminal collectrin na jigilar amino acid.
ACE2 shine furotin membrane mai wucewa guda ɗaya na nau'in I, tare da yankin aikin enzymatically wanda aka fallasa a saman ƙwayoyin cuta a cikin huhu da sauran kyallen takarda.
Ana raba yankin waje na ACE2 daga yankin transmembrane ta wani enzyme da aka sani da sheddase, kuma ana sakin furotin mai narkewa cikin jini kuma a ƙarshe ana fitar dashi cikin fitsari.
ACE2 yana cikin yawancin gabobin: ACE2 yana haɗe da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta na nau'in II, enterocytes na ƙananan hanji, ƙwayoyin ƙwayoyin jini da ƙwayoyin ƙwayoyin ƙwayoyin jini da ƙwayoyin tsoka mai laushi a yawancin gabobin.
Ana kuma samun bayanin mRNA na ACE2 a cikin ƙwayar kwakwalwa, striatum, hypothalamus, da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine yin aiki azaman daidaitawa ga ACE.
ACE yana raba angiotensin I hormone cikin angiotensin II mai ƙuntatawar jini.
ACE2 kuma yana raba carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana sarrafa shi cikin angiotensin mai fadada jini (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya raba wasu peptides da yawa ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana daidaita safarar membrane na mai jigilar amino acid mai tsaka tsaki SLC6A19 kuma an haɗa shi da cutar Hartnup.
A matsayin furotin mai wucewa, ACE2 yana aiki a matsayin babban wurin shiga cikin sel don wasu coronaviruses, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, ɗaurewar furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzymatic na ACE2 akan farfajiyar ƙwayoyin cuta yana haifar da endocytosis da sauyawar duka ƙwayoyin cuta da enzyme zuwa cikin endosomes da ke cikin ƙwayoyin cuta.
Wannan tsarin shigarwa yana buƙatar ƙaddamar da furotin S ta hanyar mai karɓar serine protease TMPRSS2, hanawa wanda ke ƙarƙashin bincike a halin yanzu azaman magani mai yuwuwa. Wannan ya sa wasu suka yi zaton cewa rage matakan ACE2, a cikin ƙwayoyin, na iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, ƙungiyoyi masu sana'a da ƙungiyoyi masu tsarawa da yawa sun ba da shawarar ci gaba da maganin ACE mai hanawa da ARB.
"Binciken da aka tsara da kuma nazarin binciken da aka buga a ranar 11 ga Yuli, 2012, ya gano cewa ""amfani da masu hana ACE yana da alaƙa da raguwar 34% mai mahimmanci a cikin haɗarin ciwon huhu idan aka kwatanta da sarrafawa. """
"Bugu da kari, ""hadarin ciwon huhu ya ragu a cikin marasa lafiya da aka bi da masu hana ACE waɗanda ke da haɗarin ciwon huhu, musamman waɗanda ke da bugun jini da rashin ƙarfi na zuciya".
"Amfani da masu hana ACE kuma yana da alaƙa da raguwar mutuwar da ke da alaƙa da ciwon huhu, kodayake sakamakon bai da ƙarfi kamar yadda yake don haɗarin ciwon huhu gaba ɗaya. """
Ana tsammanin ACE2 na mutum mai sake haɗawa (rhACE2) magani ne na sabon abu don raunin huhu mai tsanani, kuma ya bayyana don inganta hawan jini na huhu da ƙoshin oxygen a cikin aladu tare da cutar ta lipopolysaccharide- haifar da ciwon numfashi mai tsanani.
Lokacin rabi na rhACE2 a cikin mutane shine kimanin awanni 10 kuma farkon aikin yana da mintuna 30 ban da hanyar aiki (tsawon) awanni 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ba su da haƙuri ga masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko a cikin cututtukan da ke yawo da angiotensin II ya karu. An kimanta rhACE2 da aka zubo a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
"b'COVID-19 apps aikace-aikacen software ne na wayar hannu da aka tsara don taimakawa gano tuntuɓar tuntuɓar a cikin martani ga cutar coronavirus ta 2019-20, watau tsarin gano mutane (""masu tuntuɓar"") waɗanda ƙila sun kasance tare da mai kamuwa da cuta. "
An samar da aikace-aikace da yawa ko kuma aka ba da shawarar, tare da tallafin gwamnati a wasu yankuna da hukunce-hukuncen.
An samar da wasu tsarin don gina aikace-aikacen gano lamba.
An tayar da damuwa game da sirrin sirri, musamman game da tsarin da ke dogara da bin diddigin wurin da masu amfani da aikace-aikacen suke.
Sauran hanyoyin da ba su da matsala sun haɗa da amfani da siginar Bluetooth don yin rajistar kusanci mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar tare cewa za su haɗa ayyuka don tallafawa irin waɗannan aikace-aikacen da ke da tushen Bluetooth kai tsaye cikin tsarin aiki na Android da iOS.
A China, gwamnatin China, tare da Alipay, ta tura wani app wanda ke ba da damar 'yan ƙasa su bincika ko sun taɓa yin hulɗa da mutanen da ke da COVID-19.
Ana amfani da shi a cikin birane sama da 200 na kasar Sin. A Singapore, ana amfani da wata manhaja da ake kira TraceTogether.
"Ungiyar ta ci gaba da ci gaban IT na gida, an saki shi a matsayin tushen budewa kuma za a mika shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da ""Tsaya Korona!"", aikace-aikacen da ke da tushen Bluetooth don bin diddigin kamuwa da mutane masu yuwuwar kamuwa da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya".
Ma'aikatar sadarwa da fasaha da ma'aikatar lafiya ne suka kirkiro manhajar.
Ya zuwa 14 ga Afrilu 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen gano lamba yana cikin wani mataki na ci gaba, kuma zai kasance a shirye don turawa cikin makonni. Ana shirin irin wannan aikace-aikacen a Ireland, da Faransa (""TsayaCovid"")".
Australia da New Zealand suna la'akari da aikace-aikacen da ke kan aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen geofencing don marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba su bar gida ba.
Ross Anderson, farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu amfani da tsarin da ke amfani da aikace-aikace, gami da kuskuren karya da kuma yiwuwar rashin inganci idan amfani da aikace-aikacen ya iyakance ga karamin kashi na yawan jama'a.
"Domin magance damuwa game da yaduwar aikace-aikacen da ke ɓatar da hankali ko cutarwa na ""coronavirus"", Apple ya sanya iyaka kan nau'ikan ƙungiyoyi da za su iya ƙara aikace-aikacen da ke da alaƙa da coronavirus zuwa App Store, yana iyakance su ga kawai ""hukuma"" ko kuma ƙungiyoyi masu martaba".
Google da Amazon sun aiwatar da irin wannan ƙuntatawa.
Masu fafutukar kare sirrin mutane sun nuna damuwarsu game da tasirin sa ido kan mutane da yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a rushe tsarin sa ido da aka kirkira don magance annobar coronavirus da zarar barazanar ta wuce.
Amnesty International da kuma wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
Kungiyoyin sun bayyana sharudda takwas kan ayyukan gwamnati:
"sauraron dole ne ya zama "doka, dole da kuma daidaitacce"";
Za a bukaci a sanya wasu sharuddan dakatar da ayyukan sa ido da kuma sa ido.
amfani da bayanai zai kasance ne kawai don dalilai na COVID-19;
Za a kare tsaro da rashin sani na bayanai kuma za a nuna cewa an kare su bisa ga shaida;
Dole ne a kauce wa kulawar dijital don kara nuna bambanci da kuma nuna bambanci;
Duk wani musayar bayanai tare da wasu kamfanoni dole ne a bayyana shi a cikin doka;
Dole ne a samar da kariya daga cin zarafi da kuma hakkin 'yan kasa na amsawa ga cin zarafi;
"Za a buƙaci sa hannu mai ma'ana daga dukkan "'yan wasa masu dacewa", gami da na masana kiwon lafiyar jama'a da ƙungiyoyin da ba a kula da su ba.Kungiyar Kwamfuta ta Baƙin Cikin Jamus (CCC) da 'Yan Jarida ba tare da Iyaka ba (Reporter ohne Grenzen) (RSF) suma sun ba da jerin abubuwan dubawa".
Shirin da aka gabatar na Google/Apple yana da niyyar magance matsalar sa ido ta dindindin ta hanyar cire tsarin bin diddigin daga tsarin aiki na na'urorin su da zarar ba a buƙatarsa.
Wasu ƙasashe sun yi amfani da bin hanyar sadarwa maimakon aikace-aikace, kawar da buƙatar saukar da aikace-aikacen da ikon kauce wa bin sawu.
A Isra'ila, an amince da bin hanyar sadarwa.
Hanyoyin sadarwa da ke da damar yin amfani da bayanan wuri na asali suna da matsala masu mahimmanci na sirri.
Koyaya, ba duk tsarin da ke da sabar uwar garke ba ne ke buƙatar samun damar bayanan wurin mutum; an ƙirƙiri wasu tsarin tsare sirri waɗanda ke amfani da sabar uwar garke kawai don sadarwa (duba sashe a ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na aikace-aikace ba don yin binciken tuntuɓar.
Maimakon amfani da keɓaɓɓen aikace-aikace, tsarin ya tattara bayanan sa ido daga tushe daban-daban gami da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, kuma ya haɗa waɗannan don samar da sanarwa ta hanyar saƙonnin rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da abokan hulɗa, gwamnati ta kuma ba da bayanin wurin da jama'a ke da shi, wani abu da aka ba da izini saboda canje-canje masu yawa ga dokokin sirrin bayanai bayan barkewar MERS a wannan ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da yawa. Kasashe ciki har da Jamus suna la'akari da amfani da tsarin tsakiya da tsare sirri.
Ya zuwa 6 ga Afrilu 2020, ba a sake fitar da cikakkun bayanai ba tukuna.
Binciken tuntuɓar sirri shine ingantaccen ra'ayi, tare da babban ɓangaren wallafe-wallafen bincike wanda ya fara aƙalla 2013.Kamar yadda na 7 ga Afrilu 2020, sama da ƙungiyoyin masana goma sha biyu suna aiki akan hanyoyin magance sirrin sirri, kamar amfani da Bluetooth Low Energy (BLE) don yin rajistar kusanci mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT ƙoƙari ne na haɗin gwiwa wanda ya ƙunshi duka hanyoyin da aka ƙaddara da kuma rarraba, kuma ba yarjejeniya ɗaya ba.Dokar da aka rarraba ta haɗa da Bayanan Bayanai na Bayanai na Bayanai na Bayanai na Bayanai na Bayanai (DP-PPT / DP-3T), Lambar Sadarwa na Wuta (TCN, fka Lambar Sadarwa, CEN), Bayanan Bayanai na Bayanai da kuma Ma'aikatun Sadarwa na Wayar Hannu (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan sirri ba su taɓa barin na'urar ba, kuma duk daidaitawa yana faruwa a kan na'urar.
Rukunin Sirri a MIT Media Lab yana haɓaka SafePaths, dandamali don amfani da fasahohin kiyaye sirrin lokacin tattarawa da amfani da bayanan wuri ko hanyar tsallakawa don bin diddigin yaduwar COVID-19.
"Ya dogara ne akan bincike daga farar takarda ""Aikace-aikacen da suka tafi Rogue: Kula da Sirrin Keɓaɓɓu a cikin Cutar da ke yaduwa"" wanda aka fitar a watan Maris na 2020.Wani irin wannan ƙoƙarin shine dandalin SafeTrace ta Enigma MPC, wani kamfani da ke haɓaka fasahar sirri wanda kuma asali aka kafa shi a MIT Media Lab".
SafeTrace yana amfani da ingantattun fasahohin kayan aiki don bawa masu amfani damar raba bayanan wuri da lafiyar mutum tare da sauran masu amfani da jami'ai, ba tare da yin sulhu da sirrin bayanan ba.
A ranar 5 ga Afrilu 2020, ƙungiyoyin da suka haɗu a kusa da abin da ainihin hanya ɗaya ce kuma mafi yawan hanyoyin da ke kan gaba, sun kafa haɗin gwiwar TCN na duniya, tare da manufar rage rarrabuwa, da ba da damar aiki tare na duniya na bin diddigin da faɗakar da aikace-aikace, babban mahimmin al'amari na cimma karɓar karɓa.
A ranar 9 ga Afrilu 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTrace da aikace-aikacen gwamnatin hukuma ke amfani da ita.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun ba da sanarwar wani shiri don bin diddigin lamba, wanda suka yi iƙirarin zai kiyaye sirrin sirri, bisa haɗuwa da fasahar Bluetooth Low Energy da kuma ɓoye ɓoye ɓoye.
Sun kuma buga takamaiman fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, an yi niyyar aiwatar da tsarin a matakai uku:
ƙaddamar da kayan aiki don bawa gwamnatoci damar ƙirƙirar aikace-aikacen bin diddigin coronavirus na hukuma don kiyaye sirrin sirri
hade wannan aikin kai tsaye cikin iOS da AndroidGoogle da Apple suna shirin magance matsalolin karɓar da ci gaba da kula da su ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, sannan daga baya cire shi ta wannan hanyar da zarar barazanar ta wuce.
b'Sake sanya magunguna (wanda kuma aka sani da sake amfani da magunguna, sake fasalin, sake aiki ko sauya magani) shine sake amfani da magani da aka amince dashi don maganin wata cuta ko yanayin kiwon lafiya daban da wanda aka kirkira shi.
Wannan shine ɗayan layin binciken kimiyya wanda a halin yanzu ake bi don haɓaka lafiya da ingantaccen maganin COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma ƙarin jini na jini. SARS-CoV-2 yana da kusan furotin 66 masu magani, kowannensu yana da wurare masu ɗaure ligand da yawa.
Nazarin waɗannan wuraren ɗaurewa yana ba da kyakkyawan shiri na haɓaka ingantaccen maganin rigakafin ƙwayoyin cuta akan sunadarai na COVID-19.
Daga cikin mahimman sunadarai masu mahimmanci na SARS-CoV-2 sune papain-like protease, RNA mai dogaro da RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin wasu mahaɗan ɗan takara waɗanda daga baya suka inganta kuma suka bincika don kamaninsu na kwarangwal tare da mafi girman magungunan da aka amince da su don hanzarta haɓaka magungunan anti-SARS-CoV-2 masu ƙarfi a cikin binciken sa na farko don ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na cutar zazzabin cizon sauro wanda kuma ake amfani dashi akan wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine da ke da alaƙa za su kasance cikin magunguna huɗu da aka yi nazari a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin Amfani da Gaggawa (EUA).
Ba a amince da maganin ba ta hanyar gwajin gwaji na FDA kuma an ba da izini a ƙarƙashin EUA kawai azaman magani na gwaji don amfani da gaggawa a cikin marasa lafiya waɗanda ke asibiti amma ba za su iya karɓar magani a cikin gwajin asibiti ba.
"CDC ta ce ""amfani, sashi, ko tsawon lokacin hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2"" ba a tabbatar da su ba tukuna".
"Likitoci sun ce suna amfani da maganin ne lokacin da ""babu wani zaɓi".
Wata ƙungiyar bincike ta Turkiya a Istanbul tana gudanar da ƙaramin bincike kan amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan karatu a Jami'ar Duke da Jami'ar Oxford.
Makarantar Likitancin NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da rigakafin hydroxychloroquine.
"Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin nuna favipiravir yana da ""a bayyane yake tasiri"."
An gwada marasa lafiya 35 a Shenzhen marasa lafiya a matsakaicin kwanaki 4, yayin da tsawon cutar ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su karɓa ba.
A cikin binciken da aka gudanar a Wuhan akan marasa lafiya 240 da cutar huhu, an ba rabin favipiravir da rabi umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke akwai don tallafawa maganin ba ta da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiyar ta, kuma ta yi amfani da sojoji don isar da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiyar COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya yi shawarwari ga gwamnatin Trump game da siyan maganin. Magungunan na iya zama da ƙarancin tasiri a cikin mawuyacin yanayin rashin lafiya inda cutar ta riga ta ninka.
Zai iya zama ba shi da lafiya ga mata masu ciki ko waɗanda ke ƙoƙarin yin ciki.
"Wani binciken lopinavir / ritonavir (Kaletra), haɗuwa da maganin antivirals lopinavir da ritonavir, ya kammala cewa ""ba a lura da fa'ida ba"."
An tsara magungunan ne don hana HIV daga yin kwafi ta hanyar ɗaure shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magungunan don nemo fili wanda zai ɗaure tare da protease na SARS-CoV-2. Akwai suka a cikin ƙungiyar kimiyya game da jagorantar albarkatu don sake amfani da magunguna musamman don HIV / AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ne ya kirkiro da kuma bunkasa Remdesivir a matsayin magani ga cutar Ebola da kamuwa da cutar Marburg. Daga baya Gilead Sciences ta gano cewa Remdesivir yana da tasirin kwayar cuta a cikin vitro akan yawancin filo-, pneumocone-, paramyxo-, da corona-viruses.
Wata matsala da maganin rigakafin kwayar cuta ita ce ci gaban juriya ta hanyar maye gurbi wanda zai iya haifar da mummunan cuta da watsawa.
Wasu nazarin farko na gwaji sun nuna remdesivir na iya samun babban shingen kwayoyin halitta don juriya. Akwai gwaji na asibiti da yawa da ke gudana, gami da biyu da Asibitocin Jami'ar Cleveland suka gudanar; ɗaya don mutanen da ke da matsakaiciyar cuta da kuma wani don waɗanda ke da ciwo mai tsanani.
Akwai gwaji uku na asibiti na bitamin C na cikin jijiya don mutanen da ke asibiti da kuma rashin lafiya mai tsanani da COVID-19; biyu da aka sarrafa da placebo (China, Kanada) da ɗaya ba tare da iko ba (Italiya).
Jihar New York ta fara gwaji don maganin azithromycin a ranar 24 ga Maris 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin gwajin asibiti don Teijin's Alvesco (ciclesonide), corticosteroid mai shan iska don asma, don maganin marasa lafiya masu alamun cutar da cutar coronavirus ta zamani.
Wani nau'i na enzyme mai canza angiotensin 2, ana gudanar da gwajin Phase II tare da marasa lafiya 200 da za a ɗauka daga cikin masu fama da cutar, asibiti a Denmark, Jamus, da Austria don ƙayyade tasirin maganin.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine wajen rage kumburi da rikicewar huhu a cikin marasa lafiya da ke fama da alamun cutar COVID-19.
Binciken, mai suna COLCORONA, yana daukar manya 6000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna fuskantar alamun rashin lafiya waɗanda ba sa buƙatar asibiti.
Mata masu ciki ko masu shayarwa ko waɗanda ba su da hanyar hana ɗaukar ciki mai tasiri ba su cancanci.
Ana gwada magungunan hana jini da yawa a Italiya.
Ana amfani da heparin mai ƙananan kwayoyin don kula da marasa lafiya, kuma hakan ya sa Hukumar Kula da Magunguna ta Italiya ta wallafa wasu ƙa'idodin amfani da shi.
An sanar da binciken cibiyoyi da yawa akan marasa lafiya 300 da ke binciken amfani da enoxaparin sodium a cikin rigakafi da allurai na warkewa a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan mayar da hankali kan sake amfani da magungunan rigakafin ƙwayoyin cuta da aka amince da su waɗanda aka haɓaka don ɓarkewar cutar da ta gabata kamar MERS, SARS, da cutar West Nile.
Ribavirin: an ba da shawarar ribavirin don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin.
Wasu magungunan rigakafi da aka gano cewa ana iya sake amfani da su azaman maganin COVID-19:
Tocilizumab (mai karɓar IL-6 na Anti): China ta amince da shi.
Hakanan gwaji a Italiya da China. kuma duba Tocilizumab#COVID-19.
b'A allurar rigakafin COVID-19 allurar rigakafi ce ta zato game da cutar coronavirus ta 2019 (COVID-19).
Kodayake babu wani allurar rigakafi da ta kammala gwajin asibiti, akwai ƙoƙari da yawa da ake yi don haɓaka irin wannan allurar.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, a cikin ƙasa da watanni 18.
An yi gwajin lafiya na kashi na I a kan alluran rigakafi biyar a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Wani babban barkewar cutar ya bazu a duniya a cikin 2020, wanda ya haifar da babban saka hannun jari da ayyukan bincike don haɓaka allurar rigakafi.
Kungiyoyi da yawa suna amfani da bayanan kwayoyin halitta da aka buga don haɓaka yiwuwar alluran rigakafi akan SARS-CoV-2.
A watan Afrilu, muhimman abubuwan da aka tsara na shirin CEPI don ci gaban allurar rigakafi sune saurin, ƙarfin samarwa, turawa a sikelin, da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa dandamali na fasaha daban-daban 10 suna ƙarƙashin bincike da ci gaba a farkon 2020 don ƙirƙirar ingantaccen allurar rigakafi akan COVID-19.
Manyan manufofin dandamali da aka ci gaba a cikin binciken aminci na Phase I sun haɗa da:
nucleic acid (DNA da RNA) (Mai haɓaka Phase I da mai neman allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai haɓaka Phase I da mai ɗaukar hoto: CanSino Biologics, mai ɗaukar hoto na adenovirus nau'in 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, jimlar alluran rigakafi 115 suna cikin matakan farko na ci gaba, tare da tabbatar da 78 a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da kuma wasu 37 da aka sanar, amma tare da ƙananan bayanan jama'a (wanda ake tsammanin suna cikin shiri ko tsarawa).
Gwajin Mataki na I-II yana gudanar da gwajin farko na aminci da rigakafi, yawanci ana yin sa ne ta hanyar bazuwar, sarrafawa ta hanyar placebo, kuma a wurare da yawa, yayin ƙayyade mafi daidaito, ingantattun allurai.
Gwaje-gwajen Mataki na III yawanci suna ɗaukar mahalarta da yawa, gami da ƙungiyar kulawa, da gwada ingancin allurar rigakafin don hana cutar, yayin lura da tasirin sakamako mara kyau a mafi kyawun sashi.
"Daga cikin 'yan takarar allurar rigakafi 79 a cikin ci gaba mai aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su riga sun kasance a cikin kimantawar ɗan adam ba (har yanzu a cikin binciken "preclinical"")."
A kusan ranar 24 ga Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin ƙwayoyin cuta wanda zai canza kwayoyin ƙwayoyin cuta na kwayar cuta don motsa halayen rigakafi.
A kusan ranar 24 ga Janairun 2020 a Kanada, Cibiyar allurar rigakafin ƙasa da ƙasa (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin kan allurar rigakafi, da nufin fara gwajin ɗan adam a cikin 2021.
An sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta China a ranar 26 ga Janairu, 2020, da Jami'ar Hong Kong a ranar 28 ga Janairu.
A kusan ranar 29 ga Janairun 2020, Kamfanonin Magunguna na Janssen, wanda Hanneke Schuitemaker ke jagoranta, sun sanar da cewa sun fara aiki kan haɓaka allurar rigakafi.
Janssen tana haɓaka allurar rigakafin baki tare da abokin aikinta na fasahar kere-kere, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairun 2020, dakin gwaje-gwaje OncoGen a Romania ya buga takarda kan ƙirar allurar rigakafi tare da irin wannan fasaha da aka yi amfani da ita don maganin allurar rigakafin cutar kansa.
A ranar 25 ga Maris shugaban cibiyar binciken ya sanar da cewa sun kammala hada allurar rigakafi kuma suna fara gwaji.
A ranar 27 ga Fabrairun 2020, wani kamfanin reshe na Generex, NuGenerex Immuno-Oncology, ya ba da sanarwar cewa suna fara aikin allurar rigakafi don ƙirƙirar allurar peptide Ii-Key da ke kan COVID-19.
"Suna son samar da wani allurar rigakafin da za a iya gwadawa a cikin mutane ""a cikin kwanaki 90"."
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na haɓaka allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Kula da Binciken Likitocin Sojojin Amurka da Kwamandan Kayan aiki a Fort Detrick da Cibiyar Binciken Sojojin Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna aiki kan allurar rigakafi.
A kusan ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta yi aiki tare da Novavax Inc.
a cikin ci gaba da kuma samar da allurar rigakafi.
Abokan hulɗar sun kuma sanar da shirye-shiryen gwaji na farko da gwajin gwaji na Phase I zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da keɓaɓɓu 11, kuma ko da a kan hanya mai sauri zai ɗauki aƙalla kusan shekara ɗaya da rabi zuwa shekaru biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar halittu a Quebec City, Quebec, ya ba da rahoton ci gaban wani abu mai kama da coronavirus a ƙarƙashin tallafin kuɗi daga Cibiyoyin Kula da Kiwon Lafiya na Kanada.
An yi gwajin rigakafin a dakin gwaje-gwaje, tare da gwajin ɗan adam da aka shirya a watan Yuli ko Agusta 2020.
"A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba CureVac ""'manyan kuɗi' don samun damar yin allurar rigakafin Covid-19", wanda gwamnatin Jamus ta yi zanga-zanga a kansa".
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA tare.
Wani ɗan takarar allurar rigakafin da ke da tushen mRNA BNT162, a halin yanzu a cikin gwajin gwaji tare da gwajin asibiti da ake tsammanin zai fara a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar halittu na Italiya ya ba da sanarwar cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020 kuma za su iya fara gwajin mutum a ƙarshen kaka.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike ta allurar rigakafin COVID-19 da ta haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na CEPI a cikin haɓaka allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na takarar allurar rigakafi daban-daban guda shida.
Masu binciken Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka allurar rigakafin RNA mai haɓaka kanta don COVID-19.
An samar da maganin rigakafin a cikin kwanaki 14 da samun jerin daga China.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da dala miliyan 275 na C$ a cikin tallafi don ayyukan bincike 96 kan matakan magance COVID-19, gami da yawancin 'yan takarar allurar rigakafi a kamfanonin Kanada da jami'o'i, kamar Medicago da kuma Jami'ar Saskatchewan.
"Kusan a lokaci guda, gwamnatin Kanada ta sanar da dala miliyan 192 na C$ musamman don haɓaka allurar rigakafin COVID-19, tare da shirye-shiryen kafa "bankin allurar rigakafi" na ƙasa na sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su idan wani barkewar cutar coronavirus ya faru".
"A ranar 2 ga Afrilu 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar COVID-19 a cikin beraye, suna cewa ""MNA ta ba da alluran rigakafin SARS-CoV-2 S1 subunit sun haifar da ƙarfin antigen-takamaiman maganin rigakafi [a cikin berayen] wanda ya bayyana farawa makonni 2 bayan allurar rigakafi. """
A Kanada a ranar 16 ga Afrilu 2020, Makarantar Magunguna ta Jami'ar Waterloo ta sanar da ƙirar ɗan takarar allurar rigakafin DNA a matsayin yiwuwar fesa hanci.
Ta amfani da bacteriophages, za a tsara DNA don yin kwafi a cikin kwayoyin cuta na mutum don samar da ƙwayoyin cuta marasa lahani, waɗanda za su iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta akan kwayar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗu da albarkatu don samun damar kwamfutocin kwamfuta daga IBM, haɗe tare da albarkatun ƙididdigar girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da tasirin heterologous, wanda kuma ake kira tasirin da ba na musamman ba.
Wannan yana nufin za su iya samun amfani fiye da cutar da suke hanawa.
Wani gwaji na bazuwar a Ostiraliya yana neman shiga ma'aikatan kiwon lafiya 4,170.
Yana yiwuwa alluran rigakafi a cikin ci gaba ba za su kasance masu aminci ko tasiri ba.
Binciken farko don kimanta ingancin allurar rigakafi ta amfani da samfuran dabbobi na musamman na COVID-19, kamar ACE2-transgenic mice, sauran dabbobin gwaji, da manyan dabbobi ba na ɗan adam ba, suna nuna buƙatar matakan hana haɗarin matakin 3 na biosafety don sarrafa ƙwayoyin cuta masu rai, da haɗin gwiwar ƙasa da ƙasa don tabbatar da daidaitaccen hanyoyin aminci.
An gwada alluran rigakafin SARS da MERS a cikin samfuran dabbobi waɗanda ba na ɗan adam ba.
Ya zuwa 2020, babu magani ko allurar rigakafin kariya ga SARS wanda aka nuna yana da aminci da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS shine fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duk duniya. Hakanan babu ingantaccen allurar rigakafin MERS.
Lokacin da MERS ya zama ruwan dare, an yi imanin cewa binciken SARS na yanzu na iya samar da samfuri mai amfani don haɓaka alluran rigakafi da magunguna kan kamuwa da cutar MERS-CoV.
Ya zuwa watan Maris na 2020, akwai rigakafin MERS guda ɗaya (wanda ya dogara da DNA) wanda ya kammala gwajin gwaji na farko a cikin mutane, da wasu uku da ke ci gaba, dukansu alluran rigakafin ƙwayoyin cuta ne, biyu masu ɗauke da adenoviral (ChAdOx1-MERS, BVRS-GamVac), da ɗaya mai ɗauke da MVA (MVA-MERS-S).
Sakonnin kafofin sada zumunta sun inganta ka'idar makirci da ke ikirarin cewa an san kwayar cutar da ke bayan COVID-19 kuma an riga an sami allurar rigakafi.
Takaddun mallakar da aka ambata ta hanyar sakonnin kafofin watsa labarun daban-daban suna nufin takaddun mallakar da ke akwai don jerin kwayoyin halitta da alluran rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
b'Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai saurin kamuwa da cuta da ke haifar da cutar coronavirus mai tsanani mai saurin numfashi 2 (SARS-CoV-2).
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, tari, da kuma numfashi.
Sauran alamun za su iya kasancewa gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙamshi, da ciwon ciki.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne amma yana iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Duk da yake yawancin lokuta suna haifar da alamun bayyanar cututtuka, wasu suna ci gaba zuwa cutar huhu da rashin aiki da kwayoyin halitta.
Ya zuwa 17 ga Afrilu 2020, an ba da rahoton sama da mutane miliyan 2.24 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar ne tsakanin mutane yayin kusanci, galibi ta hanyar ƙananan ɗigon ruwa da ke fitowa ta tari, hancin, ko magana.
Ko da yake ana fitar da waɗannan ɗigon sa'ad da ake numfashi, yawanci suna faɗuwa ƙasa ko kuma a kan abubuwa maimakon su zama masu saurin kamuwa da cuta.
Mutane za su iya kamuwa da cutar ta wajen taɓa wani abu da ya kamu da cutar kuma su taɓa idanunsu, hancinsu, ko bakinsu.
Kwayar cutar na iya rayuwa a saman ƙasa har tsawon sa'o'i 72.
Yana da yaduwa sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan cutar. Hanyar daidaitaccen ganewar asali ita ce ta hanyar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar (rRT-PCR) daga swab na nasopharyngeal.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke da shakkar suna da kwayar cutar da masu kula da su.
Shawarwarin amfani da abin rufe fuska ta hanyar jama'a sun bambanta, tare da wasu hukumomi suna ba da shawarar kada a yi amfani da su, wasu suna ba da shawarar amfani da su, wasu kuma suna buƙatar amfani da su.
A halin yanzu, babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a cikin yawancin ƙasashe a duk yankuna shida na WHO.
Wadanda ke dauke da kwayar cutar ba za su iya nuna alamun cutar ba ko kuma su nuna alamun mura kamar zazzabi, tari, gajiya, da kuma numfashi.
Alamomin gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsin lamba, rikicewa, wahalar farkawa, da fuska ko lebe mai launin shuɗi; ana ba da shawarar gaggawa zuwa likita idan waɗannan alamun sun kasance.
A wasu lokuta, ana iya ganin alamun numfashi na sama kamar yin fitsari, hanci mai gudu ko ciwon makogwaro.
An lura da cututtukan gastrointestinal kamar tashin zuciya, amai da gudawa a cikin kashi daban-daban.
Wasu mutane a China da farko suna da ciwon kirji da bugun zuciya.
A wasu, cutar tana iya ci gaba zuwa ciwon huhu, rashin aiki na gabobin jiki da yawa, da mutuwa.
Wannan lokaci ne da ake kira lokacin ƙwanƙwasawa.
Lokacin kwantar da hankali don COVID-19 yawanci kwanaki biyar zuwa shida ne amma yana iya kasancewa daga kwana biyu zuwa 14.
97.5% na mutanen da suka kamu da cutar za su kamu da cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda ke kamuwa da cutar ba ne ke kamuwa da cutar.
Ba a san cikakken rawar da waɗannan masu ɗaukar alamun ba a cikin watsawa; duk da haka, shaidar farko ta nuna cewa suna iya ba da gudummawa ga yaduwar cutar.
Yawan mutanen da suka kamu da cutar da ba su nuna alamun cutar ba a halin yanzu ba a sani ba kuma ana nazarin su, tare da Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC) suna ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da cutar ba su da alamun cutar yayin zaman su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada da marasa alamun cutar a cikin shari'o'in ta na yau da kullun a ranar 1 ga Afrilu; daga cikin kamuwa da cutar 166 a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Dukansu sputum da ƙura na iya ɗaukar manyan nauyin kwayar cuta.
Yin magana da ƙarfi yana fitar da ƙarin ɗigon ruwa fiye da magana ta al'ada.
Wani bincike a Singapore ya gano cewa tari da ba a rufe shi ba zai iya haifar da saukad da ruwa zuwa mita 4.5 (ƙafa 15).
Kodayake kwayar cutar ba ta yawan yaduwa ta iska, Cibiyar Kimiyya ta Kasa ta ba da shawarar cewa watsawar bioaerosol na iya yiwuwa kuma masu tattara iska da aka sanya a cikin hallway a wajen ɗakunan mutane sun ba da samfuran tabbatacce don RNA na kwayar cutar.
Wasu hanyoyin likita kamar intubation da sake farfado da zuciya (CPR) na iya haifar da ɓoyayyen numfashi don yin iska kuma don haka ya haifar da yaduwar iska.
Duk da yake akwai damuwa cewa zai iya yaduwa ta hanyar feces, ana ganin wannan haɗarin yana da ƙarancin. Kwayar cutar tana da saurin yaduwa lokacin da mutane ke da alamun cutar; yayin da yaduwa na iya yiwuwa kafin bayyanar alamun cutar, haɗarin yana da ƙarancin.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce duk da cewa ba a san yadda cutar ke yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa na awanni zuwa kwanaki a kan farfajiya.
Musamman, an gano cewa ana iya gano kwayar cutar na kwana ɗaya a kan kwali, har zuwa kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), kuma har zuwa awanni huɗu a kan jan ƙarfe 99%.
Amma, wannan ya bambanta dangane da yanayin zafi da kuma zafin jiki.
Sabulu da kayan wanki ma suna da amfani idan aka yi amfani da su yadda ya kamata; sabulu yana lalata kitsen da ke kare kwayar cutar, yana kashe ta, kuma yana kawar da su daga fata da kuma wasu wurare.
Sauran mafita, kamar su benzalkonium chloride da chlorhexidine gluconate (wani maganin kashe kwayoyin cuta na tiyata), ba su da tasiri sosai. A cikin binciken Hong Kong, an ɗauki samfurin haushi a matsakaici kwana biyu bayan fara asibiti.
A cikin marasa lafiya biyar daga cikin shida, samfurin farko ya nuna mafi girman nauyin kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman nauyin kwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus ta 2 mai tsanani (SARS-CoV-2) wani sabon abu ne mai tsanani mai tsanani na cutar coronavirus, wanda aka fara warewa daga mutane uku da cutar huhu da ke da alaƙa da rukunin cututtukan cututtukan numfashi a Wuhan.
Dukkanin siffofin sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin coronaviruses masu alaƙa a cikin yanayi.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke fashe kumfa mai kare ta. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fuka-fuki sune gabobin da COVID-19 ya fi shafa saboda kwayar cutar tana shiga cikin ƙwayoyin halitta ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
"Cutar tana amfani da glycoprotein na musamman wanda ake kira ""spike"" (peplomer) don haɗawa da ACE2 kuma shiga cikin kwayar mai masaukin baki".
An gano mummunan rauni na zuciya a cikin kashi 12% na mutanen da ke dauke da cutar da aka kwantar a asibiti a Wuhan, China, kuma ya fi yawa a cikin mummunan cuta.
Yawan cututtukan cututtukan zuciya yana da yawa, saboda amsawar kumburi na tsarin jiki da cututtukan tsarin rigakafi yayin ci gaban cutar, amma mummunan rauni na myocardial na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna nunawa sosai a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An gano yawan kamuwa da cutar thrombosis (31%) da thromboembolism na jijiyoyi (25%) a cikin marasa lafiya na ICU tare da kamuwa da cutar COVID-19 kuma yana iya kasancewa da alaƙa da mummunan hangen nesa. Binciken gawa na mutanen da suka mutu da COVID-19 sun sami lalacewar alveolar (DAD), da kuma ƙwayoyin cuta masu ƙonewa a cikin huhu.
Kodayake SARS-COV-2 yana da yanayin yanayin ƙwayoyin epithelial na ACE2-mai bayyana hanyoyin numfashi, marasa lafiya da ke da mummunan COVID-19 suna da alamun cutar kumburi.
Musamman, kwayoyin T-cell masu ɓoye GM-CSF sun nuna cewa suna da alaƙa da ɗaukar ƙwayoyin IL-6 masu ɓoye ƙwayoyin cuta da kuma mummunan cututtukan huhu a cikin marasa lafiya COVID-19.
An kuma samu wasu cututtukan lymphocytic a lokacin da aka yi wa mutum gawa.
WHO ta wallafa wasu hanyoyin gwaji don cutar.
Hanyar gwaji ta yau da kullun ita ce ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR).
Ana yin gwajin ne akan samfuran numfashi da aka samo ta hanyar swab na nasopharyngeal; duk da haka, ana iya amfani da swab na hanci ko samfurin ƙura.
Ana samun sakamako a cikin sa'o'i kaɗan zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki jini biyu a mako biyu kuma sakamakon ba shi da amfani nan da nan.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in kwayar cutar coronavirus da kuma buga jerin kwayoyin halitta don dakunan gwaje-gwaje a duk duniya su iya samar da gwaje-gwajen polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar ta kwayar cutar.
Ya zuwa 4 ga Afrilu 2020, gwaje-gwajen ƙwayoyin cuta (wanda zai iya gano cututtukan da ke aiki da kuma ko mutum ya kamu da cutar a baya) suna cikin ci gaba, amma ba a yi amfani da su sosai ba tukuna.
Kwarewar kasar Sin da gwajin ya nuna daidaito ne kawai 60 zuwa 70%.
Hukumar FDA a Amurka ta amince da gwajin farko a wurin kulawa a ranar 21 ga Maris 2020 don amfani a ƙarshen wannan watan. Jagororin bincike da Asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano cututtuka bisa ga halayen asibiti da haɗarin annoba.
Rashin haske na gilashin ƙasa mai yawa tare da rarrabawa na gefe, asymmetric da na baya suna da yawa a farkon kamuwa da cuta.
Dominance na subpleural, mad paving (ƙarancin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Akwai bayanai kaɗan game da ƙananan raunuka da ilimin halittu na COVID-19.
Babban binciken cututtuka a cikin autopsy shine:
Macroscopy: pleurisy, pericarditis, ƙarfafawa na huhu da ƙwayoyin huhu
Za'a iya lura da nau'ikan nau'ikan cutar sankarar bargo guda hudu:
ƙananan ciwon huhu: ƙonewar huhu, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
mummunar ciwon huhu: lalacewar alveolar (DAD) tare da ɓarkewar alveolar.
DAD ne ke haddasa ciwon numfashi mai tsanani da kuma matsanancin rashin isashshen jini.
warkar da ciwon huhu: ƙungiyar exudates a cikin alveolar cavities da kuma ƙwayoyin cuta na huhu
Jini: yaduwar jini (DIC); amsawar leukoerythroblastic
Matakan rigakafi don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren taron jama'a, wanke hannuwanku da sabulu da ruwa sau da yawa kuma aƙalla na dakika 20, yin tsabtace numfashi da kyau da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar rufe baki da hanci da zane lokacin tari ko hancin kuma yana ba da shawarar amfani da ɓangaren ciki na gwiwar hannu idan babu zane.
Ana ƙarfafa tsabtace hannaye bayan kowane tari ko hancin.
CDC ta ba da shawarar amfani da suturar rufe fuska a wuraren jama'a, a wani ɓangare don iyakance yaduwar ta mutane marasa alamomi. Dabarun nisantar zamantakewa suna da nufin rage hulɗar mutane masu kamuwa da cuta tare da manyan ƙungiyoyi ta rufe makarantu da wuraren aiki, ƙuntata balaguro da soke manyan taron jama'a.
Ka'idojin nisantarwa sun hada da cewa mutane su kasance aƙalla mita 6 (1.8).
"Babu wani magani da aka sani da zai yi tasiri wajen hana COVID-19.Tun da ba a tsammanin allurar rigakafi har zuwa 2021 ba da wuri, babban ɓangare na sarrafa COVID-19 shine ƙoƙarin rage ƙimar annobar, wanda aka sani da ""daidaitawa da lanƙwasawa"."
CDC kuma ta ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na aƙalla dakika 20, musamman bayan zuwa bayan gida ko lokacin da hannayensu suka kasance masu datti sosai, kafin cin abinci da bayan shan iska, tari ko hancin mutum.
Ya kuma ba da shawarar yin amfani da maganin wanke hannu mai tushen giya tare da aƙalla kashi 60% na barasa, amma kawai lokacin da sabulu da ruwa ba su da sauƙi. Ga yankunan da ba a samun kayan tsabtace hannu na kasuwanci, WHO tana ba da tsari biyu don samarwa na gida.
A cikin waɗannan magungunan, aikin antimicrobial yana fitowa daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don taimakawa kawar da ƙwayoyin cuta a cikin barasa; ba "wani abu ne mai aiki ba don maganin antisepsis na hannu".
Ana ƙara glycerol a matsayin mai laushi.
Ana kula da mutane tare da kulawa mai goyan baya, wanda zai iya haɗawa da maganin ruwa, tallafin oxygen, da tallafawa sauran gabobin da ke fama da cutar.
CDC ta ba da shawarar cewa waɗanda suke zargin cewa suna ɗauke da kwayar cutar su sa abin rufe fuska mai sauƙi.
An yi amfani da iskar oxygen ta hanyar membrane (ECMO) don magance matsalar rashin ƙarfi na numfashi, amma har yanzu ana la'akari da fa'idodinta.
An ba da shawarar tsabtace jiki da salon rayuwa mai kyau da abinci don inganta rigakafi.
Magungunan tallafi na iya zama da amfani ga waɗanda ke da alamun rashin lafiya a farkon matakin kamuwa da cutar. WHO da Hukumar Kiwon Lafiya ta China sun buga shawarwari don kula da mutanen da ke asibiti da COVID-19.
Likitoci masu kula da ciwon huhu a Amirka sun haɗa shawarwarin magani daga hukumomi dabam dabam zuwa cikin littafin nan IBCC.
Ya zuwa watan Afrilu na 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu ƙwararrun likitoci suna ba da shawarar paracetamol (acetaminophen) akan ibuprofen don amfani na farko.
Dole ne a ɗauki matakan kariya don rage haɗarin yaduwar kwayar cutar, musamman a wuraren kiwon lafiya lokacin yin ayyukan da zasu iya haifar da aerosols, kamar intubation ko iska mai iska.
Ga masu aikin kiwon lafiya da ke kula da mutanen da ke da COVID-19, CDC ta ba da shawarar sanya mutumin a cikin dakin keɓewa na kamuwa da cutar iska (AIIR) ban da amfani da ƙa'idodin kiyayewa, kiyayewa na tuntuɓar mutane da kiyayewa na iska. CDC ta tsara jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan da aka ba da shawarar su ne: rigar PPE, na'urar numfashi ko abin rufe fuska, kariya ta ido, da safar hannu na likita. Idan akwai, ana fifita na'urar numfashi (maimakon abin rufe fuska).
An amince da kayan numfashi na N95 don saitunan masana'antu amma FDA ta ba da izinin amfani da masks a ƙarƙashin Izinin Amfani da Gaggawa (EUA).
An tsara su don karewa daga ƙwayoyin iska kamar ƙura amma ba a tabbatar da inganci ga takamaiman wakili na halitta ba don amfani da alama.
Lokacin da babu abin rufe fuska, CDC ta ba da shawarar yin amfani da garkuwar fuska ko, a matsayin mafita na ƙarshe, abin rufe fuska na gida.
Yawancin masu cutar COVID-19 ba su da tsanani sosai don buƙatar iska ta inji ko madadin, amma yawan adadin masu cutar suna da tsanani.
Nau'in tallafin numfashi ga mutane tare da gazawar numfashi da ke da alaƙa da COVID-19 ana nazarin shi sosai ga mutanen da ke asibiti, tare da wasu shaidu cewa ana iya kauce wa intubation tare da babban ƙwanƙwasawar hanci ko matsin lamba mai kyau na iska mai matsin lamba.
Ba a san ko ɗayan waɗannan biyun yana haifar da fa'ida iri ɗaya ga mutanen da ke da mummunan rashin lafiya ba.
Wasu likitoci sun fi son kasancewa tare da iska mai iska mai iska idan akwai saboda wannan fasaha tana iyakance yaduwar ƙwayoyin aerosol idan aka kwatanta da babban ƙarancin hanci. Yanayi masu tsanani sun fi yawa a cikin tsofaffi (waɗanda suka haura shekaru 60, kuma musamman waɗanda suka haura shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti a kowane mutum, wanda ke iyakance ikon tsarin kiwon lafiya don magance ƙaruwar kwatsam a cikin adadin masu cutar COVID-19 masu tsanani sosai don buƙatar asibiti.
Wani bincike a China ya gano cewa kashi 5% an shigar da su sashin kulawa mai tsanani, kashi 2.3% suna buƙatar taimakon inji na iska, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da ke asibiti da COVID-19 a ƙarshe ana shigar da su ICU.
Jirgin iska na inji ya zama mafi rikitarwa yayin da cutar ta kamu da cutar COVID-19 kuma oxygenation ya zama da wahala.
Ana buƙatar masu numfashi masu iya sarrafa yanayin matsin lamba da PEEP mai yawa don haɓaka isar da iskar oxygen yayin rage haɗarin raunin huhu da ke tattare da numfashi da kuma pneumothorax.
Babban PEEP bazai samu akan tsofaffin na'urorin numfashi ba.
Bincike kan yiwuwar jiyya ya fara a watan Janairun 2020, kuma magunguna masu yawa masu maganin kwayar cutar suna cikin gwaji na asibiti.
Remdesivir ya zama mafi alƙawarin.
Kodayake sabbin magunguna na iya ɗaukar har zuwa 2021 don haɓaka, da yawa daga cikin magungunan da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwajin ci gaba.
Za a iya gwada maganin rigakafin cutar a cikin mutanen da ke da mummunan cuta.
WHO ta ba da shawarar masu sa kai su shiga cikin gwaji game da inganci da amincin yiwuwar jiyya. FDA ta ba da izini na wucin gadi ga plasma mai warkewa a matsayin magani na gwaji a lokuta da rayuwar mutum ke cikin haɗari ko nan take.
Ba a yi gwajin asibiti da ake buƙata don nuna cewa yana da aminci da tasiri ga cutar ba.
A watan Fabrairun 2020, China ta ƙaddamar da wata manhajar wayar hannu don magance barkewar cutar.
Ana tambayar masu amfani da su shigar da sunayensu da lambar ID.
Manhajar na iya gano 'kusa da kusanci' ta amfani da bayanan sa ido kuma saboda haka yiwuwar kamuwa da cutar.
Kowane mai amfani kuma zai iya duba matsayin wasu masu amfani uku.
Idan an gano wata barazana mai yuwuwa, aikace-aikacen ba kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da jami'an kiwon lafiya na gida. Ana amfani da nazarin manyan bayanai kan bayanan wayar hannu, fasahar gane fuska, bin diddigin wayar hannu da hankali na wucin gadi don bin mutanen da suka kamu da cutar da mutanen da suka tuntuɓi a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zaton suna da cutar coronavirus.
An dauki matakin ne don tilasta keɓewa da kare waɗanda za su iya haɗuwa da 'yan ƙasa da ke fama da cutar.
Hakanan a cikin Maris 2020, Deutsche Telekom ta raba bayanan wurin wayar da aka tattara tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar kwayar cutar.
Rasha ta tura fasahar gane fuska don gano masu karya dokar killacewa.
"Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce masu amfani da wayar salula sun sanar da shi cewa ""kashi 40% na mutane suna ci gaba da motsawa ko ta yaya"."
Gwamnatin Jamus ta gudanar da taron hackathon na tsawon sa'o'i 48 a karshen mako tare da mahalarta sama da 42,000.
Har ila yau shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin kirkirar hanyoyin magance yaduwar cutar coronavirus.
Mutane na iya fuskantar damuwa daga keɓewa, ƙuntatawa na tafiya, sakamako masu illa na magani ko tsoron kamuwa da cutar kanta.
"BBC ta nakalto Rory O'Connor yana cewa, ""Ƙara yawan zaman kaɗaici, kadaici, damuwa da lafiyar jiki, damuwa da kuma koma bayan tattalin arziki sune hadari mai kyau don cutar da lafiyar mutane da lafiyarsu. """
Cutar na iya zama mai sauƙi tare da alamun kaɗan ko babu alamomi, kamar sauran cututtukan numfashi na sama kamar sanyi.
Masu cutar mai sauƙi yawanci suna murmurewa cikin makonni biyu, yayin da waɗanda ke da mummunan cuta ko cututtuka masu tsanani na iya ɗaukar makonni uku zuwa shida don murmurewa.
Mata masu ciki na iya zama cikin haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanai daga wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma bayanai don COVID-19 sun ɓace. A cikin wasu mutane, COVID-19 na iya shafar huhu wanda ke haifar da ciwon huhu.
A cikin waɗanda suka fi fama da cutar, COVID-19 na iya ci gaba cikin sauri zuwa ciwon ciwon numfashi mai tsanani (ARDS) wanda ke haifar da gazawar numfashi, harin ƙonewa ko gazawar gabobin da yawa.
Matsaloli da ke tattare da COVID-19 sun haɗa da sepsis, ƙwanƙwasawa da lalacewar zuciya, koda da hanta.
An bayyana rashin daidaito na clotting, musamman ƙaruwar lokacin prothrombin, a cikin 6% na waɗanda aka kwantar a asibiti tare da COVID-19, yayin da ake ganin aikin koda mara kyau a cikin 4% na wannan rukunin.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 suna nuna ƙwayoyin enzyme na hanta (transaminases) da suka ƙaru.
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki goma, tare da biyar da aka kwashe a asibiti.
Koyaya, marasa lafiya da aka sauya zuwa ICU suna da matsakaicin lokaci na kwanaki bakwai tsakanin asibiti da mutuwa.
A cikin binciken da aka yi kan marasa lafiya na farko, matsakaicin lokacin da suka fara nuna alamun farko zuwa mutuwa ya kasance kwanaki 14, tare da cikakken kewayon kwanaki shida zuwa 41.
A wani binciken da Hukumar Lafiya ta Kasa (NHC) ta kasar Sin ta yi, maza suna da yawan mace-mace da kashi 2.8% yayin da mata ke da yawan mace-mace da kashi 1.7%.
Binciken ilimin lissafi na ƙwayar cuta na ƙwayar cuta ya nuna lalacewar alveolar tare da ƙwayoyin fibromyxoid a cikin huhu biyu.
An lura da canje-canjen cytopathic na kwayar cuta a cikin ƙwayoyin cuta.
Hoton huhu ya yi kama da ciwon ciwon numfashi mai tsanani (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Kiwon Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya ta hanyar karuwar matakan troponin ko dakatarwar zuciya.
Dangane da bayanan watan Maris daga Amurka, kashi 89% na waɗanda aka kwantar a asibiti suna da yanayin da ya gabata. Samun albarkatun likita da tattalin arzikin zamantakewar yanki na iya shafar mutuwar.
Ƙididdigar mutuwar daga yanayin ya bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda matsalolin hanyoyin.
Rashin ƙididdigar ƙananan lokuta na iya haifar da ƙimar mutuwar da aka ƙaddara.
Koyaya, gaskiyar cewa mutuwar sakamakon cututtukan da aka kamu da su a baya na iya nufin cewa an rage yawan mutuwar yanzu.
Masu shan sigari sun fi sau 1.4 samun mummunan alamun COVID-19 kuma kusan sau 2.4 suna buƙatar kulawa mai tsanani ko mutuwa idan aka kwatanta da waɗanda ba masu shan sigari ba. An nuna damuwa game da sakamakon cutar na dogon lokaci.
Hukumar Asibitocin Hong Kong ta gano raguwar kashi 20% zuwa 30% a cikin ƙarfin huhu a cikin wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar gabobin.
Wannan kuma zai iya haifar da ciwon bayan kulawa mai tsanani bayan warkewa.
Ya zuwa watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata tana ba da kariya mai tasiri da na dogon lokaci ga mutanen da suka warke daga cutar ba.
Ana ganin rigakafi mai yiwuwa ne, bisa halin wasu coronaviruses, amma an ba da rahoton shari'o'in da suka warke daga COVID-19 bayan gwaje-gwaje masu kyau don coronavirus a wani lokaci na gaba.
Ana ganin waɗannan lokuta suna daɗa muni ne na kamuwa da cuta mai ɗorewa maimakon sake kamuwa da cuta.
Ana tunanin kwayar cutar ta halitta ce kuma ta samo asali ne daga dabbobi, ta hanyar kamuwa da cuta.
Ba a san ainihin asalin ba, amma a watan Disamba na 2019 yaduwar kamuwa da cuta kusan gaba ɗaya ta hanyar watsawa daga mutum zuwa mutum.
Wani bincike na farko 41 na tabbatar da COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya bayyana farkon ranar bayyanar cututtuka a ranar 1 ga Disamba 2019.
Littattafan hukuma daga WHO sun ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba 2019.
Ana amfani da ma'auni da yawa don ƙididdige mutuwar.
Waɗannan lambobin sun bambanta ta yanki da lokaci kuma suna shafar yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar da halayen jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin gaggawa na ICD-10 cututtukan U07.1 don mutuwar daga kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje da U07.2 don mutuwar daga cutar COVID-19 da aka gano a asibiti ko kuma cutar ba tare da kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje ba. Matsakaicin mutuwar-zuwa-halaye yana nuna yawan mutuwar da aka raba ta yawan adadin cututtukan da aka gano a cikin wani lokaci.
Dangane da ƙididdigar Jami'ar Johns Hopkins, adadin mutuwar duniya zuwa shari'ar ya kai 6.9% (153,822/2,240,191) har zuwa 17 ga Afrilu 2020.
Adadin ya bambanta ta yanki. Sauran matakan sun haɗa da ƙimar mutuwar shari'ar (CFR), wanda ke nuna kashi na mutanen da aka gano waɗanda suka mutu daga cuta, da ƙimar mutuwar kamuwa da cuta (IFR), wanda ke nuna kashi na mutanen da ke da cutar (wanda aka gano da wanda ba a gano ba) waɗanda suka mutu daga cuta.
Wadannan ƙididdigar ba su da iyakance lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewar shari'ar.
Ko da yake ba dukan mutanen da suka kamu da cutar ba ne suke samun ƙwayoyin cuta ba, amma idan akwai ƙwayoyin cuta, za su iya nuna yawan mutanen da suka kamu da cutar.
A cibiyar barkewar cutar a Italiya, Castiglione d'Adda, wani ƙaramin ƙauye mai mazaunan 4600, 80 (1.7%) sun riga sun mutu.
A Gangelt, cutar ta bazu ta hanyar bukukuwan Carnival, kuma ta bazu ga matasa, wanda ke haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 za a iya rarraba su a hukumance ba.
Ƙari ga haka, tsarin kiwon lafiya na Jamus bai cika da wahala ba.
A Netherlands, kusan kashi 3% na iya samun ƙwayoyin cuta, kamar yadda aka kimanta daga masu ba da jini.
An tabbatar da cewa mutane 69 (0.004% na yawan jama'a) sun mutu daga COVID-19.
Tasirin annobar da kuma yawan mace-macenta sun bambanta ga maza da mata.
Mutuwar ta fi yawa a cikin maza a cikin binciken da aka gudanar a China da Italiya.
Matsayin da ya fi girma ga maza shi ne a cikin shekarunsu na 50, inda rata tsakanin maza da mata ke rufewa kawai a 90.
A ƙasar Sin, yawan mutanen da suka mutu ya kai kashi 2.8 cikin ɗari na maza da kuma kashi 1.7 cikin ɗari na mata.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma abubuwan da suka shafi kwayoyin halitta da kuma halayyar mutane za su iya zama dalili.
Bambance-bambance na rigakafi na jinsi, ƙarancin shan sigari a cikin mata da maza waɗanda ke haɓaka yanayin rashin lafiya kamar hawan jini a ƙaramin shekaru fiye da mata na iya ba da gudummawa ga mafi girman mutuwar maza.
A Turai, 57% na mutanen da suka kamu da cutar maza ne kuma 72% na waɗanda suka mutu da COVID-19 maza ne.
Ya zuwa watan Afrilun 2020, gwamnatin Amurka ba ta bin diddigin bayanan da suka shafi jima'i na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan cututtuka kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Mafi yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna da damar kamuwa da cutar.
"Kungiyar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairun 2020 cewa sunan hukuma na cutar zai zama ""COVID-19""".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana nufin corona, VI don kwayar cuta, D don cuta, da kuma 19 don lokacin da aka fara gano barkewar cutar: 31 Disamba 2019.
An zaɓi sunan ne don kauce wa nassoshi ga takamaiman wurin wuri (misali China), nau'in dabbobi ko ƙungiyar mutane, daidai da shawarwarin ƙasashen duniya don sanya suna da nufin hana ƙazantawa. Ana kiran kwayar cutar da ke haifar da COVID-19 mai tsanani mai saurin numfashi coronavirus 2 (SARS-CoV-2).
"WHO tana amfani da ""kwayar cutar COVID-19"" da ""kwayar cutar da ke da alhakin COVID-19"" a cikin sadarwa ta jama'a".
"Dukkanin cutar da kwayar cutar ana kiransu da ""coronavirus""".
"A lokacin barkewar cutar a Wuhan, China, kwayar cutar da cutar galibi ana kiranta da ""coronavirus"" da ""Wuhan coronavirus"""."
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV cututtukan numfashi mai tsanani a matsayin sunayen wucin gadi don kwayar cutar da cutar daidai da jagorar 2015 game da amfani da wurare a cikin cututtuka da sunayen ƙwayoyin cuta.
An ba da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu 2020.
Saboda iyakancewar iya aiki a cikin daidaitattun sarƙoƙin samarwa, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar swabs na hanci da sassan injin numfashi.
A wani misali, lokacin da asibiti na Italiya ke buƙatar bawul ɗin iska mai numfashi, kuma mai ba da kaya ba zai iya isar da shi a cikin lokacin da ake buƙata ba, farawa na gida ya sake tsarawa kuma ya buga bawul ɗin 100 da ake buƙata cikin dare.
Bayan barkewar cutar COVID-19, ra'ayoyin maƙarƙashiya, rashin fahimta da rashin fahimta sun fito game da asalin, sikelin, rigakafi, magani da sauran fannoni na cutar kuma sun bazu cikin sauri akan layi.
Mutane suna iya yada kwayar cutar ga wasu dabbobi.
Binciken bai sami wata hujja ta kwayar cutar ba a aladu, ducks, da kaji.
Babu magani ko allurar rigakafi da aka amince da ita don magance cutar.
Ana gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna a COVID-19 ta kungiyoyin gwamnati, kungiyoyin ilimi da masu binciken masana'antu.
"A watan Maris, Hukumar Lafiya ta Duniya ta fara "Gwajin JINGIDAR" don tantance tasirin maganin maganin antiviral guda huɗu da ke akwai tare da mafi yawan alkawuran tasiri".
Babu riga-kafi, amma hukumomi daban-daban suna aiki sosai wajen samar da alluran rigakafi.
Ana amfani da aikin da aka yi a baya akan SARS-CoV saboda SARS-CoV da SARS-CoV-2 duka suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun allurar rigakafi guda uku da ake bincike.
Da farko, masu bincike suna da burin gina cikakken allurar rigakafin cutar.
Amfani da irin wannan kwayar cutar, ko ba ta aiki ko ta mutu, yana da nufin haifar da saurin rigakafin jikin mutum ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, alluran rigakafin subunit, tana da nufin ƙirƙirar allurar rigakafin da ke sa tsarin garkuwar jiki ya zama mai hankali ga wasu ƙananan ƙwayoyin cutar.
A game da SARS-CoV-2, irin wannan binciken yana mai da hankali ne akan furotin S-spike wanda ke taimaka wa kwayar cutar ta kutsa cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce ta allurar rigakafin nucleic acid (alluran rigakafin DNA ko RNA, sabuwar dabara don ƙirƙirar allurar rigakafi).
Dole ne a gwada alluran rigakafin gwaji daga kowane ɗayan waɗannan dabarun don aminci da inganci.A ranar 16 ga Maris, 2020, gwajin asibiti na farko na allurar rigakafi ya fara tare da masu sa kai huɗu a Seattle.
Allurar rigakafin ta ƙunshi lambar kwayoyin cuta mara lahani da aka kwafe daga kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka ƙwayoyin cuta masu dogaro da ƙwayoyin cuta a matsayin ƙalubalen da zai iya faruwa don haɓaka allurar rigakafi don SARS-COV-2, amma wannan yana da rikici.
Akwai gwaji na asibiti sama da 300 da ke gudana a watan Afrilu 2020.
Gwaje-gwaje bakwai suna kimanta magungunan da aka riga aka amince da su don zazzabin cizon sauro, gami da bincike huɗu akan hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar da aka sake amfani da su sun fi yawa a binciken kasar Sin, tare da gwaji tara na mataki na III kan remdesivir a cikin kasashe da dama da za a bayar da rahoto a ƙarshen Afrilu.
An gudanar da nazarin ci gaban asibiti don allurar rigakafi da magungunan rigakafi na COVID-19, kamar yadda na Afrilu 2020. Ana kimanta magungunan rigakafin cutar da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir / ritonavir da lopinavir / ritonavir haɗe tare da interferon beta.
Akwai shaidar farko game da ingancin remdesivir, kamar na Maris 2020.
An lura da ci gaba a cikin marasa lafiya da aka yi wa remdesivir mai tausayi.
Ana gudanar da gwajin asibiti na Mataki na III a Amurka, China da Italiya. An yi nazarin Chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, a China a watan Fabrairun 2020, tare da sakamakon farko.
Koyaya, akwai kira don nazarin takwarorinsu game da binciken.
Hukumomin kiwon lafiya na Koriya da na China sun ba da shawarar amfani da chloroquine.
Koyaya, Cibiyar Wuhan ta Virology, yayin da take ba da shawarar kashi na gram ɗaya a kowace rana, ta lura cewa sau biyu wannan kashi yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa don hydroxychloroquine da chloroquine bisa ga shawarar likitocin da ke kula da mutanen da ke da COVID-19. Jagororin fitowar 7 na kasar Sin sun haɗa da interferon, ribavirin ko umifenovir don amfani da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar manyan allurai na ribavirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar Nitazoxanide don ƙarin binciken in vivo bayan nuna ƙarancin ƙarancin SARS-CoV-2. Nazarin ya nuna cewa farkon furotin na farko ta hanyar transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana ƙungiyar likitoci karɓar waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 a cikin vitro kuma ba shi da sanannen rawa a cikin maganin COVID-19.
Cytokine hadari na iya zama matsala a cikin matakai na ƙarshe na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin anti-cytokine storm. Hukumar Lafiya ta Kasa ta kasar Sin ta hada da Tocilizumab a cikin jagororin magani bayan an kammala karamin bincike.
Ana yin gwajin gwaji na 2 a matakin ƙasa a Italiya bayan nuna sakamako mai kyau a cikin mutane masu fama da mummunan cuta.
A hade tare da gwajin jini na ferritin na jini don gano guguwar cytokine, ana nufin magance irin wannan ci gaban, wanda ake tsammanin shine dalilin mutuwa a wasu mutanen da ke fama da cutar.
An amince da mai karɓar mai karɓar interleukin-6 ta FDA bisa ga nazarin shari'ar baya don maganin cutar ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta hanyar wani dalili daban, maganin ƙwayar CAR T, a cikin 2017.
Har zuwa yau, babu wata shaida ta bazuwar, da aka sarrafa cewa tocilizumab magani ne mai tasiri don CRS.
Canja wurin tsarkakewa da kuma mayar da hankali akan kwayoyin cuta da tsarin garkuwar jiki na waɗanda suka warke daga COVID-19 zuwa ga mutanen da suke buƙatar su ana bincika su azaman hanyar rigakafin rigakafin rigakafi.
An gwada wannan dabarar don SARS ba tare da sakamako mai gamsarwa ba.
Rashin tasirin kwayar cuta shine tsarin aikin da ake tsammani wanda maganin rigakafin jiki na iya zama matsakaici na kariya daga SARS-CoV-2.
Duk da haka, wasu hanyoyin, kamar su kwayar halitta mai dogara da kwayar halitta da / ko phagocytosis, na iya yiwuwa.
Sauran nau'ikan maganin maganin rigakafi, alal misali, ta amfani da rigakafin rigakafin monoclonal, ana haɓaka su.
Samun maganin warkewa, wanda ya ƙunshi ɓangaren ruwa na jinin daga marasa lafiya da suka warke kuma ya ƙunshi ƙwayoyin cuta na musamman ga wannan kwayar cutar, za a iya ƙarawa don saurin turawa.
Cutar coronavirus, ƙungiyar cututtukan da ke da alaƙa da juna
Li Wenliang, likita a babban asibitin Wuhan, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya wayar da kan mutane game da yaduwar cutar.
